data_1agt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1agt _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo . . . . . 0 CA--C 1.557 1.649 0 N-CA-C 113.446 0.518 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.9 pt -106.49 142.28 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -82.47 89.69 6.66 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.806 0.812 . . . . 0.0 110.785 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.4 t -142.84 118.14 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -176.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.8 p -78.52 117.78 20.03 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 80.9 m -101.65 155.58 18.02 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -174.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -104.33 -41.0 5.9 Favored 'General case' 0 CA--C 1.582 2.197 0 CA-C-N 113.145 -1.843 . . . . 0.0 107.976 167.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.17 -166.56 12.14 Favored Glycine 0 CA--C 1.554 2.478 0 C-N-CA 124.396 0.998 . . . . 0.0 111.707 169.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.9 m -67.76 -41.94 31.94 Favored Pre-proline 0 CA--C 1.573 1.861 0 CA-C-O 115.208 -2.329 . . . . 0.0 115.897 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.61 -22.44 28.43 Favored 'Trans proline' 0 CA--C 1.564 1.989 0 N-CA-C 120.248 3.134 . . . . 0.0 120.248 174.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -58.05 -42.05 84.61 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 59.7 m -76.81 -10.26 59.25 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mm -58.83 -55.23 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 120.915 1.689 . . . . 0.0 112.924 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -68.43 -51.27 24.35 Favored Pre-proline 0 CA--C 1.572 1.798 0 CA-C-O 114.951 -2.452 . . . . 0.0 113.079 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -49.18 -43.08 38.21 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 CA-C-N 125.581 3.029 . . . . 0.0 118.326 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.8 m -60.89 -52.27 65.74 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.49 -48.95 77.85 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -62.15 -37.21 84.34 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.28 -52.9 51.24 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.36 53.22 0.02 OUTLIER Glycine 0 CA--C 1.545 1.942 0 C-N-CA 124.015 0.817 . . . . 0.0 113.095 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -142.18 166.59 24.28 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.66 1.219 . . . . 0.0 110.167 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -81.67 -63.03 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.119 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -119.49 165.34 14.51 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 122.355 1.074 . . . . 0.0 110.388 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.91 94.29 0.25 Allowed Glycine 0 N--CA 1.477 1.385 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.66 119.12 38.29 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.3 t -99.98 127.54 46.18 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.328 0.585 . . . . 0.0 112.426 -175.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 92.4 mmm -83.2 -173.42 4.7 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.78 169.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -62.32 101.14 0.21 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.784 -1.197 . . . . 0.0 112.063 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 65.96 6.32 3.98 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -141.48 127.11 19.01 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 122.686 2.493 . . . . 0.0 110.643 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.2 m -69.35 142.65 53.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -133.96 109.22 8.87 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.0 m -84.0 154.39 23.32 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.7 m . . . . . 0 CA--C 1.569 1.709 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.948 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 CA--C 1.558 1.675 0 N-CA-C 114.537 0.937 . . . . 0.0 114.537 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.2 pt -113.47 143.37 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -80.17 84.14 5.92 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.95 0.881 . . . . 0.0 111.878 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.3 t -144.51 115.34 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.4 p -80.45 120.45 24.48 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.862 0.465 . . . . 0.0 111.206 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.59 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 59.7 m -91.41 155.5 18.42 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -171.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -135.98 70.58 1.42 Allowed 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 168.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.71 155.95 28.36 Favored Glycine 0 CA--C 1.553 2.423 0 CA-C-O 121.742 0.634 . . . . 0.0 113.232 -169.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 m -63.35 -39.62 51.53 Favored Pre-proline 0 CA--C 1.573 1.856 0 CA-C-O 115.213 -2.327 . . . . 0.0 116.095 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.26 -25.25 23.17 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 CA-C-N 125.336 2.941 . . . . 0.0 119.734 171.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -59.13 -40.66 86.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.59 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 65.8 m -73.67 -14.86 61.23 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.0 mm -57.07 -56.57 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-N 120.727 1.603 . . . . 0.0 113.069 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -66.29 -51.42 43.93 Favored Pre-proline 0 CA--C 1.572 1.816 0 CA-C-O 114.696 -2.573 . . . . 0.0 113.447 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -46.75 -46.0 19.02 Favored 'Trans proline' 0 CA--C 1.564 1.992 0 CA-C-N 125.78 3.1 . . . . 0.0 118.071 171.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -59.8 -49.24 78.49 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -61.88 -49.91 74.32 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.7 -31.12 72.21 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.86 -56.02 14.02 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.082 1.31 . . . . 0.0 113.637 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.31 51.77 0.01 OUTLIER Glycine 0 CA--C 1.545 1.949 0 C-N-CA 123.707 0.67 . . . . 0.0 113.516 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -142.83 168.73 19.03 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 122.534 1.159 . . . . 0.0 110.181 -174.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -82.28 -64.02 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.534 -0.729 . . . . 0.0 111.747 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -116.45 163.57 15.85 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.245 1.021 . . . . 0.0 110.348 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -132.45 95.58 0.3 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -108.98 122.93 48.28 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.8 t -102.06 132.36 47.96 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -171.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.97 -164.04 1.08 Allowed 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -63.29 99.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.415 -1.428 . . . . 0.0 112.227 -171.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 58.83 15.24 3.71 Favored 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -139.6 122.61 16.74 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.524 1.965 . . . . 0.0 110.595 -170.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 66.2 m -71.05 135.88 48.0 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -132.61 112.71 12.28 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.7 m -86.35 151.51 23.51 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.0 m . . . . . 0 CA--C 1.569 1.699 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 175.745 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.558 1.687 0 N-CA-C 114.743 1.017 . . . . 0.0 114.743 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.3 pt -118.45 142.35 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 169.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -81.07 88.99 5.94 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.671 0.748 . . . . 0.0 111.276 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.6 t -143.62 119.8 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.8 p -75.91 119.69 20.23 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.992 0.517 . . . . 0.0 112.306 -176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 70.2 m -97.24 154.81 17.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -174.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 t -135.29 70.03 1.44 Allowed 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.52 157.45 25.76 Favored Glycine 0 CA--C 1.551 2.331 0 CA-C-O 121.877 0.709 . . . . 0.0 113.579 -169.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.4 m -65.48 -41.13 47.89 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 115.328 -2.272 . . . . 0.0 115.899 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.6 -21.73 20.07 Favored 'Trans proline' 0 CA--C 1.566 2.124 0 N-CA-C 119.88 2.992 . . . . 0.0 119.88 171.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -60.63 -37.58 81.94 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 66.3 m -74.83 -8.79 57.49 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.67 -54.75 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 120.983 1.72 . . . . 0.0 112.847 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.33 -51.16 54.83 Favored Pre-proline 0 CA--C 1.574 1.867 0 CA-C-O 114.758 -2.544 . . . . 0.0 112.713 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.59 -41.0 30.58 Favored 'Trans proline' 0 CA--C 1.565 2.031 0 CA-C-N 125.856 3.127 . . . . 0.0 118.636 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.0 m -62.36 -54.81 34.99 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -59.81 -46.7 88.41 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.21 -41.44 79.44 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.47 -49.75 67.92 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.8 55.49 0.07 OUTLIER Glycine 0 CA--C 1.545 1.925 0 C-N-CA 124.413 1.006 . . . . 0.0 112.228 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.9 mtt -147.24 162.53 38.71 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.434 1.111 . . . . 0.0 109.364 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -79.48 -71.24 0.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 112.582 -170.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -110.96 166.0 11.4 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.972 0.891 . . . . 0.0 110.474 -170.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.68 90.55 0.24 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -107.43 118.56 37.04 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.508 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.4 t -97.97 131.76 44.13 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -175.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 79.9 mtp -87.2 -167.28 1.83 Allowed 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 169.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -62.11 99.83 0.14 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.572 -1.33 . . . . 0.0 112.713 -170.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 58.63 13.5 2.63 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -172.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -143.45 124.69 14.58 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 121.85 2.114 . . . . 0.0 109.874 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.7 m -66.19 141.74 57.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -126.69 105.34 8.63 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.7 m -88.54 136.54 32.94 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.465 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.0 m . . . . . 0 CA--C 1.568 1.667 0 CA-C-O 117.176 -1.392 . . . . 0.0 107.767 178.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 CA--C 1.558 1.704 0 N-CA-C 113.378 0.492 . . . . 0.0 113.378 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.9 pt -98.54 146.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -80.16 84.82 5.79 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.864 0.84 . . . . 0.0 111.683 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.8 t -145.83 115.31 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.1 p -81.34 120.41 24.92 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.793 0.437 . . . . 0.0 111.293 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 71.6 m -95.34 153.77 17.52 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -172.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -130.05 50.03 2.22 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.562 168.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.69 162.85 11.66 Favored Glycine 0 CA--C 1.553 2.43 0 C-N-CA 124.212 0.911 . . . . 0.0 112.342 -169.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.0 m -66.47 -41.39 40.39 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 115.167 -2.349 . . . . 0.0 116.288 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -53.66 -24.25 29.05 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 N-CA-C 120.134 3.09 . . . . 0.0 120.134 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -58.7 -39.51 80.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 175.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 60.7 m -76.0 -11.8 60.02 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.8 mm -59.43 -57.93 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 120.723 1.601 . . . . 0.0 112.982 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -68.15 -45.59 40.12 Favored Pre-proline 0 CA--C 1.571 1.76 0 CA-C-O 114.931 -2.461 . . . . 0.0 114.249 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.02 -42.46 64.41 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.757 3.092 . . . . 0.0 117.697 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 99.0 m -59.73 -52.35 65.86 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -56.72 -48.64 77.28 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 174.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.12 -40.05 84.22 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.82 -50.62 68.2 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 171.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.85 57.12 0.05 OUTLIER Glycine 0 CA--C 1.545 1.923 0 C-N-CA 124.481 1.039 . . . . 0.0 111.713 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.6 mmt -144.36 158.85 43.53 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.441 1.115 . . . . 0.0 109.112 -172.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -80.3 -74.84 0.29 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.841 0.856 . . . . 0.0 111.487 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -98.75 161.85 13.43 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.264 1.031 . . . . 0.0 111.071 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.83 93.42 0.3 Allowed Glycine 0 N--CA 1.478 1.434 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -111.36 120.19 41.38 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.488 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 4.5 t -99.02 129.85 45.33 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -171.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 86.2 mtp -84.9 -167.95 2.02 Favored 'General case' 0 CA--C 1.575 1.926 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.792 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.83 100.14 0.28 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.58 -1.325 . . . . 0.0 112.086 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 59.25 15.61 4.37 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -172.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -142.21 122.51 13.92 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.365 1.893 . . . . 0.0 110.024 -170.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.3 m -70.6 134.91 48.03 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -129.19 109.52 11.22 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.4 m -83.67 150.52 25.82 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.2 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.684 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo . . . . . 0 CA--C 1.558 1.719 0 N-CA-C 116.678 1.761 . . . . 0.0 116.678 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.6 pt -129.18 143.53 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 169.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.69 87.62 6.74 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.812 0.815 . . . . 0.0 111.546 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.9 t -144.5 119.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.8 p -79.9 121.89 25.99 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.972 0.509 . . . . 0.0 112.157 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 83.0 m -104.52 156.63 17.78 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -174.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 t -103.98 -42.37 5.59 Favored 'General case' 0 CA--C 1.582 2.197 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.484 167.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.7 -164.53 10.85 Favored Glycine 0 CA--C 1.554 2.485 0 C-N-CA 124.476 1.036 . . . . 0.0 111.411 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.3 m -67.6 -41.2 29.42 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-O 115.238 -2.315 . . . . 0.0 115.822 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.48 -22.89 29.25 Favored 'Trans proline' 0 CA--C 1.564 2.0 0 N-CA-C 120.433 3.205 . . . . 0.0 120.433 175.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -58.62 -41.76 86.65 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 40.9 m -75.84 -10.34 59.34 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.44 -55.26 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.824 1.647 . . . . 0.0 112.831 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.73 -51.57 48.34 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 114.607 -2.616 . . . . 0.0 112.568 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.47 -41.36 36.47 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 CA-C-N 125.962 3.165 . . . . 0.0 118.717 170.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 76.9 m -63.12 -54.48 37.14 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -60.98 -46.16 91.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.87 -41.5 78.11 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.59 -49.35 71.48 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 170.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.13 56.08 0.08 OUTLIER Glycine 0 CA--C 1.543 1.826 0 C-N-CA 124.566 1.079 . . . . 0.0 112.174 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 51.2 mtt -143.79 164.6 30.04 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.611 1.196 . . . . 0.0 109.754 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -76.52 -64.2 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.82 0.848 . . . . 0.0 113.286 -169.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -125.2 162.44 24.67 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.014 0.911 . . . . 0.0 110.171 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.09 92.67 0.45 Allowed Glycine 0 N--CA 1.477 1.429 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -109.45 116.32 31.59 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.51 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.4 t -101.31 127.5 47.89 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -173.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.9 mtt -84.24 -168.66 2.25 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.028 169.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -63.05 100.56 0.22 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.755 -1.216 . . . . 0.0 112.166 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 60.81 13.04 4.13 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -141.87 123.23 14.85 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.808 2.094 . . . . 0.0 110.324 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.402 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 39.1 m -70.36 141.62 52.23 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -133.0 108.15 8.71 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.6 m -87.73 136.28 33.02 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.331 0.652 . . . . 0.0 111.505 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 CA--C 1.57 1.721 0 CA-C-O 117.082 -1.437 . . . . 0.0 107.456 177.328 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 CA--C 1.557 1.636 0 N-CA-C 113.566 0.564 . . . . 0.0 113.566 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.4 pt -95.24 145.41 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.83 83.98 6.45 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.933 0.873 . . . . 0.0 111.598 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.3 t -145.06 114.95 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 103.876 -2.638 . . . . 0.0 103.876 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.0 p -81.03 120.79 25.25 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.709 0.404 . . . . 0.0 110.924 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 27.3 m -89.64 153.33 20.83 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -170.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -132.26 69.69 1.48 Allowed 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.81 150.9 22.88 Favored Glycine 0 CA--C 1.552 2.348 0 C-N-CA 123.497 0.57 . . . . 0.0 112.813 -169.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 t -61.83 -41.46 77.27 Favored Pre-proline 0 CA--C 1.574 1.891 0 CA-C-O 115.241 -2.314 . . . . 0.0 115.913 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -54.19 -24.15 32.5 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 N-CA-C 119.755 2.944 . . . . 0.0 119.755 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -57.58 -38.18 74.43 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 67.4 m -72.13 -14.24 61.77 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 176.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 71.5 mt -65.1 -51.48 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.88 1.673 . . . . 0.0 112.617 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -64.1 -49.61 73.04 Favored Pre-proline 0 CA--C 1.577 2.013 0 CA-C-O 115.008 -2.425 . . . . 0.0 112.97 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.02 -41.28 65.03 Favored 'Trans proline' 0 CA--C 1.565 2.04 0 CA-C-N 125.493 2.998 . . . . 0.0 118.046 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.8 m -61.41 -51.25 69.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -59.11 -46.77 87.47 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -57.57 -41.15 80.53 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 -51.61 58.64 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 170.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.16 55.25 0.04 OUTLIER Glycine 0 CA--C 1.544 1.848 0 C-N-CA 124.192 0.901 . . . . 0.0 113.114 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -143.09 165.79 26.44 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.817 1.294 . . . . 0.0 110.218 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -83.51 -74.55 0.36 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 124.23 1.012 . . . . 0.0 111.021 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -95.82 159.71 14.84 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.25 1.024 . . . . 0.0 111.077 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.22 94.58 0.33 Allowed Glycine 0 N--CA 1.478 1.496 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -113.94 125.0 53.54 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.426 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 11.7 t -102.27 132.31 48.3 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -169.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -85.26 -161.25 0.57 Allowed 'General case' 0 CA--C 1.578 2.055 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.296 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -63.74 94.16 0.09 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.402 -1.436 . . . . 0.0 111.827 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.1 mtp-105 51.24 30.1 5.53 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -169.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -139.79 117.68 11.73 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 119.706 1.139 . . . . 0.0 109.409 -171.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.9 m -71.89 131.05 42.46 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -126.88 115.27 19.05 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -87.93 146.71 25.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.203 0.601 . . . . 0.0 112.255 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 CA--C 1.566 1.592 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 175.276 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo . . . . . 0 CA--C 1.557 1.671 0 N-CA-C 115.249 1.211 . . . . 0.0 115.249 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.5 pt -122.97 140.05 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -81.77 87.01 6.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.805 0.812 . . . . 0.0 111.293 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.2 t -144.34 118.8 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 87.6 p -78.3 122.54 25.86 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.897 0.479 . . . . 0.0 111.852 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.599 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 62.6 m -96.09 155.04 16.92 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -172.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 t -134.94 69.68 1.45 Allowed 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 168.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 156.48 24.89 Favored Glycine 0 CA--C 1.553 2.436 0 C-N-CA 123.58 0.61 . . . . 0.0 113.717 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 t -64.74 -41.56 57.51 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 115.22 -2.324 . . . . 0.0 115.684 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -53.58 -22.77 23.17 Favored 'Trans proline' 0 CA--C 1.566 2.101 0 N-CA-C 119.846 2.979 . . . . 0.0 119.846 171.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -59.76 -39.03 83.46 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.599 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 63.8 m -75.02 -10.07 59.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.0 mm -59.21 -56.15 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-N 120.838 1.654 . . . . 0.0 112.817 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -67.04 -48.06 50.74 Favored Pre-proline 0 CA--C 1.574 1.887 0 CA-C-O 115.022 -2.418 . . . . 0.0 113.776 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.68 -41.82 59.72 Favored 'Trans proline' 0 CA--C 1.564 2.02 0 CA-C-N 125.668 3.06 . . . . 0.0 118.065 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.2 m -60.86 -50.97 71.28 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -57.4 -46.78 83.1 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 173.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.49 -41.25 89.42 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.39 -50.38 65.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.75 54.44 0.04 OUTLIER Glycine 0 CA--C 1.545 1.923 0 C-N-CA 124.212 0.91 . . . . 0.0 112.768 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -143.63 162.8 34.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.869 1.319 . . . . 0.0 110.029 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -81.78 -72.45 0.43 Allowed 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.19 0.996 . . . . 0.0 111.233 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -101.34 165.35 11.31 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.399 1.095 . . . . 0.0 110.887 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.16 94.04 0.22 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 174.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -107.61 125.23 51.07 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.506 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.4 t -104.32 133.46 49.19 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -172.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 86.0 mtp -87.71 -165.92 1.44 Allowed 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.316 169.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -63.47 99.66 0.22 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.458 -1.401 . . . . 0.0 112.096 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 59.72 16.81 5.79 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -140.85 118.83 11.86 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 121.677 2.035 . . . . 0.0 110.443 -169.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.4 m -69.8 137.91 52.24 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -134.25 108.69 8.39 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.3 m -82.98 153.19 25.12 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 m . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 174.444 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 CA--C 1.558 1.694 0 N-CA-C 113.712 0.62 . . . . 0.0 113.712 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.9 pt -99.2 144.57 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 170.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.45 87.46 5.07 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.86 0.838 . . . . 0.0 111.515 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.6 t -145.55 116.98 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.1 p -80.07 117.79 21.21 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.728 0.411 . . . . 0.0 111.571 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 86.2 m -95.17 155.22 16.82 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -174.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 t -130.54 48.97 2.35 Favored 'General case' 0 CA--C 1.58 2.134 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.381 168.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.57 160.62 10.98 Favored Glycine 0 CA--C 1.555 2.57 0 C-N-CA 124.369 0.985 . . . . 0.0 112.17 -169.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.0 m -64.75 -40.33 47.34 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-O 115.118 -2.372 . . . . 0.0 116.201 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.15 -23.68 23.34 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 N-CA-C 120.191 3.112 . . . . 0.0 120.191 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -61.53 -41.45 97.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 62.7 m -73.43 -12.45 60.81 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 117.954 2.575 . . . . 0.0 117.954 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.2 mm -60.46 -49.84 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 120.884 1.674 . . . . 0.0 113.065 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.64 -53.93 40.48 Favored Pre-proline 0 CA--C 1.572 1.823 0 CA-C-O 115.1 -2.381 . . . . 0.0 112.756 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.59 -43.61 44.48 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 125.351 2.947 . . . . 0.0 118.738 171.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.0 m -63.4 -51.0 67.63 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 173.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -61.46 -45.45 94.21 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -58.37 -40.95 83.66 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.2 -50.43 70.34 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.71 55.79 0.06 OUTLIER Glycine 0 CA--C 1.543 1.798 0 C-N-CA 124.262 0.934 . . . . 0.0 112.293 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 43.3 mtt -143.59 168.47 19.81 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.617 1.199 . . . . 0.0 109.968 -174.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -75.81 -62.76 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -170.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -129.97 160.56 33.26 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.228 1.013 . . . . 0.0 110.076 -170.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.47 93.22 0.59 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -106.3 111.7 24.4 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 6.1 t -97.67 128.13 44.14 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 83.1 mtp -84.19 -165.9 1.28 Allowed 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.158 169.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -63.51 98.41 0.17 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.738 -1.226 . . . . 0.0 112.445 -170.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 54.18 22.01 3.37 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -170.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -143.73 122.8 12.86 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 120.886 1.676 . . . . 0.0 109.718 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 67.1 m -68.98 134.87 50.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -125.12 110.79 14.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.7 m -83.83 140.51 31.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.142 0.577 . . . . 0.0 112.077 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.3 m . . . . . 0 CA--C 1.57 1.739 0 CA-C-O 117.193 -1.384 . . . . 0.0 107.321 178.677 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 CA--C 1.557 1.631 0 N-CA-C 113.304 0.463 . . . . 0.0 113.304 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.1 pt -94.46 145.61 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.02 86.49 6.11 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.852 0.834 . . . . 0.0 111.382 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.8 t -144.44 116.97 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.9 p -81.61 119.53 23.91 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.807 0.443 . . . . 0.0 111.445 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 64.1 m -98.65 156.65 16.71 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -174.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -104.7 -42.98 5.24 Favored 'General case' 0 CA--C 1.582 2.185 0 CA-C-N 113.445 -1.707 . . . . 0.0 107.26 167.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.16 -167.0 11.4 Favored Glycine 0 CA--C 1.555 2.591 0 C-N-CA 124.441 1.019 . . . . 0.0 111.316 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.2 m -67.85 -41.72 30.08 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-O 115.215 -2.326 . . . . 0.0 115.665 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.64 -22.66 29.39 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 N-CA-C 120.368 3.18 . . . . 0.0 120.368 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -58.03 -43.37 86.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 55.5 m -74.71 -9.78 58.89 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.1 mm -58.63 -57.24 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-N 121.548 1.977 . . . . 0.0 112.187 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -57.04 -53.99 59.35 Favored Pre-proline 0 CA--C 1.573 1.836 0 CA-C-O 115.347 -2.263 . . . . 0.0 114.35 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -62.36 -43.51 22.59 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.41 2.968 . . . . 0.0 116.446 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.9 m -60.93 -54.68 42.01 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 173.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.36 -52.37 65.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.87 -30.98 71.67 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.39 -56.33 13.14 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 120.646 1.566 . . . . 0.0 113.735 172.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.27 49.74 0.01 OUTLIER Glycine 0 CA--C 1.544 1.855 0 CA-C-O 119.416 -0.658 . . . . 0.0 114.142 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -139.92 175.75 9.32 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 122.643 1.211 . . . . 0.0 109.91 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -84.22 -61.88 1.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 111.933 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.99 160.51 28.79 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.329 1.061 . . . . 0.0 110.452 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.81 97.61 0.61 Allowed Glycine 0 N--CA 1.478 1.469 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.528 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 118.85 37.31 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 4.6 t -102.99 128.75 49.68 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -170.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -82.13 -168.48 1.97 Allowed 'General case' 0 CA--C 1.575 1.924 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.168 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.6 98.69 0.19 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.84 -1.163 . . . . 0.0 111.965 -173.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 56.83 20.67 5.38 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -171.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -143.41 120.67 11.55 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 121.149 1.795 . . . . 0.0 110.093 -172.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.2 m -70.21 137.79 51.18 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -131.69 116.59 17.51 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -83.29 150.75 25.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.5 m . . . . . 0 CA--C 1.569 1.698 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.961 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 CA--C 1.557 1.634 0 N-CA-C 113.975 0.721 . . . . 0.0 113.975 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 pt -108.1 139.31 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.33 90.28 6.13 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.895 0.855 . . . . 0.0 110.87 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.6 t -141.96 115.61 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.1 p -74.41 116.83 15.53 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 64.5 m -91.15 154.19 19.52 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -135.14 68.78 1.46 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.93 156.33 23.0 Favored Glycine 0 CA--C 1.551 2.322 0 CA-C-O 121.713 0.619 . . . . 0.0 112.921 -169.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -67.95 -42.86 34.77 Favored Pre-proline 0 N--CA 1.495 1.812 0 CA-C-O 115.287 -2.292 . . . . 0.0 115.785 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -54.11 -22.42 25.29 Favored 'Trans proline' 0 CA--C 1.563 1.973 0 N-CA-C 119.704 2.924 . . . . 0.0 119.704 171.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -55.33 -39.07 69.55 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 75.0 m -73.44 -10.78 60.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.68 -51.95 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 120.75 1.614 . . . . 0.0 112.257 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -66.86 -49.53 47.83 Favored Pre-proline 0 CA--C 1.576 1.971 0 CA-C-O 115.034 -2.412 . . . . 0.0 113.505 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.44 -41.7 51.06 Favored 'Trans proline' 0 CA--C 1.565 2.069 0 CA-C-N 125.704 3.073 . . . . 0.0 117.95 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.0 m -60.96 -50.07 74.87 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -55.59 -52.18 64.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -64.69 -33.66 76.48 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.8 -53.73 29.88 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 119.824 1.193 . . . . 0.0 113.95 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.65 53.51 0.02 OUTLIER Glycine 0 CA--C 1.544 1.906 0 C-N-CA 124.012 0.815 . . . . 0.0 113.13 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -145.92 164.01 33.34 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.77 1.272 . . . . 0.0 110.11 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -81.21 -73.43 0.38 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.003 0.921 . . . . 0.0 111.432 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -102.44 167.91 9.65 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.03 0.919 . . . . 0.0 111.128 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.71 100.22 0.23 Allowed Glycine 0 N--CA 1.477 1.392 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 129.31 56.68 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.5 t -95.73 133.09 40.24 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.8 mmt -88.4 -166.37 1.57 Allowed 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.387 169.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -61.91 98.91 0.11 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.407 -1.433 . . . . 0.0 112.837 -170.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 56.44 13.14 1.21 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 -171.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -141.92 130.23 22.33 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 121.266 1.848 . . . . 0.0 109.951 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.3 m -66.75 135.8 54.53 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -123.66 107.78 11.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.2 m -83.96 158.56 21.5 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.772 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.3 m . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 173.134 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 CA--C 1.557 1.648 0 N-CA-C 114.611 0.966 . . . . 0.0 114.611 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.8 pt -114.59 150.46 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.68 87.04 6.32 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.817 0.818 . . . . 0.0 111.38 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.7 115.72 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.2 p -78.91 118.13 20.65 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.836 0.455 . . . . 0.0 111.576 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 77.9 m -95.05 155.56 16.68 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -171.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -135.79 70.11 1.43 Allowed 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 168.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.0 157.98 25.31 Favored Glycine 0 CA--C 1.551 2.316 0 CA-C-O 121.917 0.732 . . . . 0.0 113.564 -169.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -64.19 -41.65 62.63 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 115.3 -2.286 . . . . 0.0 115.962 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.74 -22.89 24.52 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.946 3.018 . . . . 0.0 119.946 172.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -60.98 -36.67 80.05 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.9 m -71.3 -19.8 62.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.3 mm -57.73 -56.61 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 120.802 1.637 . . . . 0.0 113.575 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -68.13 -51.45 26.52 Favored Pre-proline 0 CA--C 1.575 1.941 0 CA-C-O 114.99 -2.433 . . . . 0.0 113.39 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.82 -45.55 24.01 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 125.649 3.053 . . . . 0.0 118.049 170.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.4 m -67.62 -45.25 75.94 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -59.17 -47.91 83.56 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 173.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -61.18 -37.42 82.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 172.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.89 -52.92 57.7 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.4 59.48 0.03 OUTLIER Glycine 0 CA--C 1.543 1.833 0 C-N-CA 124.275 0.941 . . . . 0.0 111.851 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 20.4 mmt -140.91 164.18 30.96 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.77 1.272 . . . . 0.0 109.892 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -93.37 -72.15 0.62 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.4 1.08 . . . . 0.0 110.114 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -99.25 164.75 12.01 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.993 0.901 . . . . 0.0 110.846 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.414 ' HA2' ' SG ' ' A' ' 35' ' ' CYS . . . -142.52 88.86 0.18 Allowed Glycine 0 N--CA 1.481 1.667 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.082 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -107.28 116.74 32.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.489 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.0 t -97.67 130.94 44.63 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.556 0.693 . . . . 0.0 112.863 -173.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -87.55 -164.74 1.14 Allowed 'General case' 0 CA--C 1.575 1.937 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.771 169.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -63.42 99.12 0.19 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.764 -1.21 . . . . 0.0 112.398 -170.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 55.6 19.31 3.21 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -171.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -144.85 121.43 11.09 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 121.574 1.988 . . . . 0.0 110.144 -172.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.7 m -67.34 136.28 54.57 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -127.14 100.67 6.19 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 170.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.414 ' SG ' ' HA2' ' A' ' 26' ' ' GLY . 69.1 m -107.62 128.78 54.84 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.453 -172.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.8 m . . . . . 0 CA--C 1.566 1.558 0 CA-C-O 117.102 -1.428 . . . . 0.0 108.272 -175.882 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 CA--C 1.559 1.736 0 CA-C-O 121.123 0.385 . . . . 0.0 113.01 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.2 pt -100.06 144.0 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -78.91 88.24 4.72 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.948 0.88 . . . . 0.0 111.258 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.6 t -145.16 114.44 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -76.97 114.62 15.96 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.066 0.46 . . . . 0.0 111.726 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.8 m -88.54 154.85 20.01 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -137.23 71.15 1.4 Allowed 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.0 159.09 29.38 Favored Glycine 0 CA--C 1.552 2.362 0 CA-C-O 121.845 0.692 . . . . 0.0 113.402 -169.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.2 m -65.63 -40.19 38.76 Favored Pre-proline 0 CA--C 1.572 1.822 0 CA-C-O 115.191 -2.337 . . . . 0.0 115.979 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.21 -23.22 22.23 Favored 'Trans proline' 0 CA--C 1.566 2.079 0 CA-C-N 125.399 2.964 . . . . 0.0 119.764 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -58.76 -38.7 79.05 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 172.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 82.4 m -73.96 -10.05 59.26 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 117.928 2.566 . . . . 0.0 117.928 177.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.76 -55.86 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 120.852 1.66 . . . . 0.0 112.606 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -64.22 -49.75 71.5 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 114.896 -2.478 . . . . 0.0 113.399 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.19 -43.3 43.65 Favored 'Trans proline' 0 CA--C 1.564 2.023 0 CA-C-N 125.714 3.076 . . . . 0.0 118.378 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.9 m -62.95 -51.63 66.15 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -59.15 -46.92 87.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -57.41 -40.85 79.17 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.71 -48.95 72.77 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.22 59.04 0.08 OUTLIER Glycine 0 CA--C 1.543 1.813 0 C-N-CA 124.478 1.037 . . . . 0.0 111.607 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.7 mmt -140.47 166.04 25.8 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.544 1.164 . . . . 0.0 109.609 -171.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -80.12 -56.66 4.08 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.914 0.886 . . . . 0.0 113.21 -176.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -131.93 164.38 26.27 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.997 0.903 . . . . 0.0 110.223 -172.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.42 95.25 0.39 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -115.66 116.39 28.03 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.4 t -93.8 129.58 40.13 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -170.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 93.5 mmm -84.44 -172.1 3.98 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.737 169.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -61.0 101.18 0.14 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.641 -1.287 . . . . 0.0 112.573 -171.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? 64.74 5.25 2.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -175.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -145.96 132.83 20.12 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 122.141 2.246 . . . . 0.0 111.013 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.4 m -66.64 138.5 57.48 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -124.39 110.39 14.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 171.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.3 m -87.28 139.8 30.19 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.863 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 173.221 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 CA--C 1.557 1.644 0 N-CA-C 113.126 0.395 . . . . 0.0 113.126 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.4 pt -97.36 140.88 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 169.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -80.25 88.34 5.51 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.798 0.808 . . . . 0.0 111.195 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.2 t -144.86 119.65 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.3 p -78.14 119.51 21.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.824 0.449 . . . . 0.0 111.655 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 60.7 m -92.59 153.87 18.76 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -173.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -132.99 69.07 1.49 Allowed 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 168.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.44 156.53 23.57 Favored Glycine 0 CA--C 1.552 2.347 0 CA-C-O 121.945 0.747 . . . . 0.0 113.441 -169.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.7 p -63.14 -40.67 63.51 Favored Pre-proline 0 CA--C 1.572 1.791 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -68.92 -14.84 39.51 Favored 'Trans proline' 0 CA--C 1.564 2.018 0 CA-C-N 126.428 3.331 . . . . 0.0 118.384 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -55.37 -37.9 68.14 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 171.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 81.8 m -72.86 -14.26 61.46 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.24 -50.58 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 121.096 1.771 . . . . 0.0 112.684 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.6 -51.82 63.54 Favored Pre-proline 0 CA--C 1.576 1.95 0 CA-C-O 115.258 -2.306 . . . . 0.0 113.08 174.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.54 -43.34 39.44 Favored 'Trans proline' 0 CA--C 1.563 1.965 0 C-N-CA 123.841 3.028 . . . . 0.0 118.072 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.1 m -60.46 -46.07 91.4 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 170.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.66 -52.51 65.21 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -64.45 -30.46 71.5 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.56 -55.26 14.14 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.984 1.266 . . . . 0.0 113.663 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 148.75 51.66 0.02 OUTLIER Glycine 0 N--CA 1.485 1.96 0 C-N-CA 123.847 0.737 . . . . 0.0 113.534 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -147.29 165.49 29.95 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 122.334 1.064 . . . . 0.0 109.75 -174.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -80.29 -67.78 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.527 -0.733 . . . . 0.0 112.373 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -110.7 165.21 12.01 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.024 0.916 . . . . 0.0 110.862 -169.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.61 97.77 0.28 Allowed Glycine 0 N--CA 1.477 1.407 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -108.88 123.59 49.31 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.7 t -101.43 132.75 46.86 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -170.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 92.6 mmm -84.92 -166.08 1.38 Allowed 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.786 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -63.86 98.17 0.19 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.452 -1.405 . . . . 0.0 112.228 -171.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 55.63 20.11 3.7 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -170.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.31 120.66 11.61 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 121.062 1.755 . . . . 0.0 109.79 -171.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.4 m -68.1 138.68 55.93 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -129.62 110.71 12.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.8 m -81.49 159.59 24.16 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.2 m . . . . . 0 CA--C 1.568 1.652 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 175.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 CA--C 1.557 1.65 0 N-CA-C 114.756 1.021 . . . . 0.0 114.756 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.0 pt -106.98 141.75 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.43 89.07 5.58 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.753 0.787 . . . . 0.0 111.397 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.9 t -144.14 119.05 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.0 p -76.01 119.09 19.48 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.926 0.49 . . . . 0.0 112.115 -176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 66.5 m -93.21 155.22 17.58 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -174.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -136.04 69.72 1.43 Allowed 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.48 156.32 25.64 Favored Glycine 0 CA--C 1.552 2.38 0 CA-C-O 121.669 0.594 . . . . 0.0 113.165 -169.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m -65.98 -41.23 44.0 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 115.271 -2.3 . . . . 0.0 115.789 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.68 -21.98 21.29 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 N-CA-C 119.753 2.944 . . . . 0.0 119.753 171.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -59.24 -37.44 77.58 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 74.2 m -73.52 -9.8 59.06 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.36 -55.95 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.904 1.684 . . . . 0.0 112.584 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.49 -50.12 74.79 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 114.935 -2.46 . . . . 0.0 113.507 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.57 -40.28 37.5 Favored 'Trans proline' 0 CA--C 1.564 2.015 0 CA-C-N 125.58 3.028 . . . . 0.0 118.476 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 77.0 m -63.62 -53.73 47.0 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -60.32 -47.11 87.45 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 175.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.65 -41.5 81.57 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 173.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.63 -48.02 73.62 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 171.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.42 54.73 0.09 OUTLIER Glycine 0 CA--C 1.545 1.91 0 C-N-CA 124.472 1.034 . . . . 0.0 112.297 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 46.5 mtt -147.65 163.05 37.84 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.45 1.119 . . . . 0.0 109.013 -171.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -80.35 -72.14 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.428 -0.795 . . . . 0.0 112.638 -169.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.65 166.78 10.64 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.922 0.867 . . . . 0.0 110.42 -171.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.01 91.19 0.2 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.386 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -111.7 123.54 50.45 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.7 t -96.28 132.34 41.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.12 -164.59 1.14 Allowed 'General case' 0 CA--C 1.576 1.965 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.54 169.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -62.85 98.78 0.13 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.595 -1.316 . . . . 0.0 112.602 -170.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? 57.15 15.39 2.44 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -171.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -144.07 124.74 14.11 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 121.154 1.797 . . . . 0.0 109.832 -171.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.5 m -66.33 139.29 58.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -123.17 108.01 12.36 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.7 m -91.31 132.89 35.86 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.868 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.0 m . . . . . 0 CA--C 1.57 1.716 0 CA-C-O 117.317 -1.325 . . . . 0.0 107.786 179.506 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 CA--C 1.556 1.609 0 N-CA-C 114.93 1.088 . . . . 0.0 114.93 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.5 pt -106.28 160.2 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.883 0.849 . . . . 0.0 108.752 169.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -82.1 81.64 7.96 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.909 0.862 . . . . 0.0 111.61 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.419 ' HB ' ' SG ' ' A' ' 33' ' ' CYS . 40.7 t -145.17 114.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.3 p -84.28 117.19 23.4 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.933 0.493 . . . . 0.0 110.519 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 59.6 m -94.95 156.69 16.22 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -169.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -98.49 -48.98 4.81 Favored 'General case' 0 CA--C 1.581 2.136 0 CA-C-N 113.575 -1.648 . . . . 0.0 106.937 167.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.93 -152.3 5.6 Favored Glycine 0 CA--C 1.554 2.527 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -68.05 -42.08 30.03 Favored Pre-proline 0 CA--C 1.576 1.958 0 CA-C-O 115.236 -2.316 . . . . 0.0 115.853 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.87 -32.42 77.48 Favored 'Trans proline' 0 C--N 1.376 1.974 0 N-CA-C 120.682 3.301 . . . . 0.0 120.682 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -62.28 -26.91 68.66 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 72.1 m -82.2 -25.8 33.92 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 171.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.38 -53.87 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-N 120.534 1.515 . . . . 0.0 112.413 -172.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -65.27 -54.05 35.26 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 114.943 -2.456 . . . . 0.0 113.003 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -47.7 -47.19 19.03 Favored 'Trans proline' 0 CA--C 1.562 1.922 0 C-N-CA 123.922 3.081 . . . . 0.0 118.521 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -65.88 -48.74 70.5 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -59.21 -46.76 87.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -61.97 -37.81 86.15 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.42 -54.64 33.52 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 172.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.97 53.73 0.01 OUTLIER Glycine 0 CA--C 1.545 1.965 0 C-N-CA 123.884 0.754 . . . . 0.0 112.985 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 17.8 mmt -137.28 169.64 17.45 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 122.484 1.135 . . . . 0.0 109.694 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -90.05 -62.37 1.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.457 -0.777 . . . . 0.0 110.783 174.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -118.18 164.25 15.43 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.167 0.984 . . . . 0.0 110.491 -172.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.0 90.15 0.25 Allowed Glycine 0 N--CA 1.478 1.473 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 173.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -97.97 109.08 21.9 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.2 t -94.48 125.23 38.99 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.238 0.542 . . . . 0.0 111.98 -174.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.2 mmt -83.26 -168.36 2.06 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.992 169.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -61.98 100.53 0.16 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.683 -1.26 . . . . 0.0 112.254 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.3 mtm-85 62.76 10.39 4.2 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 117.149 2.278 . . . . 0.0 117.149 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -145.4 127.1 15.24 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 122.028 2.195 . . . . 0.0 110.82 -173.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.419 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 91.2 m -63.84 145.99 54.79 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -142.36 103.04 4.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.0 m -103.57 149.07 25.25 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -171.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 CA--C 1.568 1.669 0 CA-C-O 116.792 -1.575 . . . . 0.0 107.876 -177.817 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.556 1.604 0 N-CA-C 114.641 0.977 . . . . 0.0 114.641 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.0 pt -110.12 143.49 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.42 89.12 5.57 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.635 0.731 . . . . 0.0 111.359 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.9 t -144.81 120.09 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.9 p -76.75 119.1 20.08 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.2 m -95.98 154.23 17.35 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -135.74 70.73 1.42 Allowed 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 168.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.71 158.8 27.71 Favored Glycine 0 CA--C 1.552 2.362 0 CA-C-O 121.805 0.669 . . . . 0.0 113.688 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -64.96 -40.51 47.23 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 115.233 -2.317 . . . . 0.0 115.802 174.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.04 -22.61 19.32 Favored 'Trans proline' 0 CA--C 1.564 2.023 0 N-CA-C 119.94 3.016 . . . . 0.0 119.94 171.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -60.94 -38.44 85.86 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 64.1 m -74.73 -8.48 56.54 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.6 mm -61.03 -55.07 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 121.151 1.796 . . . . 0.0 112.805 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.5 mmmp? -64.73 -49.76 67.79 Favored Pre-proline 0 CA--C 1.573 1.833 0 CA-C-O 114.987 -2.435 . . . . 0.0 113.704 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.76 -40.24 47.65 Favored 'Trans proline' 0 CA--C 1.565 2.06 0 CA-C-N 125.464 2.987 . . . . 0.0 118.318 169.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.4 m -63.57 -52.81 59.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -61.15 -46.42 90.6 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -58.26 -41.38 84.12 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.36 -49.67 68.47 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.52 55.81 0.07 OUTLIER Glycine 0 CA--C 1.544 1.881 0 C-N-CA 124.36 0.981 . . . . 0.0 112.403 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 33.8 mtt -150.6 166.96 28.71 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.401 1.08 . . . . 0.0 108.939 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -84.9 -73.94 0.41 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.126 -0.984 . . . . 0.0 112.459 -171.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.32 160.09 14.84 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.146 0.974 . . . . 0.0 111.071 -169.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.84 89.04 0.37 Allowed Glycine 0 N--CA 1.478 1.499 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.698 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -105.14 118.11 35.72 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.483 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.6 t -103.27 130.16 50.44 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 91.6 mmm -85.49 -170.66 3.22 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.002 169.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -62.51 102.73 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.706 -1.246 . . . . 0.0 112.113 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 62.42 7.41 2.33 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -142.34 124.05 15.07 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 122.203 2.274 . . . . 0.0 110.244 -170.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.6 m -66.35 143.93 56.86 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -127.18 109.96 12.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -93.2 127.67 38.86 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.326 0.651 . . . . 0.0 110.862 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.6 m . . . . . 0 CA--C 1.57 1.743 0 CA-C-O 116.954 -1.498 . . . . 0.0 108.802 -176.359 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 CA--C 1.555 1.543 0 N-CA-C 114.335 0.859 . . . . 0.0 114.335 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -97.25 150.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.6 84.44 7.26 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.838 0.828 . . . . 0.0 111.387 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.407 ' HB ' ' SG ' ' A' ' 33' ' ' CYS . 72.3 t -144.51 115.7 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.5 p -82.08 122.86 28.38 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.837 0.455 . . . . 0.0 111.585 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 85.6 m -103.42 156.05 18.04 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 -172.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -103.17 -42.92 5.61 Favored 'General case' 0 CA--C 1.582 2.204 0 CA-C-N 112.98 -1.918 . . . . 0.0 107.378 167.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.58 -162.34 9.8 Favored Glycine 0 CA--C 1.554 2.471 0 C-N-CA 124.567 1.079 . . . . 0.0 111.212 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.1 m -66.26 -40.99 39.76 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 115.249 -2.31 . . . . 0.0 116.044 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.11 -24.95 35.21 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 N-CA-C 120.471 3.219 . . . . 0.0 120.471 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -58.97 -43.61 91.37 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 37.5 m -76.41 -13.6 60.11 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 117.507 2.41 . . . . 0.0 117.507 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.4 mm -56.53 -58.47 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-N 120.854 1.661 . . . . 0.0 113.328 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -67.53 -51.15 33.51 Favored Pre-proline 0 CA--C 1.572 1.805 0 CA-C-O 114.705 -2.569 . . . . 0.0 113.227 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -47.42 -44.96 23.92 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 CA-C-N 125.764 3.094 . . . . 0.0 118.26 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 87.9 m -60.85 -47.78 84.82 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -61.94 -49.8 74.68 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -67.11 -30.39 70.4 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.13 -55.58 13.6 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.258 1.39 . . . . 0.0 113.796 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.61 47.1 0.01 OUTLIER Glycine 0 CA--C 1.546 1.983 0 CA-C-O 119.365 -0.686 . . . . 0.0 114.353 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -142.77 178.3 7.73 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-O 122.564 1.173 . . . . 0.0 109.518 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -93.87 -74.47 0.53 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.095 0.958 . . . . 0.0 110.4 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -99.59 162.06 13.24 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.222 1.011 . . . . 0.0 110.843 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.73 97.08 0.57 Allowed Glycine 0 N--CA 1.477 1.422 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 171.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.73 111.34 23.98 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.5 t -98.08 127.13 43.85 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -171.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.2 mmt -81.02 -178.0 6.69 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.726 169.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -62.92 101.84 0.3 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.708 -1.245 . . . . 0.0 111.818 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 68.96 0.58 2.82 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 -173.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.62 125.69 27.68 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 122.416 2.371 . . . . 0.0 110.065 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.407 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 56.6 m -68.93 139.28 55.08 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -132.71 106.38 7.74 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 171.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.3 m -74.74 149.44 39.8 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.7 m . . . . . 0 CA--C 1.564 1.514 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 178.518 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.385 0 CA-C-O 119.554 -0.581 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.6 t -115.32 105.07 52.96 Favored Pre-proline 0 CA--C 1.57 1.723 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.04 119.14 6.15 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 123.076 2.517 . . . . 0.0 113.446 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.9 pt -106.49 142.28 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -82.47 89.69 6.66 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.806 0.812 . . . . 0.0 110.785 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.4 t -142.84 118.14 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -176.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.8 p -78.52 117.78 20.03 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 80.9 m -101.65 155.58 18.02 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -174.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -104.33 -41.0 5.9 Favored 'General case' 0 CA--C 1.582 2.197 0 CA-C-N 113.145 -1.843 . . . . 0.0 107.976 167.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.17 -166.56 12.14 Favored Glycine 0 CA--C 1.554 2.478 0 C-N-CA 124.396 0.998 . . . . 0.0 111.707 169.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.9 m -67.76 -41.94 31.94 Favored Pre-proline 0 CA--C 1.573 1.861 0 CA-C-O 115.208 -2.329 . . . . 0.0 115.897 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.61 -22.44 28.43 Favored 'Trans proline' 0 CA--C 1.564 1.989 0 N-CA-C 120.248 3.134 . . . . 0.0 120.248 174.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -58.05 -42.05 84.61 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 59.7 m -76.81 -10.26 59.25 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mm -58.83 -55.23 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 120.915 1.689 . . . . 0.0 112.924 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -68.43 -51.27 24.35 Favored Pre-proline 0 CA--C 1.572 1.798 0 CA-C-O 114.951 -2.452 . . . . 0.0 113.079 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -49.18 -43.08 38.21 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 CA-C-N 125.581 3.029 . . . . 0.0 118.326 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.8 m -60.89 -52.27 65.74 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.49 -48.95 77.85 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -62.15 -37.21 84.34 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.28 -52.9 51.24 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.36 53.22 0.02 OUTLIER Glycine 0 CA--C 1.545 1.942 0 C-N-CA 124.015 0.817 . . . . 0.0 113.095 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -142.18 166.59 24.28 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.66 1.219 . . . . 0.0 110.167 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -81.67 -63.03 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.119 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -119.49 165.34 14.51 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 122.355 1.074 . . . . 0.0 110.388 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.91 94.29 0.25 Allowed Glycine 0 N--CA 1.477 1.385 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.66 119.12 38.29 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.3 t -99.98 127.54 46.18 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.328 0.585 . . . . 0.0 112.426 -175.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 92.4 mmm -83.2 -173.42 4.7 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.78 169.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -62.32 101.14 0.21 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.784 -1.197 . . . . 0.0 112.063 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 65.96 6.32 3.98 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -141.48 127.11 19.01 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 122.686 2.493 . . . . 0.0 110.643 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.2 m -69.35 142.65 53.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -133.96 109.22 8.87 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.0 m -84.0 154.39 23.32 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.7 m -101.42 106.1 43.86 Favored Pre-proline 0 CA--C 1.569 1.709 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.23 146.38 86.26 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.13 2.553 . . . . 0.0 116.27 -171.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm . . . . . 0 C--O 1.253 1.24 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.086 -175.797 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.444 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.36 107.37 39.2 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.43 117.32 4.27 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.164 2.576 . . . . 0.0 114.537 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.2 pt -113.47 143.37 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -80.17 84.14 5.92 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.95 0.881 . . . . 0.0 111.878 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.3 t -144.51 115.34 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.4 p -80.45 120.45 24.48 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.862 0.465 . . . . 0.0 111.206 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.59 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 59.7 m -91.41 155.5 18.42 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -171.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -135.98 70.58 1.42 Allowed 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 168.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.71 155.95 28.36 Favored Glycine 0 CA--C 1.553 2.423 0 CA-C-O 121.742 0.634 . . . . 0.0 113.232 -169.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 m -63.35 -39.62 51.53 Favored Pre-proline 0 CA--C 1.573 1.856 0 CA-C-O 115.213 -2.327 . . . . 0.0 116.095 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.26 -25.25 23.17 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 CA-C-N 125.336 2.941 . . . . 0.0 119.734 171.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -59.13 -40.66 86.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.59 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 65.8 m -73.67 -14.86 61.23 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.0 mm -57.07 -56.57 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-N 120.727 1.603 . . . . 0.0 113.069 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -66.29 -51.42 43.93 Favored Pre-proline 0 CA--C 1.572 1.816 0 CA-C-O 114.696 -2.573 . . . . 0.0 113.447 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -46.75 -46.0 19.02 Favored 'Trans proline' 0 CA--C 1.564 1.992 0 CA-C-N 125.78 3.1 . . . . 0.0 118.071 171.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -59.8 -49.24 78.49 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -61.88 -49.91 74.32 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.7 -31.12 72.21 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.86 -56.02 14.02 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.082 1.31 . . . . 0.0 113.637 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.31 51.77 0.01 OUTLIER Glycine 0 CA--C 1.545 1.949 0 C-N-CA 123.707 0.67 . . . . 0.0 113.516 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -142.83 168.73 19.03 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 122.534 1.159 . . . . 0.0 110.181 -174.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -82.28 -64.02 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.534 -0.729 . . . . 0.0 111.747 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -116.45 163.57 15.85 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.245 1.021 . . . . 0.0 110.348 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -132.45 95.58 0.3 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -108.98 122.93 48.28 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.8 t -102.06 132.36 47.96 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -171.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.97 -164.04 1.08 Allowed 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -63.29 99.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.415 -1.428 . . . . 0.0 112.227 -171.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 58.83 15.24 3.71 Favored 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -139.6 122.61 16.74 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.524 1.965 . . . . 0.0 110.595 -170.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 66.2 m -71.05 135.88 48.0 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -132.61 112.71 12.28 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.7 m -86.35 151.51 23.51 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.0 m -98.96 107.13 42.1 Favored Pre-proline 0 CA--C 1.569 1.699 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.47 146.29 67.72 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 123.029 2.486 . . . . 0.0 115.955 -170.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt . . . . . 0 C--O 1.254 1.303 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.2 -175.279 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.422 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.5 m -80.22 139.12 52.36 Favored Pre-proline 0 CA--C 1.575 1.927 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.607 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.55 133.64 16.02 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 122.988 2.459 . . . . 0.0 114.743 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.3 pt -118.45 142.35 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 169.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -81.07 88.99 5.94 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.671 0.748 . . . . 0.0 111.276 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.6 t -143.62 119.8 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.8 p -75.91 119.69 20.23 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.992 0.517 . . . . 0.0 112.306 -176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 70.2 m -97.24 154.81 17.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -174.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 t -135.29 70.03 1.44 Allowed 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.52 157.45 25.76 Favored Glycine 0 CA--C 1.551 2.331 0 CA-C-O 121.877 0.709 . . . . 0.0 113.579 -169.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.4 m -65.48 -41.13 47.89 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 115.328 -2.272 . . . . 0.0 115.899 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.6 -21.73 20.07 Favored 'Trans proline' 0 CA--C 1.566 2.124 0 N-CA-C 119.88 2.992 . . . . 0.0 119.88 171.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -60.63 -37.58 81.94 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 66.3 m -74.83 -8.79 57.49 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.67 -54.75 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 120.983 1.72 . . . . 0.0 112.847 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.33 -51.16 54.83 Favored Pre-proline 0 CA--C 1.574 1.867 0 CA-C-O 114.758 -2.544 . . . . 0.0 112.713 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.59 -41.0 30.58 Favored 'Trans proline' 0 CA--C 1.565 2.031 0 CA-C-N 125.856 3.127 . . . . 0.0 118.636 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.0 m -62.36 -54.81 34.99 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -59.81 -46.7 88.41 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.21 -41.44 79.44 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.47 -49.75 67.92 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.8 55.49 0.07 OUTLIER Glycine 0 CA--C 1.545 1.925 0 C-N-CA 124.413 1.006 . . . . 0.0 112.228 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.9 mtt -147.24 162.53 38.71 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.434 1.111 . . . . 0.0 109.364 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -79.48 -71.24 0.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 112.582 -170.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -110.96 166.0 11.4 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.972 0.891 . . . . 0.0 110.474 -170.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.68 90.55 0.24 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -107.43 118.56 37.04 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.508 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.4 t -97.97 131.76 44.13 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -175.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 79.9 mtp -87.2 -167.28 1.83 Allowed 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 169.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -62.11 99.83 0.14 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.572 -1.33 . . . . 0.0 112.713 -170.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 58.63 13.5 2.63 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -172.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -143.45 124.69 14.58 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 121.85 2.114 . . . . 0.0 109.874 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.7 m -66.19 141.74 57.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -126.69 105.34 8.63 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.7 m -88.54 136.54 32.94 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.465 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.0 m -83.25 115.19 57.84 Favored Pre-proline 0 CA--C 1.568 1.667 0 CA-C-O 117.176 -1.392 . . . . 0.0 107.767 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.53 138.34 29.45 Favored 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 122.788 2.325 . . . . 0.0 114.811 -169.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.874 -178.78 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 85.8 t -99.7 112.78 64.33 Favored Pre-proline 0 CA--C 1.571 1.769 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.4 107.87 2.55 Favored 'Trans proline' 0 CA--C 1.558 1.704 0 C-N-CA 122.864 2.376 . . . . 0.0 113.378 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.9 pt -98.54 146.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -80.16 84.82 5.79 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.864 0.84 . . . . 0.0 111.683 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.8 t -145.83 115.31 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.1 p -81.34 120.41 24.92 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.793 0.437 . . . . 0.0 111.293 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 71.6 m -95.34 153.77 17.52 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -172.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -130.05 50.03 2.22 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.562 168.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.69 162.85 11.66 Favored Glycine 0 CA--C 1.553 2.43 0 C-N-CA 124.212 0.911 . . . . 0.0 112.342 -169.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.0 m -66.47 -41.39 40.39 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 115.167 -2.349 . . . . 0.0 116.288 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -53.66 -24.25 29.05 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 N-CA-C 120.134 3.09 . . . . 0.0 120.134 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -58.7 -39.51 80.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 175.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 60.7 m -76.0 -11.8 60.02 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.8 mm -59.43 -57.93 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 120.723 1.601 . . . . 0.0 112.982 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -68.15 -45.59 40.12 Favored Pre-proline 0 CA--C 1.571 1.76 0 CA-C-O 114.931 -2.461 . . . . 0.0 114.249 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.02 -42.46 64.41 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.757 3.092 . . . . 0.0 117.697 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 99.0 m -59.73 -52.35 65.86 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -56.72 -48.64 77.28 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 174.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.12 -40.05 84.22 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.82 -50.62 68.2 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 171.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.85 57.12 0.05 OUTLIER Glycine 0 CA--C 1.545 1.923 0 C-N-CA 124.481 1.039 . . . . 0.0 111.713 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.6 mmt -144.36 158.85 43.53 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.441 1.115 . . . . 0.0 109.112 -172.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -80.3 -74.84 0.29 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.841 0.856 . . . . 0.0 111.487 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -98.75 161.85 13.43 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.264 1.031 . . . . 0.0 111.071 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.83 93.42 0.3 Allowed Glycine 0 N--CA 1.478 1.434 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -111.36 120.19 41.38 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.488 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 4.5 t -99.02 129.85 45.33 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -171.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 86.2 mtp -84.9 -167.95 2.02 Favored 'General case' 0 CA--C 1.575 1.926 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.792 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.83 100.14 0.28 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.58 -1.325 . . . . 0.0 112.086 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 59.25 15.61 4.37 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -172.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -142.21 122.51 13.92 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.365 1.893 . . . . 0.0 110.024 -170.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.3 m -70.6 134.91 48.03 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -129.19 109.52 11.22 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.4 m -83.67 150.52 25.82 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.2 m -106.11 111.67 64.31 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -59.25 149.85 78.1 Favored 'Trans proline' 0 CA--C 1.558 1.711 0 C-N-CA 123.212 2.608 . . . . 0.0 117.304 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt . . . . . 0 N--CA 1.488 1.429 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.354 177.516 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.475 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.2 m -74.49 132.95 77.75 Favored Pre-proline 0 CA--C 1.577 2.009 0 CA-C-O 117.713 -1.137 . . . . 0.0 111.663 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -64.99 141.76 71.89 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 123.114 2.542 . . . . 0.0 116.678 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.6 pt -129.18 143.53 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 169.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.69 87.62 6.74 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.812 0.815 . . . . 0.0 111.546 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.9 t -144.5 119.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.8 p -79.9 121.89 25.99 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.972 0.509 . . . . 0.0 112.157 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 83.0 m -104.52 156.63 17.78 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -174.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 t -103.98 -42.37 5.59 Favored 'General case' 0 CA--C 1.582 2.197 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.484 167.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.7 -164.53 10.85 Favored Glycine 0 CA--C 1.554 2.485 0 C-N-CA 124.476 1.036 . . . . 0.0 111.411 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.3 m -67.6 -41.2 29.42 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-O 115.238 -2.315 . . . . 0.0 115.822 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.48 -22.89 29.25 Favored 'Trans proline' 0 CA--C 1.564 2.0 0 N-CA-C 120.433 3.205 . . . . 0.0 120.433 175.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -58.62 -41.76 86.65 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 40.9 m -75.84 -10.34 59.34 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.44 -55.26 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.824 1.647 . . . . 0.0 112.831 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.73 -51.57 48.34 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 114.607 -2.616 . . . . 0.0 112.568 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.47 -41.36 36.47 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 CA-C-N 125.962 3.165 . . . . 0.0 118.717 170.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 76.9 m -63.12 -54.48 37.14 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -60.98 -46.16 91.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.87 -41.5 78.11 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.59 -49.35 71.48 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 170.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.13 56.08 0.08 OUTLIER Glycine 0 CA--C 1.543 1.826 0 C-N-CA 124.566 1.079 . . . . 0.0 112.174 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 51.2 mtt -143.79 164.6 30.04 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.611 1.196 . . . . 0.0 109.754 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -76.52 -64.2 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.82 0.848 . . . . 0.0 113.286 -169.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -125.2 162.44 24.67 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.014 0.911 . . . . 0.0 110.171 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.09 92.67 0.45 Allowed Glycine 0 N--CA 1.477 1.429 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -109.45 116.32 31.59 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.51 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.4 t -101.31 127.5 47.89 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -173.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.9 mtt -84.24 -168.66 2.25 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.028 169.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -63.05 100.56 0.22 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.755 -1.216 . . . . 0.0 112.166 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 60.81 13.04 4.13 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -141.87 123.23 14.85 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.808 2.094 . . . . 0.0 110.324 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.402 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 39.1 m -70.36 141.62 52.23 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -133.0 108.15 8.71 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.6 m -87.73 136.28 33.02 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.331 0.652 . . . . 0.0 111.505 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m -82.49 115.08 56.07 Favored Pre-proline 0 CA--C 1.57 1.721 0 CA-C-O 117.082 -1.437 . . . . 0.0 107.456 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.97 142.71 39.2 Favored 'Trans proline' 0 CA--C 1.56 1.78 0 C-N-CA 122.755 2.303 . . . . 0.0 115.088 -169.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.1 tttp . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.289 -178.853 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.387 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.7 t -120.0 107.22 40.15 Favored Pre-proline 0 CA--C 1.567 1.63 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 -176.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.32 107.14 2.31 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.745 2.297 . . . . 0.0 113.566 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.4 pt -95.24 145.41 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.83 83.98 6.45 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.933 0.873 . . . . 0.0 111.598 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.3 t -145.06 114.95 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 103.876 -2.638 . . . . 0.0 103.876 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.0 p -81.03 120.79 25.25 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.709 0.404 . . . . 0.0 110.924 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 27.3 m -89.64 153.33 20.83 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -170.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -132.26 69.69 1.48 Allowed 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.81 150.9 22.88 Favored Glycine 0 CA--C 1.552 2.348 0 C-N-CA 123.497 0.57 . . . . 0.0 112.813 -169.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 t -61.83 -41.46 77.27 Favored Pre-proline 0 CA--C 1.574 1.891 0 CA-C-O 115.241 -2.314 . . . . 0.0 115.913 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -54.19 -24.15 32.5 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 N-CA-C 119.755 2.944 . . . . 0.0 119.755 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -57.58 -38.18 74.43 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 67.4 m -72.13 -14.24 61.77 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 176.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 71.5 mt -65.1 -51.48 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.88 1.673 . . . . 0.0 112.617 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -64.1 -49.61 73.04 Favored Pre-proline 0 CA--C 1.577 2.013 0 CA-C-O 115.008 -2.425 . . . . 0.0 112.97 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.02 -41.28 65.03 Favored 'Trans proline' 0 CA--C 1.565 2.04 0 CA-C-N 125.493 2.998 . . . . 0.0 118.046 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.8 m -61.41 -51.25 69.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -59.11 -46.77 87.47 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -57.57 -41.15 80.53 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 -51.61 58.64 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 170.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.16 55.25 0.04 OUTLIER Glycine 0 CA--C 1.544 1.848 0 C-N-CA 124.192 0.901 . . . . 0.0 113.114 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -143.09 165.79 26.44 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.817 1.294 . . . . 0.0 110.218 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -83.51 -74.55 0.36 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 124.23 1.012 . . . . 0.0 111.021 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -95.82 159.71 14.84 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.25 1.024 . . . . 0.0 111.077 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.22 94.58 0.33 Allowed Glycine 0 N--CA 1.478 1.496 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -113.94 125.0 53.54 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.426 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 11.7 t -102.27 132.31 48.3 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -169.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -85.26 -161.25 0.57 Allowed 'General case' 0 CA--C 1.578 2.055 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.296 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -63.74 94.16 0.09 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.402 -1.436 . . . . 0.0 111.827 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.1 mtp-105 51.24 30.1 5.53 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -169.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -139.79 117.68 11.73 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 119.706 1.139 . . . . 0.0 109.409 -171.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.9 m -71.89 131.05 42.46 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -126.88 115.27 19.05 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -87.93 146.71 25.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.203 0.601 . . . . 0.0 112.255 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m -106.91 109.83 63.3 Favored Pre-proline 0 CA--C 1.566 1.592 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -54.43 149.09 39.76 Favored 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 123.609 2.873 . . . . 0.0 118.223 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt . . . . . 0 N--CA 1.485 1.325 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.3 -178.593 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.464 0 N-CA-C 111.806 -0.517 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.4 m -79.24 123.52 84.66 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.611 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -67.05 134.71 35.05 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.99 2.46 . . . . 0.0 115.249 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.5 pt -122.97 140.05 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -81.77 87.01 6.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.805 0.812 . . . . 0.0 111.293 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.2 t -144.34 118.8 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 87.6 p -78.3 122.54 25.86 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.897 0.479 . . . . 0.0 111.852 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.599 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 62.6 m -96.09 155.04 16.92 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -172.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 t -134.94 69.68 1.45 Allowed 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 168.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 156.48 24.89 Favored Glycine 0 CA--C 1.553 2.436 0 C-N-CA 123.58 0.61 . . . . 0.0 113.717 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 t -64.74 -41.56 57.51 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 115.22 -2.324 . . . . 0.0 115.684 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -53.58 -22.77 23.17 Favored 'Trans proline' 0 CA--C 1.566 2.101 0 N-CA-C 119.846 2.979 . . . . 0.0 119.846 171.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -59.76 -39.03 83.46 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.599 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 63.8 m -75.02 -10.07 59.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.0 mm -59.21 -56.15 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-N 120.838 1.654 . . . . 0.0 112.817 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -67.04 -48.06 50.74 Favored Pre-proline 0 CA--C 1.574 1.887 0 CA-C-O 115.022 -2.418 . . . . 0.0 113.776 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.68 -41.82 59.72 Favored 'Trans proline' 0 CA--C 1.564 2.02 0 CA-C-N 125.668 3.06 . . . . 0.0 118.065 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.2 m -60.86 -50.97 71.28 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -57.4 -46.78 83.1 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 173.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.49 -41.25 89.42 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.39 -50.38 65.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.75 54.44 0.04 OUTLIER Glycine 0 CA--C 1.545 1.923 0 C-N-CA 124.212 0.91 . . . . 0.0 112.768 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -143.63 162.8 34.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.869 1.319 . . . . 0.0 110.029 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -81.78 -72.45 0.43 Allowed 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.19 0.996 . . . . 0.0 111.233 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -101.34 165.35 11.31 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.399 1.095 . . . . 0.0 110.887 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.16 94.04 0.22 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 174.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -107.61 125.23 51.07 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.506 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.4 t -104.32 133.46 49.19 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -172.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 86.0 mtp -87.71 -165.92 1.44 Allowed 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.316 169.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -63.47 99.66 0.22 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.458 -1.401 . . . . 0.0 112.096 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 59.72 16.81 5.79 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -140.85 118.83 11.86 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 121.677 2.035 . . . . 0.0 110.443 -169.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.4 m -69.8 137.91 52.24 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -134.25 108.69 8.39 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.3 m -82.98 153.19 25.12 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 m -109.35 106.08 58.1 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -60.03 144.97 99.43 Favored 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 123.152 2.568 . . . . 0.0 117.39 -175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 117.838 -1.077 . . . . 0.0 113.213 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.459 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.6 t -135.35 113.21 11.17 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.86 107.5 2.36 Favored 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 122.854 2.369 . . . . 0.0 113.712 -175.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.9 pt -99.2 144.57 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 170.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.45 87.46 5.07 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.86 0.838 . . . . 0.0 111.515 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.6 t -145.55 116.98 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.1 p -80.07 117.79 21.21 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.728 0.411 . . . . 0.0 111.571 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 86.2 m -95.17 155.22 16.82 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -174.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 t -130.54 48.97 2.35 Favored 'General case' 0 CA--C 1.58 2.134 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.381 168.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.57 160.62 10.98 Favored Glycine 0 CA--C 1.555 2.57 0 C-N-CA 124.369 0.985 . . . . 0.0 112.17 -169.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.0 m -64.75 -40.33 47.34 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-O 115.118 -2.372 . . . . 0.0 116.201 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.15 -23.68 23.34 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 N-CA-C 120.191 3.112 . . . . 0.0 120.191 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -61.53 -41.45 97.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 62.7 m -73.43 -12.45 60.81 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 117.954 2.575 . . . . 0.0 117.954 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.2 mm -60.46 -49.84 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 120.884 1.674 . . . . 0.0 113.065 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.64 -53.93 40.48 Favored Pre-proline 0 CA--C 1.572 1.823 0 CA-C-O 115.1 -2.381 . . . . 0.0 112.756 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.59 -43.61 44.48 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 125.351 2.947 . . . . 0.0 118.738 171.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.0 m -63.4 -51.0 67.63 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 173.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -61.46 -45.45 94.21 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -58.37 -40.95 83.66 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.2 -50.43 70.34 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.71 55.79 0.06 OUTLIER Glycine 0 CA--C 1.543 1.798 0 C-N-CA 124.262 0.934 . . . . 0.0 112.293 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 43.3 mtt -143.59 168.47 19.81 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.617 1.199 . . . . 0.0 109.968 -174.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -75.81 -62.76 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -170.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -129.97 160.56 33.26 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.228 1.013 . . . . 0.0 110.076 -170.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.47 93.22 0.59 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -106.3 111.7 24.4 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 6.1 t -97.67 128.13 44.14 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 83.1 mtp -84.19 -165.9 1.28 Allowed 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.158 169.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -63.51 98.41 0.17 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.738 -1.226 . . . . 0.0 112.445 -170.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 54.18 22.01 3.37 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -170.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -143.73 122.8 12.86 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 120.886 1.676 . . . . 0.0 109.718 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 67.1 m -68.98 134.87 50.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -125.12 110.79 14.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.7 m -83.83 140.51 31.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.142 0.577 . . . . 0.0 112.077 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.3 m -90.25 111.09 45.05 Favored Pre-proline 0 CA--C 1.57 1.739 0 CA-C-O 117.193 -1.384 . . . . 0.0 107.321 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.63 148.47 25.97 Favored 'Trans proline' 0 CA--C 1.558 1.703 0 C-N-CA 122.737 2.291 . . . . 0.0 115.04 -170.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.771 174.924 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.353 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.2 t -108.93 108.17 60.5 Favored Pre-proline 0 CA--C 1.567 1.634 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.64 105.2 2.01 Favored 'Trans proline' 0 CA--C 1.557 1.631 0 C-N-CA 122.784 2.323 . . . . 0.0 113.304 -175.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.1 pt -94.46 145.61 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.02 86.49 6.11 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.852 0.834 . . . . 0.0 111.382 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.8 t -144.44 116.97 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.9 p -81.61 119.53 23.91 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.807 0.443 . . . . 0.0 111.445 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 64.1 m -98.65 156.65 16.71 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -174.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -104.7 -42.98 5.24 Favored 'General case' 0 CA--C 1.582 2.185 0 CA-C-N 113.445 -1.707 . . . . 0.0 107.26 167.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.16 -167.0 11.4 Favored Glycine 0 CA--C 1.555 2.591 0 C-N-CA 124.441 1.019 . . . . 0.0 111.316 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.2 m -67.85 -41.72 30.08 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-O 115.215 -2.326 . . . . 0.0 115.665 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.64 -22.66 29.39 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 N-CA-C 120.368 3.18 . . . . 0.0 120.368 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -58.03 -43.37 86.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 55.5 m -74.71 -9.78 58.89 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.1 mm -58.63 -57.24 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-N 121.548 1.977 . . . . 0.0 112.187 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -57.04 -53.99 59.35 Favored Pre-proline 0 CA--C 1.573 1.836 0 CA-C-O 115.347 -2.263 . . . . 0.0 114.35 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -62.36 -43.51 22.59 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.41 2.968 . . . . 0.0 116.446 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.9 m -60.93 -54.68 42.01 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 173.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.36 -52.37 65.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.87 -30.98 71.67 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.39 -56.33 13.14 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 120.646 1.566 . . . . 0.0 113.735 172.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.27 49.74 0.01 OUTLIER Glycine 0 CA--C 1.544 1.855 0 CA-C-O 119.416 -0.658 . . . . 0.0 114.142 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -139.92 175.75 9.32 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 122.643 1.211 . . . . 0.0 109.91 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -84.22 -61.88 1.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 111.933 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.99 160.51 28.79 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.329 1.061 . . . . 0.0 110.452 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.81 97.61 0.61 Allowed Glycine 0 N--CA 1.478 1.469 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.528 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 118.85 37.31 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 4.6 t -102.99 128.75 49.68 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -170.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -82.13 -168.48 1.97 Allowed 'General case' 0 CA--C 1.575 1.924 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.168 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.6 98.69 0.19 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.84 -1.163 . . . . 0.0 111.965 -173.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 56.83 20.67 5.38 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -171.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -143.41 120.67 11.55 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 121.149 1.795 . . . . 0.0 110.093 -172.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.2 m -70.21 137.79 51.18 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -131.69 116.59 17.51 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -83.29 150.75 25.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.5 m -104.15 100.51 21.57 Favored Pre-proline 0 CA--C 1.569 1.698 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.33 154.07 50.98 Favored 'Trans proline' 0 CA--C 1.557 1.658 0 C-N-CA 122.917 2.411 . . . . 0.0 115.199 -172.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 118.249 -0.881 . . . . 0.0 109.653 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.389 0 CA-C-O 119.754 -0.47 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.3 m -98.04 122.1 55.43 Favored Pre-proline 0 CA--C 1.571 1.759 0 CA-C-O 117.838 -1.077 . . . . 0.0 108.236 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.71 114.16 3.96 Favored 'Trans proline' 0 CA--C 1.557 1.634 0 C-N-CA 122.979 2.453 . . . . 0.0 113.975 -173.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 pt -108.1 139.31 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.33 90.28 6.13 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.895 0.855 . . . . 0.0 110.87 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.6 t -141.96 115.61 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.1 p -74.41 116.83 15.53 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 64.5 m -91.15 154.19 19.52 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -135.14 68.78 1.46 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.93 156.33 23.0 Favored Glycine 0 CA--C 1.551 2.322 0 CA-C-O 121.713 0.619 . . . . 0.0 112.921 -169.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -67.95 -42.86 34.77 Favored Pre-proline 0 N--CA 1.495 1.812 0 CA-C-O 115.287 -2.292 . . . . 0.0 115.785 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -54.11 -22.42 25.29 Favored 'Trans proline' 0 CA--C 1.563 1.973 0 N-CA-C 119.704 2.924 . . . . 0.0 119.704 171.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -55.33 -39.07 69.55 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 75.0 m -73.44 -10.78 60.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.68 -51.95 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 120.75 1.614 . . . . 0.0 112.257 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -66.86 -49.53 47.83 Favored Pre-proline 0 CA--C 1.576 1.971 0 CA-C-O 115.034 -2.412 . . . . 0.0 113.505 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.44 -41.7 51.06 Favored 'Trans proline' 0 CA--C 1.565 2.069 0 CA-C-N 125.704 3.073 . . . . 0.0 117.95 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.0 m -60.96 -50.07 74.87 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -55.59 -52.18 64.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -64.69 -33.66 76.48 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.8 -53.73 29.88 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 119.824 1.193 . . . . 0.0 113.95 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.65 53.51 0.02 OUTLIER Glycine 0 CA--C 1.544 1.906 0 C-N-CA 124.012 0.815 . . . . 0.0 113.13 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -145.92 164.01 33.34 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.77 1.272 . . . . 0.0 110.11 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -81.21 -73.43 0.38 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.003 0.921 . . . . 0.0 111.432 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -102.44 167.91 9.65 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.03 0.919 . . . . 0.0 111.128 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.71 100.22 0.23 Allowed Glycine 0 N--CA 1.477 1.392 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 129.31 56.68 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.5 t -95.73 133.09 40.24 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.8 mmt -88.4 -166.37 1.57 Allowed 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.387 169.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -61.91 98.91 0.11 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.407 -1.433 . . . . 0.0 112.837 -170.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 56.44 13.14 1.21 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 -171.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -141.92 130.23 22.33 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 121.266 1.848 . . . . 0.0 109.951 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.3 m -66.75 135.8 54.53 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -123.66 107.78 11.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.2 m -83.96 158.56 21.5 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.772 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.3 m -111.33 103.4 54.94 Favored Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 173.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -59.15 147.77 88.97 Favored 'Trans proline' 0 CA--C 1.556 1.615 0 C-N-CA 123.224 2.616 . . . . 0.0 116.965 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.6 tptp . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.389 -176.181 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.472 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 79.6 t -86.57 122.42 71.83 Favored Pre-proline 0 CA--C 1.573 1.854 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.72 127.15 12.05 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.889 2.393 . . . . 0.0 114.611 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.8 pt -114.59 150.46 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.68 87.04 6.32 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.817 0.818 . . . . 0.0 111.38 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.7 115.72 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.2 p -78.91 118.13 20.65 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.836 0.455 . . . . 0.0 111.576 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 77.9 m -95.05 155.56 16.68 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -171.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -135.79 70.11 1.43 Allowed 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 168.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.0 157.98 25.31 Favored Glycine 0 CA--C 1.551 2.316 0 CA-C-O 121.917 0.732 . . . . 0.0 113.564 -169.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -64.19 -41.65 62.63 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 115.3 -2.286 . . . . 0.0 115.962 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.74 -22.89 24.52 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.946 3.018 . . . . 0.0 119.946 172.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -60.98 -36.67 80.05 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.9 m -71.3 -19.8 62.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.3 mm -57.73 -56.61 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 120.802 1.637 . . . . 0.0 113.575 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -68.13 -51.45 26.52 Favored Pre-proline 0 CA--C 1.575 1.941 0 CA-C-O 114.99 -2.433 . . . . 0.0 113.39 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.82 -45.55 24.01 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 125.649 3.053 . . . . 0.0 118.049 170.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.4 m -67.62 -45.25 75.94 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -59.17 -47.91 83.56 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 173.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -61.18 -37.42 82.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 172.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.89 -52.92 57.7 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.4 59.48 0.03 OUTLIER Glycine 0 CA--C 1.543 1.833 0 C-N-CA 124.275 0.941 . . . . 0.0 111.851 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 20.4 mmt -140.91 164.18 30.96 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.77 1.272 . . . . 0.0 109.892 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -93.37 -72.15 0.62 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.4 1.08 . . . . 0.0 110.114 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -99.25 164.75 12.01 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.993 0.901 . . . . 0.0 110.846 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.414 ' HA2' ' SG ' ' A' ' 35' ' ' CYS . . . -142.52 88.86 0.18 Allowed Glycine 0 N--CA 1.481 1.667 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.082 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -107.28 116.74 32.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.489 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.0 t -97.67 130.94 44.63 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.556 0.693 . . . . 0.0 112.863 -173.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -87.55 -164.74 1.14 Allowed 'General case' 0 CA--C 1.575 1.937 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.771 169.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -63.42 99.12 0.19 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.764 -1.21 . . . . 0.0 112.398 -170.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 55.6 19.31 3.21 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -171.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -144.85 121.43 11.09 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 121.574 1.988 . . . . 0.0 110.144 -172.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.7 m -67.34 136.28 54.57 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -127.14 100.67 6.19 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 170.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.414 ' SG ' ' HA2' ' A' ' 26' ' ' GLY . 69.1 m -107.62 128.78 54.84 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.453 -172.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.8 m -81.28 123.61 81.33 Favored Pre-proline 0 CA--C 1.566 1.558 0 CA-C-O 117.102 -1.428 . . . . 0.0 108.272 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.18 149.98 46.86 Favored 'Trans proline' 0 CA--C 1.559 1.726 0 C-N-CA 122.796 2.331 . . . . 0.0 114.658 -173.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt . . . . . 0 N--CA 1.488 1.432 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.768 -178.689 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.408 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.97 110.92 56.63 Favored Pre-proline 0 CA--C 1.568 1.665 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.66 103.45 1.64 Allowed 'Trans proline' 0 CA--C 1.559 1.736 0 C-N-CA 122.821 2.347 . . . . 0.0 113.01 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.2 pt -100.06 144.0 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -78.91 88.24 4.72 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.948 0.88 . . . . 0.0 111.258 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.6 t -145.16 114.44 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -76.97 114.62 15.96 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.066 0.46 . . . . 0.0 111.726 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.8 m -88.54 154.85 20.01 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -137.23 71.15 1.4 Allowed 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.0 159.09 29.38 Favored Glycine 0 CA--C 1.552 2.362 0 CA-C-O 121.845 0.692 . . . . 0.0 113.402 -169.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.2 m -65.63 -40.19 38.76 Favored Pre-proline 0 CA--C 1.572 1.822 0 CA-C-O 115.191 -2.337 . . . . 0.0 115.979 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.21 -23.22 22.23 Favored 'Trans proline' 0 CA--C 1.566 2.079 0 CA-C-N 125.399 2.964 . . . . 0.0 119.764 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -58.76 -38.7 79.05 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 172.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 82.4 m -73.96 -10.05 59.26 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 117.928 2.566 . . . . 0.0 117.928 177.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.76 -55.86 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 120.852 1.66 . . . . 0.0 112.606 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -64.22 -49.75 71.5 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 114.896 -2.478 . . . . 0.0 113.399 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.19 -43.3 43.65 Favored 'Trans proline' 0 CA--C 1.564 2.023 0 CA-C-N 125.714 3.076 . . . . 0.0 118.378 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.9 m -62.95 -51.63 66.15 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -59.15 -46.92 87.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -57.41 -40.85 79.17 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.71 -48.95 72.77 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.22 59.04 0.08 OUTLIER Glycine 0 CA--C 1.543 1.813 0 C-N-CA 124.478 1.037 . . . . 0.0 111.607 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' A' ' 37' ' ' PRO . 8.7 mmt -140.47 166.04 25.8 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.544 1.164 . . . . 0.0 109.609 -171.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -80.12 -56.66 4.08 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.914 0.886 . . . . 0.0 113.21 -176.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -131.93 164.38 26.27 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.997 0.903 . . . . 0.0 110.223 -172.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.42 95.25 0.39 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -115.66 116.39 28.03 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.4 t -93.8 129.58 40.13 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -170.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 93.5 mmm -84.44 -172.1 3.98 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.737 169.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -61.0 101.18 0.14 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.641 -1.287 . . . . 0.0 112.573 -171.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? 64.74 5.25 2.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -175.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -145.96 132.83 20.12 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 122.141 2.246 . . . . 0.0 111.013 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.4 m -66.64 138.5 57.48 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -124.39 110.39 14.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 171.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.3 m -87.28 139.8 30.19 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.863 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -83.67 115.34 59.11 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 173.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.425 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 60.8 Cg_endo -73.83 150.1 43.73 Favored 'Trans proline' 0 CA--C 1.557 1.674 0 CA-C-N 123.42 2.257 . . . . 0.0 115.843 -169.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt . . . . . 0 N--CA 1.486 1.326 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.102 -176.282 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.353 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.4 t -92.03 117.72 67.85 Favored Pre-proline 0 CA--C 1.571 1.785 0 CA-C-O 117.475 -1.25 . . . . 0.0 107.914 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.95 115.87 4.27 Favored 'Trans proline' 0 CA--C 1.557 1.644 0 C-N-CA 122.891 2.394 . . . . 0.0 113.126 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.4 pt -97.36 140.88 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 169.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -80.25 88.34 5.51 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.798 0.808 . . . . 0.0 111.195 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.2 t -144.86 119.65 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.3 p -78.14 119.51 21.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.824 0.449 . . . . 0.0 111.655 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 60.7 m -92.59 153.87 18.76 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -173.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -132.99 69.07 1.49 Allowed 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 168.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.44 156.53 23.57 Favored Glycine 0 CA--C 1.552 2.347 0 CA-C-O 121.945 0.747 . . . . 0.0 113.441 -169.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.7 p -63.14 -40.67 63.51 Favored Pre-proline 0 CA--C 1.572 1.791 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -68.92 -14.84 39.51 Favored 'Trans proline' 0 CA--C 1.564 2.018 0 CA-C-N 126.428 3.331 . . . . 0.0 118.384 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -55.37 -37.9 68.14 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 171.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 81.8 m -72.86 -14.26 61.46 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.24 -50.58 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 121.096 1.771 . . . . 0.0 112.684 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.6 -51.82 63.54 Favored Pre-proline 0 CA--C 1.576 1.95 0 CA-C-O 115.258 -2.306 . . . . 0.0 113.08 174.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.54 -43.34 39.44 Favored 'Trans proline' 0 CA--C 1.563 1.965 0 C-N-CA 123.841 3.028 . . . . 0.0 118.072 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.1 m -60.46 -46.07 91.4 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 170.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.66 -52.51 65.21 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -64.45 -30.46 71.5 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.56 -55.26 14.14 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.984 1.266 . . . . 0.0 113.663 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 148.75 51.66 0.02 OUTLIER Glycine 0 N--CA 1.485 1.96 0 C-N-CA 123.847 0.737 . . . . 0.0 113.534 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -147.29 165.49 29.95 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 122.334 1.064 . . . . 0.0 109.75 -174.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -80.29 -67.78 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.527 -0.733 . . . . 0.0 112.373 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -110.7 165.21 12.01 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.024 0.916 . . . . 0.0 110.862 -169.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.61 97.77 0.28 Allowed Glycine 0 N--CA 1.477 1.407 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -108.88 123.59 49.31 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.7 t -101.43 132.75 46.86 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -170.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 92.6 mmm -84.92 -166.08 1.38 Allowed 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.786 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -63.86 98.17 0.19 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.452 -1.405 . . . . 0.0 112.228 -171.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 55.63 20.11 3.7 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -170.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.31 120.66 11.61 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 121.062 1.755 . . . . 0.0 109.79 -171.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.4 m -68.1 138.68 55.93 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -129.62 110.71 12.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.8 m -81.49 159.59 24.16 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.2 m -113.32 101.46 53.57 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 175.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -57.66 155.4 31.95 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 123.533 2.822 . . . . 0.0 118.51 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.4 tptt . . . . . 0 N--CA 1.486 1.341 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.055 176.992 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.461 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.7 m -94.92 135.66 23.46 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 118.184 -0.912 . . . . 0.0 109.458 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.66 121.96 7.05 Favored 'Trans proline' 0 CA--C 1.557 1.65 0 C-N-CA 122.874 2.383 . . . . 0.0 114.756 -174.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.0 pt -106.98 141.75 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.43 89.07 5.58 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.753 0.787 . . . . 0.0 111.397 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.9 t -144.14 119.05 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.0 p -76.01 119.09 19.48 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.926 0.49 . . . . 0.0 112.115 -176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 66.5 m -93.21 155.22 17.58 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -174.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -136.04 69.72 1.43 Allowed 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.48 156.32 25.64 Favored Glycine 0 CA--C 1.552 2.38 0 CA-C-O 121.669 0.594 . . . . 0.0 113.165 -169.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m -65.98 -41.23 44.0 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 115.271 -2.3 . . . . 0.0 115.789 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.68 -21.98 21.29 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 N-CA-C 119.753 2.944 . . . . 0.0 119.753 171.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -59.24 -37.44 77.58 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 74.2 m -73.52 -9.8 59.06 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.36 -55.95 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.904 1.684 . . . . 0.0 112.584 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.49 -50.12 74.79 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 114.935 -2.46 . . . . 0.0 113.507 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.57 -40.28 37.5 Favored 'Trans proline' 0 CA--C 1.564 2.015 0 CA-C-N 125.58 3.028 . . . . 0.0 118.476 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 77.0 m -63.62 -53.73 47.0 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -60.32 -47.11 87.45 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 175.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.65 -41.5 81.57 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 173.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.63 -48.02 73.62 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 171.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.42 54.73 0.09 OUTLIER Glycine 0 CA--C 1.545 1.91 0 C-N-CA 124.472 1.034 . . . . 0.0 112.297 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 46.5 mtt -147.65 163.05 37.84 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.45 1.119 . . . . 0.0 109.013 -171.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -80.35 -72.14 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.428 -0.795 . . . . 0.0 112.638 -169.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.65 166.78 10.64 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.922 0.867 . . . . 0.0 110.42 -171.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.01 91.19 0.2 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.386 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -111.7 123.54 50.45 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.7 t -96.28 132.34 41.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.12 -164.59 1.14 Allowed 'General case' 0 CA--C 1.576 1.965 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.54 169.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -62.85 98.78 0.13 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.595 -1.316 . . . . 0.0 112.602 -170.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? 57.15 15.39 2.44 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -171.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -144.07 124.74 14.11 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 121.154 1.797 . . . . 0.0 109.832 -171.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.5 m -66.33 139.29 58.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -123.17 108.01 12.36 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.7 m -91.31 132.89 35.86 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.868 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.0 m -80.17 115.46 54.67 Favored Pre-proline 0 CA--C 1.57 1.716 0 CA-C-O 117.317 -1.325 . . . . 0.0 107.786 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.67 140.82 33.19 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.682 2.255 . . . . 0.0 115.161 -169.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.0 tptp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.023 178.926 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.395 0 CA-C-O 119.807 -0.441 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.1 m -94.57 122.57 60.6 Favored Pre-proline 0 CA--C 1.571 1.75 0 CA-C-O 117.92 -1.038 . . . . 0.0 108.531 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.11 133.06 9.73 Favored 'Trans proline' 0 CA--C 1.556 1.609 0 C-N-CA 122.477 2.118 . . . . 0.0 114.93 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.5 pt -106.28 160.2 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.883 0.849 . . . . 0.0 108.752 169.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -82.1 81.64 7.96 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.909 0.862 . . . . 0.0 111.61 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.419 ' HB ' ' SG ' ' A' ' 33' ' ' CYS . 40.7 t -145.17 114.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.3 p -84.28 117.19 23.4 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.933 0.493 . . . . 0.0 110.519 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 59.6 m -94.95 156.69 16.22 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -169.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -98.49 -48.98 4.81 Favored 'General case' 0 CA--C 1.581 2.136 0 CA-C-N 113.575 -1.648 . . . . 0.0 106.937 167.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.93 -152.3 5.6 Favored Glycine 0 CA--C 1.554 2.527 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -68.05 -42.08 30.03 Favored Pre-proline 0 CA--C 1.576 1.958 0 CA-C-O 115.236 -2.316 . . . . 0.0 115.853 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.87 -32.42 77.48 Favored 'Trans proline' 0 C--N 1.376 1.974 0 N-CA-C 120.682 3.301 . . . . 0.0 120.682 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -62.28 -26.91 68.66 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 72.1 m -82.2 -25.8 33.92 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 171.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.38 -53.87 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-N 120.534 1.515 . . . . 0.0 112.413 -172.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -65.27 -54.05 35.26 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 114.943 -2.456 . . . . 0.0 113.003 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -47.7 -47.19 19.03 Favored 'Trans proline' 0 CA--C 1.562 1.922 0 C-N-CA 123.922 3.081 . . . . 0.0 118.521 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -65.88 -48.74 70.5 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -59.21 -46.76 87.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -61.97 -37.81 86.15 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.42 -54.64 33.52 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 172.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.97 53.73 0.01 OUTLIER Glycine 0 CA--C 1.545 1.965 0 C-N-CA 123.884 0.754 . . . . 0.0 112.985 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.426 ' SD ' ' HA ' ' A' ' 37' ' ' PRO . 17.8 mmt -137.28 169.64 17.45 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 122.484 1.135 . . . . 0.0 109.694 -176.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -90.05 -62.37 1.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.457 -0.777 . . . . 0.0 110.783 174.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -118.18 164.25 15.43 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.167 0.984 . . . . 0.0 110.491 -172.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.0 90.15 0.25 Allowed Glycine 0 N--CA 1.478 1.473 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 173.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -97.97 109.08 21.9 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.2 t -94.48 125.23 38.99 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.238 0.542 . . . . 0.0 111.98 -174.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.2 mmt -83.26 -168.36 2.06 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.992 169.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -61.98 100.53 0.16 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.683 -1.26 . . . . 0.0 112.254 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.3 mtm-85 62.76 10.39 4.2 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 117.149 2.278 . . . . 0.0 117.149 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -145.4 127.1 15.24 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 122.028 2.195 . . . . 0.0 110.82 -173.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.419 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 91.2 m -63.84 145.99 54.79 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -142.36 103.04 4.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.0 m -103.57 149.07 25.25 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -171.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.0 m -96.52 111.91 58.46 Favored Pre-proline 0 CA--C 1.568 1.669 0 CA-C-O 116.792 -1.575 . . . . 0.0 107.876 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.426 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 51.1 Cg_exo -64.97 156.91 59.81 Favored 'Trans proline' 0 CA--C 1.557 1.653 0 C-N-CA 122.978 2.452 . . . . 0.0 117.523 -174.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? . . . . . 0 C--O 1.255 1.36 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.635 179.778 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.29 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.7 t 67.18 93.05 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.032 0 C-N-CA 125.039 1.336 . . . . 0.0 109.937 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -79.13 130.13 9.16 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.703 2.268 . . . . 0.0 114.641 -175.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.0 pt -110.12 143.49 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.42 89.12 5.57 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.635 0.731 . . . . 0.0 111.359 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.9 t -144.81 120.09 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.9 p -76.75 119.1 20.08 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.2 m -95.98 154.23 17.35 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -135.74 70.73 1.42 Allowed 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 168.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.71 158.8 27.71 Favored Glycine 0 CA--C 1.552 2.362 0 CA-C-O 121.805 0.669 . . . . 0.0 113.688 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -64.96 -40.51 47.23 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 115.233 -2.317 . . . . 0.0 115.802 174.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.04 -22.61 19.32 Favored 'Trans proline' 0 CA--C 1.564 2.023 0 N-CA-C 119.94 3.016 . . . . 0.0 119.94 171.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -60.94 -38.44 85.86 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 64.1 m -74.73 -8.48 56.54 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.6 mm -61.03 -55.07 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 121.151 1.796 . . . . 0.0 112.805 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.5 mmmp? -64.73 -49.76 67.79 Favored Pre-proline 0 CA--C 1.573 1.833 0 CA-C-O 114.987 -2.435 . . . . 0.0 113.704 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.76 -40.24 47.65 Favored 'Trans proline' 0 CA--C 1.565 2.06 0 CA-C-N 125.464 2.987 . . . . 0.0 118.318 169.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.4 m -63.57 -52.81 59.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -61.15 -46.42 90.6 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -58.26 -41.38 84.12 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.36 -49.67 68.47 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.52 55.81 0.07 OUTLIER Glycine 0 CA--C 1.544 1.881 0 C-N-CA 124.36 0.981 . . . . 0.0 112.403 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 33.8 mtt -150.6 166.96 28.71 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.401 1.08 . . . . 0.0 108.939 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -84.9 -73.94 0.41 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.126 -0.984 . . . . 0.0 112.459 -171.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.32 160.09 14.84 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.146 0.974 . . . . 0.0 111.071 -169.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.84 89.04 0.37 Allowed Glycine 0 N--CA 1.478 1.499 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.698 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -105.14 118.11 35.72 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.483 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.6 t -103.27 130.16 50.44 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 91.6 mmm -85.49 -170.66 3.22 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.002 169.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -62.51 102.73 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.706 -1.246 . . . . 0.0 112.113 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 62.42 7.41 2.33 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -142.34 124.05 15.07 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 122.203 2.274 . . . . 0.0 110.244 -170.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.6 m -66.35 143.93 56.86 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -127.18 109.96 12.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -93.2 127.67 38.86 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.326 0.651 . . . . 0.0 110.862 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.6 m -83.37 114.82 55.77 Favored Pre-proline 0 CA--C 1.57 1.743 0 CA-C-O 116.954 -1.498 . . . . 0.0 108.802 -176.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.59 147.12 95.66 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.22 2.613 . . . . 0.0 117.151 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.4 pttp . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 123.16 0.584 . . . . 0.0 111.846 178.433 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.312 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.293 16.4 m 40.76 80.26 0.29 Allowed Pre-proline 0 N--CA 1.502 2.131 0 C-N-CA 125.623 1.569 . . . . 0.0 115.17 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -76.16 126.46 9.24 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.689 2.259 . . . . 0.0 114.335 -172.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -97.25 150.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.6 84.44 7.26 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.838 0.828 . . . . 0.0 111.387 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.407 ' HB ' ' SG ' ' A' ' 33' ' ' CYS . 72.3 t -144.51 115.7 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.5 p -82.08 122.86 28.38 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.837 0.455 . . . . 0.0 111.585 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 85.6 m -103.42 156.05 18.04 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 -172.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -103.17 -42.92 5.61 Favored 'General case' 0 CA--C 1.582 2.204 0 CA-C-N 112.98 -1.918 . . . . 0.0 107.378 167.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.58 -162.34 9.8 Favored Glycine 0 CA--C 1.554 2.471 0 C-N-CA 124.567 1.079 . . . . 0.0 111.212 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.1 m -66.26 -40.99 39.76 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 115.249 -2.31 . . . . 0.0 116.044 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.11 -24.95 35.21 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 N-CA-C 120.471 3.219 . . . . 0.0 120.471 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -58.97 -43.61 91.37 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 37.5 m -76.41 -13.6 60.11 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 117.507 2.41 . . . . 0.0 117.507 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.4 mm -56.53 -58.47 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-N 120.854 1.661 . . . . 0.0 113.328 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -67.53 -51.15 33.51 Favored Pre-proline 0 CA--C 1.572 1.805 0 CA-C-O 114.705 -2.569 . . . . 0.0 113.227 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -47.42 -44.96 23.92 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 CA-C-N 125.764 3.094 . . . . 0.0 118.26 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 87.9 m -60.85 -47.78 84.82 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -61.94 -49.8 74.68 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -67.11 -30.39 70.4 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.13 -55.58 13.6 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.258 1.39 . . . . 0.0 113.796 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.61 47.1 0.01 OUTLIER Glycine 0 CA--C 1.546 1.983 0 CA-C-O 119.365 -0.686 . . . . 0.0 114.353 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -142.77 178.3 7.73 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-O 122.564 1.173 . . . . 0.0 109.518 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -93.87 -74.47 0.53 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.095 0.958 . . . . 0.0 110.4 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -99.59 162.06 13.24 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.222 1.011 . . . . 0.0 110.843 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.73 97.08 0.57 Allowed Glycine 0 N--CA 1.477 1.422 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 171.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.73 111.34 23.98 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.5 t -98.08 127.13 43.85 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -171.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.2 mmt -81.02 -178.0 6.69 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.726 169.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -62.92 101.84 0.3 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.708 -1.245 . . . . 0.0 111.818 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 68.96 0.58 2.82 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 -173.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.62 125.69 27.68 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 122.416 2.371 . . . . 0.0 110.065 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.407 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 56.6 m -68.93 139.28 55.08 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -132.71 106.38 7.74 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 171.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.3 m -74.74 149.44 39.8 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.7 m -109.3 106.17 58.26 Favored Pre-proline 0 CA--C 1.564 1.514 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.1 153.67 37.73 Favored 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 123.473 2.782 . . . . 0.0 116.994 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.451 -177.7 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo . . . . . 0 CA--C 1.557 1.649 0 N-CA-C 113.446 0.518 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.9 pt -106.49 142.28 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -82.47 89.69 6.66 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.806 0.812 . . . . 0.0 110.785 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.4 t -142.84 118.14 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -176.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.8 p -78.52 117.78 20.03 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 80.9 m -101.65 155.58 18.02 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -174.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -104.33 -41.0 5.9 Favored 'General case' 0 CA--C 1.582 2.197 0 CA-C-N 113.145 -1.843 . . . . 0.0 107.976 167.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.17 -166.56 12.14 Favored Glycine 0 CA--C 1.554 2.478 0 C-N-CA 124.396 0.998 . . . . 0.0 111.707 169.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.9 m -67.76 -41.94 31.94 Favored Pre-proline 0 CA--C 1.573 1.861 0 CA-C-O 115.208 -2.329 . . . . 0.0 115.897 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.61 -22.44 28.43 Favored 'Trans proline' 0 CA--C 1.564 1.989 0 N-CA-C 120.248 3.134 . . . . 0.0 120.248 174.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -58.05 -42.05 84.61 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 59.7 m -76.81 -10.26 59.25 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mm -58.83 -55.23 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 120.915 1.689 . . . . 0.0 112.924 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -68.43 -51.27 24.35 Favored Pre-proline 0 CA--C 1.572 1.798 0 CA-C-O 114.951 -2.452 . . . . 0.0 113.079 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -49.18 -43.08 38.21 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 CA-C-N 125.581 3.029 . . . . 0.0 118.326 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.8 m -60.89 -52.27 65.74 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.49 -48.95 77.85 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -62.15 -37.21 84.34 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.28 -52.9 51.24 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.36 53.22 0.02 OUTLIER Glycine 0 CA--C 1.545 1.942 0 C-N-CA 124.015 0.817 . . . . 0.0 113.095 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -142.18 166.59 24.28 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.66 1.219 . . . . 0.0 110.167 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -81.67 -63.03 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.119 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -119.49 165.34 14.51 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 122.355 1.074 . . . . 0.0 110.388 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.91 94.29 0.25 Allowed Glycine 0 N--CA 1.477 1.385 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.66 119.12 38.29 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.3 t -99.98 127.54 46.18 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.328 0.585 . . . . 0.0 112.426 -175.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 92.4 mmm -83.2 -173.42 4.7 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.78 169.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -62.32 101.14 0.21 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.784 -1.197 . . . . 0.0 112.063 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 65.96 6.32 3.98 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -141.48 127.11 19.01 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 122.686 2.493 . . . . 0.0 110.643 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.2 m -69.35 142.65 53.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -133.96 109.22 8.87 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.0 m -84.0 154.39 23.32 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.7 m . . . . . 0 CA--C 1.569 1.709 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.948 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 CA--C 1.558 1.675 0 N-CA-C 114.537 0.937 . . . . 0.0 114.537 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.2 pt -113.47 143.37 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -80.17 84.14 5.92 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.95 0.881 . . . . 0.0 111.878 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.3 t -144.51 115.34 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.4 p -80.45 120.45 24.48 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.862 0.465 . . . . 0.0 111.206 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.59 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 59.7 m -91.41 155.5 18.42 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -171.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -135.98 70.58 1.42 Allowed 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 168.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.71 155.95 28.36 Favored Glycine 0 CA--C 1.553 2.423 0 CA-C-O 121.742 0.634 . . . . 0.0 113.232 -169.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 m -63.35 -39.62 51.53 Favored Pre-proline 0 CA--C 1.573 1.856 0 CA-C-O 115.213 -2.327 . . . . 0.0 116.095 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.26 -25.25 23.17 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 CA-C-N 125.336 2.941 . . . . 0.0 119.734 171.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -59.13 -40.66 86.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.59 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 65.8 m -73.67 -14.86 61.23 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.0 mm -57.07 -56.57 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-N 120.727 1.603 . . . . 0.0 113.069 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -66.29 -51.42 43.93 Favored Pre-proline 0 CA--C 1.572 1.816 0 CA-C-O 114.696 -2.573 . . . . 0.0 113.447 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -46.75 -46.0 19.02 Favored 'Trans proline' 0 CA--C 1.564 1.992 0 CA-C-N 125.78 3.1 . . . . 0.0 118.071 171.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -59.8 -49.24 78.49 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -61.88 -49.91 74.32 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.7 -31.12 72.21 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.86 -56.02 14.02 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.082 1.31 . . . . 0.0 113.637 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.31 51.77 0.01 OUTLIER Glycine 0 CA--C 1.545 1.949 0 C-N-CA 123.707 0.67 . . . . 0.0 113.516 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -142.83 168.73 19.03 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 122.534 1.159 . . . . 0.0 110.181 -174.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -82.28 -64.02 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.534 -0.729 . . . . 0.0 111.747 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -116.45 163.57 15.85 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.245 1.021 . . . . 0.0 110.348 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -132.45 95.58 0.3 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -108.98 122.93 48.28 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.474 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.8 t -102.06 132.36 47.96 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -171.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.97 -164.04 1.08 Allowed 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -63.29 99.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.415 -1.428 . . . . 0.0 112.227 -171.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 58.83 15.24 3.71 Favored 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -139.6 122.61 16.74 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.524 1.965 . . . . 0.0 110.595 -170.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 66.2 m -71.05 135.88 48.0 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -132.61 112.71 12.28 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.7 m -86.35 151.51 23.51 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.0 m . . . . . 0 CA--C 1.569 1.699 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 175.745 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.558 1.687 0 N-CA-C 114.743 1.017 . . . . 0.0 114.743 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.3 pt -118.45 142.35 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 169.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -81.07 88.99 5.94 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.671 0.748 . . . . 0.0 111.276 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.6 t -143.62 119.8 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.8 p -75.91 119.69 20.23 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.992 0.517 . . . . 0.0 112.306 -176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 70.2 m -97.24 154.81 17.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -174.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 t -135.29 70.03 1.44 Allowed 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.52 157.45 25.76 Favored Glycine 0 CA--C 1.551 2.331 0 CA-C-O 121.877 0.709 . . . . 0.0 113.579 -169.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.4 m -65.48 -41.13 47.89 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 115.328 -2.272 . . . . 0.0 115.899 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.6 -21.73 20.07 Favored 'Trans proline' 0 CA--C 1.566 2.124 0 N-CA-C 119.88 2.992 . . . . 0.0 119.88 171.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -60.63 -37.58 81.94 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 66.3 m -74.83 -8.79 57.49 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.67 -54.75 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 120.983 1.72 . . . . 0.0 112.847 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.33 -51.16 54.83 Favored Pre-proline 0 CA--C 1.574 1.867 0 CA-C-O 114.758 -2.544 . . . . 0.0 112.713 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.59 -41.0 30.58 Favored 'Trans proline' 0 CA--C 1.565 2.031 0 CA-C-N 125.856 3.127 . . . . 0.0 118.636 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.0 m -62.36 -54.81 34.99 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -59.81 -46.7 88.41 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.21 -41.44 79.44 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.47 -49.75 67.92 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.8 55.49 0.07 OUTLIER Glycine 0 CA--C 1.545 1.925 0 C-N-CA 124.413 1.006 . . . . 0.0 112.228 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.9 mtt -147.24 162.53 38.71 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.434 1.111 . . . . 0.0 109.364 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -79.48 -71.24 0.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 112.582 -170.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -110.96 166.0 11.4 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.972 0.891 . . . . 0.0 110.474 -170.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.68 90.55 0.24 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -107.43 118.56 37.04 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.4 t -97.97 131.76 44.13 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -175.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 79.9 mtp -87.2 -167.28 1.83 Allowed 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 169.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -62.11 99.83 0.14 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.572 -1.33 . . . . 0.0 112.713 -170.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 58.63 13.5 2.63 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -172.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -143.45 124.69 14.58 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 121.85 2.114 . . . . 0.0 109.874 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.7 m -66.19 141.74 57.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -126.69 105.34 8.63 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.7 m -88.54 136.54 32.94 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.465 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.0 m . . . . . 0 CA--C 1.568 1.667 0 CA-C-O 117.176 -1.392 . . . . 0.0 107.767 178.969 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 CA--C 1.558 1.704 0 N-CA-C 113.378 0.492 . . . . 0.0 113.378 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.9 pt -98.54 146.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -80.16 84.82 5.79 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.864 0.84 . . . . 0.0 111.683 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.8 t -145.83 115.31 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.1 p -81.34 120.41 24.92 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.793 0.437 . . . . 0.0 111.293 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 71.6 m -95.34 153.77 17.52 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -172.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -130.05 50.03 2.22 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.562 168.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.69 162.85 11.66 Favored Glycine 0 CA--C 1.553 2.43 0 C-N-CA 124.212 0.911 . . . . 0.0 112.342 -169.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.0 m -66.47 -41.39 40.39 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 115.167 -2.349 . . . . 0.0 116.288 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -53.66 -24.25 29.05 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 N-CA-C 120.134 3.09 . . . . 0.0 120.134 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -58.7 -39.51 80.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 175.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 60.7 m -76.0 -11.8 60.02 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.8 mm -59.43 -57.93 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 120.723 1.601 . . . . 0.0 112.982 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -68.15 -45.59 40.12 Favored Pre-proline 0 CA--C 1.571 1.76 0 CA-C-O 114.931 -2.461 . . . . 0.0 114.249 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.02 -42.46 64.41 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.757 3.092 . . . . 0.0 117.697 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 99.0 m -59.73 -52.35 65.86 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -56.72 -48.64 77.28 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 174.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.12 -40.05 84.22 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.82 -50.62 68.2 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 171.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.85 57.12 0.05 OUTLIER Glycine 0 CA--C 1.545 1.923 0 C-N-CA 124.481 1.039 . . . . 0.0 111.713 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.6 mmt -144.36 158.85 43.53 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.441 1.115 . . . . 0.0 109.112 -172.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -80.3 -74.84 0.29 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.841 0.856 . . . . 0.0 111.487 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -98.75 161.85 13.43 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.264 1.031 . . . . 0.0 111.071 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.83 93.42 0.3 Allowed Glycine 0 N--CA 1.478 1.434 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -111.36 120.19 41.38 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 4.5 t -99.02 129.85 45.33 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -171.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 86.2 mtp -84.9 -167.95 2.02 Favored 'General case' 0 CA--C 1.575 1.926 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.792 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.83 100.14 0.28 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.58 -1.325 . . . . 0.0 112.086 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 59.25 15.61 4.37 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -172.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -142.21 122.51 13.92 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.365 1.893 . . . . 0.0 110.024 -170.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.3 m -70.6 134.91 48.03 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -129.19 109.52 11.22 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.4 m -83.67 150.52 25.82 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.2 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.684 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo . . . . . 0 CA--C 1.558 1.719 0 N-CA-C 116.678 1.761 . . . . 0.0 116.678 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.6 pt -129.18 143.53 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 169.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.69 87.62 6.74 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.812 0.815 . . . . 0.0 111.546 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.9 t -144.5 119.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.8 p -79.9 121.89 25.99 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.972 0.509 . . . . 0.0 112.157 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 83.0 m -104.52 156.63 17.78 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -174.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 t -103.98 -42.37 5.59 Favored 'General case' 0 CA--C 1.582 2.197 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.484 167.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.7 -164.53 10.85 Favored Glycine 0 CA--C 1.554 2.485 0 C-N-CA 124.476 1.036 . . . . 0.0 111.411 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.3 m -67.6 -41.2 29.42 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-O 115.238 -2.315 . . . . 0.0 115.822 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.48 -22.89 29.25 Favored 'Trans proline' 0 CA--C 1.564 2.0 0 N-CA-C 120.433 3.205 . . . . 0.0 120.433 175.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -58.62 -41.76 86.65 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 40.9 m -75.84 -10.34 59.34 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.44 -55.26 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.824 1.647 . . . . 0.0 112.831 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.73 -51.57 48.34 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 114.607 -2.616 . . . . 0.0 112.568 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.47 -41.36 36.47 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 CA-C-N 125.962 3.165 . . . . 0.0 118.717 170.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 76.9 m -63.12 -54.48 37.14 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -60.98 -46.16 91.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.87 -41.5 78.11 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.59 -49.35 71.48 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 170.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.13 56.08 0.08 OUTLIER Glycine 0 CA--C 1.543 1.826 0 C-N-CA 124.566 1.079 . . . . 0.0 112.174 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 51.2 mtt -143.79 164.6 30.04 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.611 1.196 . . . . 0.0 109.754 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -76.52 -64.2 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.82 0.848 . . . . 0.0 113.286 -169.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -125.2 162.44 24.67 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.014 0.911 . . . . 0.0 110.171 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.09 92.67 0.45 Allowed Glycine 0 N--CA 1.477 1.429 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -109.45 116.32 31.59 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.4 t -101.31 127.5 47.89 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -173.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.9 mtt -84.24 -168.66 2.25 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.028 169.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -63.05 100.56 0.22 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.755 -1.216 . . . . 0.0 112.166 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 60.81 13.04 4.13 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -141.87 123.23 14.85 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.808 2.094 . . . . 0.0 110.324 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.402 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 39.1 m -70.36 141.62 52.23 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -133.0 108.15 8.71 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.6 m -87.73 136.28 33.02 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.331 0.652 . . . . 0.0 111.505 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 CA--C 1.57 1.721 0 CA-C-O 117.082 -1.437 . . . . 0.0 107.456 177.328 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 CA--C 1.557 1.636 0 N-CA-C 113.566 0.564 . . . . 0.0 113.566 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.4 pt -95.24 145.41 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.83 83.98 6.45 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.933 0.873 . . . . 0.0 111.598 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.3 t -145.06 114.95 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 103.876 -2.638 . . . . 0.0 103.876 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.0 p -81.03 120.79 25.25 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.709 0.404 . . . . 0.0 110.924 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 27.3 m -89.64 153.33 20.83 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -170.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -132.26 69.69 1.48 Allowed 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.81 150.9 22.88 Favored Glycine 0 CA--C 1.552 2.348 0 C-N-CA 123.497 0.57 . . . . 0.0 112.813 -169.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 t -61.83 -41.46 77.27 Favored Pre-proline 0 CA--C 1.574 1.891 0 CA-C-O 115.241 -2.314 . . . . 0.0 115.913 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -54.19 -24.15 32.5 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 N-CA-C 119.755 2.944 . . . . 0.0 119.755 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -57.58 -38.18 74.43 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 67.4 m -72.13 -14.24 61.77 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 176.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 71.5 mt -65.1 -51.48 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.88 1.673 . . . . 0.0 112.617 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -64.1 -49.61 73.04 Favored Pre-proline 0 CA--C 1.577 2.013 0 CA-C-O 115.008 -2.425 . . . . 0.0 112.97 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.02 -41.28 65.03 Favored 'Trans proline' 0 CA--C 1.565 2.04 0 CA-C-N 125.493 2.998 . . . . 0.0 118.046 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.8 m -61.41 -51.25 69.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -59.11 -46.77 87.47 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -57.57 -41.15 80.53 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 -51.61 58.64 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 170.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.16 55.25 0.04 OUTLIER Glycine 0 CA--C 1.544 1.848 0 C-N-CA 124.192 0.901 . . . . 0.0 113.114 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -143.09 165.79 26.44 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.817 1.294 . . . . 0.0 110.218 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -83.51 -74.55 0.36 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 124.23 1.012 . . . . 0.0 111.021 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -95.82 159.71 14.84 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.25 1.024 . . . . 0.0 111.077 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.22 94.58 0.33 Allowed Glycine 0 N--CA 1.478 1.496 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -113.94 125.0 53.54 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.402 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 11.7 t -102.27 132.31 48.3 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -169.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -85.26 -161.25 0.57 Allowed 'General case' 0 CA--C 1.578 2.055 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.296 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -63.74 94.16 0.09 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.402 -1.436 . . . . 0.0 111.827 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.1 mtp-105 51.24 30.1 5.53 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -169.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -139.79 117.68 11.73 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 119.706 1.139 . . . . 0.0 109.409 -171.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.9 m -71.89 131.05 42.46 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -126.88 115.27 19.05 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -87.93 146.71 25.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.203 0.601 . . . . 0.0 112.255 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 CA--C 1.566 1.592 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 175.276 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo . . . . . 0 CA--C 1.557 1.671 0 N-CA-C 115.249 1.211 . . . . 0.0 115.249 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.5 pt -122.97 140.05 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -81.77 87.01 6.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.805 0.812 . . . . 0.0 111.293 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.2 t -144.34 118.8 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 87.6 p -78.3 122.54 25.86 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.897 0.479 . . . . 0.0 111.852 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.599 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 62.6 m -96.09 155.04 16.92 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -172.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 t -134.94 69.68 1.45 Allowed 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 168.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 156.48 24.89 Favored Glycine 0 CA--C 1.553 2.436 0 C-N-CA 123.58 0.61 . . . . 0.0 113.717 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 t -64.74 -41.56 57.51 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 115.22 -2.324 . . . . 0.0 115.684 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -53.58 -22.77 23.17 Favored 'Trans proline' 0 CA--C 1.566 2.101 0 N-CA-C 119.846 2.979 . . . . 0.0 119.846 171.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -59.76 -39.03 83.46 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.599 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 63.8 m -75.02 -10.07 59.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.0 mm -59.21 -56.15 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-N 120.838 1.654 . . . . 0.0 112.817 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -67.04 -48.06 50.74 Favored Pre-proline 0 CA--C 1.574 1.887 0 CA-C-O 115.022 -2.418 . . . . 0.0 113.776 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.68 -41.82 59.72 Favored 'Trans proline' 0 CA--C 1.564 2.02 0 CA-C-N 125.668 3.06 . . . . 0.0 118.065 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.2 m -60.86 -50.97 71.28 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -57.4 -46.78 83.1 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 173.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.49 -41.25 89.42 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.39 -50.38 65.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.75 54.44 0.04 OUTLIER Glycine 0 CA--C 1.545 1.923 0 C-N-CA 124.212 0.91 . . . . 0.0 112.768 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -143.63 162.8 34.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.869 1.319 . . . . 0.0 110.029 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -81.78 -72.45 0.43 Allowed 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.19 0.996 . . . . 0.0 111.233 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -101.34 165.35 11.31 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.399 1.095 . . . . 0.0 110.887 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.16 94.04 0.22 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 174.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -107.61 125.23 51.07 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.4 t -104.32 133.46 49.19 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -172.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 86.0 mtp -87.71 -165.92 1.44 Allowed 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.316 169.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -63.47 99.66 0.22 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.458 -1.401 . . . . 0.0 112.096 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 59.72 16.81 5.79 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -140.85 118.83 11.86 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 121.677 2.035 . . . . 0.0 110.443 -169.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.4 m -69.8 137.91 52.24 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -134.25 108.69 8.39 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.3 m -82.98 153.19 25.12 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 m . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 174.444 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 CA--C 1.558 1.694 0 N-CA-C 113.712 0.62 . . . . 0.0 113.712 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.9 pt -99.2 144.57 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 170.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.45 87.46 5.07 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.86 0.838 . . . . 0.0 111.515 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.6 t -145.55 116.98 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.1 p -80.07 117.79 21.21 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.728 0.411 . . . . 0.0 111.571 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 86.2 m -95.17 155.22 16.82 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -174.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 t -130.54 48.97 2.35 Favored 'General case' 0 CA--C 1.58 2.134 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.381 168.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.57 160.62 10.98 Favored Glycine 0 CA--C 1.555 2.57 0 C-N-CA 124.369 0.985 . . . . 0.0 112.17 -169.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.0 m -64.75 -40.33 47.34 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-O 115.118 -2.372 . . . . 0.0 116.201 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.15 -23.68 23.34 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 N-CA-C 120.191 3.112 . . . . 0.0 120.191 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -61.53 -41.45 97.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 62.7 m -73.43 -12.45 60.81 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 117.954 2.575 . . . . 0.0 117.954 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.2 mm -60.46 -49.84 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 120.884 1.674 . . . . 0.0 113.065 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.64 -53.93 40.48 Favored Pre-proline 0 CA--C 1.572 1.823 0 CA-C-O 115.1 -2.381 . . . . 0.0 112.756 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.59 -43.61 44.48 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 125.351 2.947 . . . . 0.0 118.738 171.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.0 m -63.4 -51.0 67.63 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 173.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -61.46 -45.45 94.21 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -58.37 -40.95 83.66 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.2 -50.43 70.34 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.71 55.79 0.06 OUTLIER Glycine 0 CA--C 1.543 1.798 0 C-N-CA 124.262 0.934 . . . . 0.0 112.293 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 43.3 mtt -143.59 168.47 19.81 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.617 1.199 . . . . 0.0 109.968 -174.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -75.81 -62.76 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -170.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -129.97 160.56 33.26 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.228 1.013 . . . . 0.0 110.076 -170.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.47 93.22 0.59 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -106.3 111.7 24.4 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 6.1 t -97.67 128.13 44.14 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 83.1 mtp -84.19 -165.9 1.28 Allowed 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.158 169.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -63.51 98.41 0.17 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.738 -1.226 . . . . 0.0 112.445 -170.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 54.18 22.01 3.37 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -170.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -143.73 122.8 12.86 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 120.886 1.676 . . . . 0.0 109.718 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 67.1 m -68.98 134.87 50.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -125.12 110.79 14.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.7 m -83.83 140.51 31.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.142 0.577 . . . . 0.0 112.077 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.3 m . . . . . 0 CA--C 1.57 1.739 0 CA-C-O 117.193 -1.384 . . . . 0.0 107.321 178.677 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 CA--C 1.557 1.631 0 N-CA-C 113.304 0.463 . . . . 0.0 113.304 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.1 pt -94.46 145.61 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.02 86.49 6.11 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.852 0.834 . . . . 0.0 111.382 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.8 t -144.44 116.97 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.9 p -81.61 119.53 23.91 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.807 0.443 . . . . 0.0 111.445 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 64.1 m -98.65 156.65 16.71 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -174.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -104.7 -42.98 5.24 Favored 'General case' 0 CA--C 1.582 2.185 0 CA-C-N 113.445 -1.707 . . . . 0.0 107.26 167.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.16 -167.0 11.4 Favored Glycine 0 CA--C 1.555 2.591 0 C-N-CA 124.441 1.019 . . . . 0.0 111.316 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.2 m -67.85 -41.72 30.08 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-O 115.215 -2.326 . . . . 0.0 115.665 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.64 -22.66 29.39 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 N-CA-C 120.368 3.18 . . . . 0.0 120.368 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -58.03 -43.37 86.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 55.5 m -74.71 -9.78 58.89 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.1 mm -58.63 -57.24 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-N 121.548 1.977 . . . . 0.0 112.187 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -57.04 -53.99 59.35 Favored Pre-proline 0 CA--C 1.573 1.836 0 CA-C-O 115.347 -2.263 . . . . 0.0 114.35 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -62.36 -43.51 22.59 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.41 2.968 . . . . 0.0 116.446 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.9 m -60.93 -54.68 42.01 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 173.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.36 -52.37 65.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.87 -30.98 71.67 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.39 -56.33 13.14 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 120.646 1.566 . . . . 0.0 113.735 172.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.27 49.74 0.01 OUTLIER Glycine 0 CA--C 1.544 1.855 0 CA-C-O 119.416 -0.658 . . . . 0.0 114.142 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -139.92 175.75 9.32 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 122.643 1.211 . . . . 0.0 109.91 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -84.22 -61.88 1.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 111.933 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.99 160.51 28.79 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.329 1.061 . . . . 0.0 110.452 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.81 97.61 0.61 Allowed Glycine 0 N--CA 1.478 1.469 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.528 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 118.85 37.31 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 4.6 t -102.99 128.75 49.68 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -170.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -82.13 -168.48 1.97 Allowed 'General case' 0 CA--C 1.575 1.924 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.168 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.6 98.69 0.19 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.84 -1.163 . . . . 0.0 111.965 -173.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 56.83 20.67 5.38 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -171.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -143.41 120.67 11.55 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 121.149 1.795 . . . . 0.0 110.093 -172.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.2 m -70.21 137.79 51.18 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -131.69 116.59 17.51 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -83.29 150.75 25.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.5 m . . . . . 0 CA--C 1.569 1.698 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.961 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 CA--C 1.557 1.634 0 N-CA-C 113.975 0.721 . . . . 0.0 113.975 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 pt -108.1 139.31 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.33 90.28 6.13 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.895 0.855 . . . . 0.0 110.87 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.6 t -141.96 115.61 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.1 p -74.41 116.83 15.53 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 64.5 m -91.15 154.19 19.52 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -135.14 68.78 1.46 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.93 156.33 23.0 Favored Glycine 0 CA--C 1.551 2.322 0 CA-C-O 121.713 0.619 . . . . 0.0 112.921 -169.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -67.95 -42.86 34.77 Favored Pre-proline 0 N--CA 1.495 1.812 0 CA-C-O 115.287 -2.292 . . . . 0.0 115.785 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -54.11 -22.42 25.29 Favored 'Trans proline' 0 CA--C 1.563 1.973 0 N-CA-C 119.704 2.924 . . . . 0.0 119.704 171.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -55.33 -39.07 69.55 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 75.0 m -73.44 -10.78 60.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.68 -51.95 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 120.75 1.614 . . . . 0.0 112.257 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -66.86 -49.53 47.83 Favored Pre-proline 0 CA--C 1.576 1.971 0 CA-C-O 115.034 -2.412 . . . . 0.0 113.505 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.44 -41.7 51.06 Favored 'Trans proline' 0 CA--C 1.565 2.069 0 CA-C-N 125.704 3.073 . . . . 0.0 117.95 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.0 m -60.96 -50.07 74.87 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -55.59 -52.18 64.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -64.69 -33.66 76.48 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.8 -53.73 29.88 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 119.824 1.193 . . . . 0.0 113.95 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.65 53.51 0.02 OUTLIER Glycine 0 CA--C 1.544 1.906 0 C-N-CA 124.012 0.815 . . . . 0.0 113.13 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -145.92 164.01 33.34 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.77 1.272 . . . . 0.0 110.11 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -81.21 -73.43 0.38 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.003 0.921 . . . . 0.0 111.432 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -102.44 167.91 9.65 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.03 0.919 . . . . 0.0 111.128 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.71 100.22 0.23 Allowed Glycine 0 N--CA 1.477 1.392 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 129.31 56.68 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.5 t -95.73 133.09 40.24 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.8 mmt -88.4 -166.37 1.57 Allowed 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.387 169.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -61.91 98.91 0.11 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.407 -1.433 . . . . 0.0 112.837 -170.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 56.44 13.14 1.21 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 -171.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -141.92 130.23 22.33 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 121.266 1.848 . . . . 0.0 109.951 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.3 m -66.75 135.8 54.53 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -123.66 107.78 11.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.2 m -83.96 158.56 21.5 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.772 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.3 m . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 173.134 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 CA--C 1.557 1.648 0 N-CA-C 114.611 0.966 . . . . 0.0 114.611 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.446 HD11 ' SG ' ' A' ' 18' ' ' CYS . 19.8 pt -114.59 150.46 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.68 87.04 6.32 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.817 0.818 . . . . 0.0 111.38 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.7 115.72 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.2 p -78.91 118.13 20.65 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.836 0.455 . . . . 0.0 111.576 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 77.9 m -95.05 155.56 16.68 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -171.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -135.79 70.11 1.43 Allowed 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 168.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.0 157.98 25.31 Favored Glycine 0 CA--C 1.551 2.316 0 CA-C-O 121.917 0.732 . . . . 0.0 113.564 -169.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -64.19 -41.65 62.63 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 115.3 -2.286 . . . . 0.0 115.962 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.74 -22.89 24.52 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.946 3.018 . . . . 0.0 119.946 172.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -60.98 -36.67 80.05 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.9 m -71.3 -19.8 62.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.3 mm -57.73 -56.61 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 120.802 1.637 . . . . 0.0 113.575 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -68.13 -51.45 26.52 Favored Pre-proline 0 CA--C 1.575 1.941 0 CA-C-O 114.99 -2.433 . . . . 0.0 113.39 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.82 -45.55 24.01 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 125.649 3.053 . . . . 0.0 118.049 170.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 4' ' ' ILE . 98.4 m -67.62 -45.25 75.94 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -59.17 -47.91 83.56 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 173.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -61.18 -37.42 82.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 172.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.89 -52.92 57.7 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.4 59.48 0.03 OUTLIER Glycine 0 CA--C 1.543 1.833 0 C-N-CA 124.275 0.941 . . . . 0.0 111.851 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 20.4 mmt -140.91 164.18 30.96 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.77 1.272 . . . . 0.0 109.892 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -93.37 -72.15 0.62 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.4 1.08 . . . . 0.0 110.114 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -99.25 164.75 12.01 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.993 0.901 . . . . 0.0 110.846 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.52 88.86 0.18 Allowed Glycine 0 N--CA 1.481 1.667 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.082 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -107.28 116.74 32.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.0 t -97.67 130.94 44.63 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.556 0.693 . . . . 0.0 112.863 -173.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -87.55 -164.74 1.14 Allowed 'General case' 0 CA--C 1.575 1.937 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.771 169.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -63.42 99.12 0.19 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.764 -1.21 . . . . 0.0 112.398 -170.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 55.6 19.31 3.21 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -171.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -144.85 121.43 11.09 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 121.574 1.988 . . . . 0.0 110.144 -172.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.7 m -67.34 136.28 54.57 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -127.14 100.67 6.19 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 170.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.1 m -107.62 128.78 54.84 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.453 -172.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.8 m . . . . . 0 CA--C 1.566 1.558 0 CA-C-O 117.102 -1.428 . . . . 0.0 108.272 -175.882 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 CA--C 1.559 1.736 0 CA-C-O 121.123 0.385 . . . . 0.0 113.01 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.2 pt -100.06 144.0 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -78.91 88.24 4.72 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.948 0.88 . . . . 0.0 111.258 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.6 t -145.16 114.44 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -76.97 114.62 15.96 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.066 0.46 . . . . 0.0 111.726 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.8 m -88.54 154.85 20.01 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -137.23 71.15 1.4 Allowed 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.0 159.09 29.38 Favored Glycine 0 CA--C 1.552 2.362 0 CA-C-O 121.845 0.692 . . . . 0.0 113.402 -169.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.2 m -65.63 -40.19 38.76 Favored Pre-proline 0 CA--C 1.572 1.822 0 CA-C-O 115.191 -2.337 . . . . 0.0 115.979 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.21 -23.22 22.23 Favored 'Trans proline' 0 CA--C 1.566 2.079 0 CA-C-N 125.399 2.964 . . . . 0.0 119.764 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -58.76 -38.7 79.05 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 172.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 82.4 m -73.96 -10.05 59.26 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 117.928 2.566 . . . . 0.0 117.928 177.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.76 -55.86 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 120.852 1.66 . . . . 0.0 112.606 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -64.22 -49.75 71.5 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 114.896 -2.478 . . . . 0.0 113.399 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.19 -43.3 43.65 Favored 'Trans proline' 0 CA--C 1.564 2.023 0 CA-C-N 125.714 3.076 . . . . 0.0 118.378 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.9 m -62.95 -51.63 66.15 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -59.15 -46.92 87.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -57.41 -40.85 79.17 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.71 -48.95 72.77 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.22 59.04 0.08 OUTLIER Glycine 0 CA--C 1.543 1.813 0 C-N-CA 124.478 1.037 . . . . 0.0 111.607 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.7 mmt -140.47 166.04 25.8 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.544 1.164 . . . . 0.0 109.609 -171.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -80.12 -56.66 4.08 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.914 0.886 . . . . 0.0 113.21 -176.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -131.93 164.38 26.27 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.997 0.903 . . . . 0.0 110.223 -172.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.42 95.25 0.39 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -115.66 116.39 28.03 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.4 t -93.8 129.58 40.13 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -170.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 93.5 mmm -84.44 -172.1 3.98 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.737 169.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -61.0 101.18 0.14 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.641 -1.287 . . . . 0.0 112.573 -171.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? 64.74 5.25 2.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -175.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -145.96 132.83 20.12 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 122.141 2.246 . . . . 0.0 111.013 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.4 m -66.64 138.5 57.48 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -124.39 110.39 14.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 171.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.3 m -87.28 139.8 30.19 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.863 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 173.221 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 CA--C 1.557 1.644 0 N-CA-C 113.126 0.395 . . . . 0.0 113.126 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.4 pt -97.36 140.88 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 169.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -80.25 88.34 5.51 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.798 0.808 . . . . 0.0 111.195 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.2 t -144.86 119.65 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.3 p -78.14 119.51 21.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.824 0.449 . . . . 0.0 111.655 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 60.7 m -92.59 153.87 18.76 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -173.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -132.99 69.07 1.49 Allowed 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 168.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.44 156.53 23.57 Favored Glycine 0 CA--C 1.552 2.347 0 CA-C-O 121.945 0.747 . . . . 0.0 113.441 -169.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.7 p -63.14 -40.67 63.51 Favored Pre-proline 0 CA--C 1.572 1.791 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -68.92 -14.84 39.51 Favored 'Trans proline' 0 CA--C 1.564 2.018 0 CA-C-N 126.428 3.331 . . . . 0.0 118.384 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -55.37 -37.9 68.14 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 171.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 81.8 m -72.86 -14.26 61.46 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.24 -50.58 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 121.096 1.771 . . . . 0.0 112.684 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.6 -51.82 63.54 Favored Pre-proline 0 CA--C 1.576 1.95 0 CA-C-O 115.258 -2.306 . . . . 0.0 113.08 174.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.54 -43.34 39.44 Favored 'Trans proline' 0 CA--C 1.563 1.965 0 C-N-CA 123.841 3.028 . . . . 0.0 118.072 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.1 m -60.46 -46.07 91.4 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 170.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.66 -52.51 65.21 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -64.45 -30.46 71.5 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.56 -55.26 14.14 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.984 1.266 . . . . 0.0 113.663 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 148.75 51.66 0.02 OUTLIER Glycine 0 N--CA 1.485 1.96 0 C-N-CA 123.847 0.737 . . . . 0.0 113.534 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -147.29 165.49 29.95 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 122.334 1.064 . . . . 0.0 109.75 -174.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -80.29 -67.78 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.527 -0.733 . . . . 0.0 112.373 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -110.7 165.21 12.01 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.024 0.916 . . . . 0.0 110.862 -169.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.61 97.77 0.28 Allowed Glycine 0 N--CA 1.477 1.407 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -108.88 123.59 49.31 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.7 t -101.43 132.75 46.86 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -170.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 92.6 mmm -84.92 -166.08 1.38 Allowed 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.786 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -63.86 98.17 0.19 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.452 -1.405 . . . . 0.0 112.228 -171.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 55.63 20.11 3.7 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -170.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.31 120.66 11.61 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 121.062 1.755 . . . . 0.0 109.79 -171.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.4 m -68.1 138.68 55.93 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -129.62 110.71 12.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.8 m -81.49 159.59 24.16 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.2 m . . . . . 0 CA--C 1.568 1.652 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 175.916 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 CA--C 1.557 1.65 0 N-CA-C 114.756 1.021 . . . . 0.0 114.756 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.0 pt -106.98 141.75 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.43 89.07 5.58 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.753 0.787 . . . . 0.0 111.397 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.9 t -144.14 119.05 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.0 p -76.01 119.09 19.48 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.926 0.49 . . . . 0.0 112.115 -176.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 66.5 m -93.21 155.22 17.58 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -174.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -136.04 69.72 1.43 Allowed 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.48 156.32 25.64 Favored Glycine 0 CA--C 1.552 2.38 0 CA-C-O 121.669 0.594 . . . . 0.0 113.165 -169.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m -65.98 -41.23 44.0 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 115.271 -2.3 . . . . 0.0 115.789 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.68 -21.98 21.29 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 N-CA-C 119.753 2.944 . . . . 0.0 119.753 171.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -59.24 -37.44 77.58 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 74.2 m -73.52 -9.8 59.06 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.36 -55.95 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.904 1.684 . . . . 0.0 112.584 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.49 -50.12 74.79 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 114.935 -2.46 . . . . 0.0 113.507 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.57 -40.28 37.5 Favored 'Trans proline' 0 CA--C 1.564 2.015 0 CA-C-N 125.58 3.028 . . . . 0.0 118.476 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 77.0 m -63.62 -53.73 47.0 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -60.32 -47.11 87.45 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 175.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.65 -41.5 81.57 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 173.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.63 -48.02 73.62 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 171.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.42 54.73 0.09 OUTLIER Glycine 0 CA--C 1.545 1.91 0 C-N-CA 124.472 1.034 . . . . 0.0 112.297 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 46.5 mtt -147.65 163.05 37.84 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.45 1.119 . . . . 0.0 109.013 -171.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -80.35 -72.14 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.428 -0.795 . . . . 0.0 112.638 -169.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.65 166.78 10.64 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.922 0.867 . . . . 0.0 110.42 -171.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.01 91.19 0.2 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.386 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -111.7 123.54 50.45 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.7 t -96.28 132.34 41.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.12 -164.59 1.14 Allowed 'General case' 0 CA--C 1.576 1.965 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.54 169.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -62.85 98.78 0.13 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.595 -1.316 . . . . 0.0 112.602 -170.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? 57.15 15.39 2.44 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -171.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -144.07 124.74 14.11 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 121.154 1.797 . . . . 0.0 109.832 -171.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.5 m -66.33 139.29 58.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -123.17 108.01 12.36 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.7 m -91.31 132.89 35.86 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.868 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.0 m . . . . . 0 CA--C 1.57 1.716 0 CA-C-O 117.317 -1.325 . . . . 0.0 107.786 179.506 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 CA--C 1.556 1.609 0 N-CA-C 114.93 1.088 . . . . 0.0 114.93 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.5 pt -106.28 160.2 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.883 0.849 . . . . 0.0 108.752 169.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -82.1 81.64 7.96 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.909 0.862 . . . . 0.0 111.61 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.7 t -145.17 114.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.3 p -84.28 117.19 23.4 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.933 0.493 . . . . 0.0 110.519 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 59.6 m -94.95 156.69 16.22 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -169.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -98.49 -48.98 4.81 Favored 'General case' 0 CA--C 1.581 2.136 0 CA-C-N 113.575 -1.648 . . . . 0.0 106.937 167.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.93 -152.3 5.6 Favored Glycine 0 CA--C 1.554 2.527 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -68.05 -42.08 30.03 Favored Pre-proline 0 CA--C 1.576 1.958 0 CA-C-O 115.236 -2.316 . . . . 0.0 115.853 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.87 -32.42 77.48 Favored 'Trans proline' 0 C--N 1.376 1.974 0 N-CA-C 120.682 3.301 . . . . 0.0 120.682 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -62.28 -26.91 68.66 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 72.1 m -82.2 -25.8 33.92 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 171.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.38 -53.87 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-N 120.534 1.515 . . . . 0.0 112.413 -172.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -65.27 -54.05 35.26 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 114.943 -2.456 . . . . 0.0 113.003 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -47.7 -47.19 19.03 Favored 'Trans proline' 0 CA--C 1.562 1.922 0 C-N-CA 123.922 3.081 . . . . 0.0 118.521 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -65.88 -48.74 70.5 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -59.21 -46.76 87.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -61.97 -37.81 86.15 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.42 -54.64 33.52 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 172.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.97 53.73 0.01 OUTLIER Glycine 0 CA--C 1.545 1.965 0 C-N-CA 123.884 0.754 . . . . 0.0 112.985 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 17.8 mmt -137.28 169.64 17.45 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 122.484 1.135 . . . . 0.0 109.694 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -90.05 -62.37 1.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.457 -0.777 . . . . 0.0 110.783 174.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -118.18 164.25 15.43 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.167 0.984 . . . . 0.0 110.491 -172.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.0 90.15 0.25 Allowed Glycine 0 N--CA 1.478 1.473 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 173.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -97.97 109.08 21.9 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.441 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.2 t -94.48 125.23 38.99 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.238 0.542 . . . . 0.0 111.98 -174.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.2 mmt -83.26 -168.36 2.06 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.992 169.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -61.98 100.53 0.16 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.683 -1.26 . . . . 0.0 112.254 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.3 mtm-85 62.76 10.39 4.2 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 117.149 2.278 . . . . 0.0 117.149 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -145.4 127.1 15.24 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 122.028 2.195 . . . . 0.0 110.82 -173.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.2 m -63.84 145.99 54.79 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -142.36 103.04 4.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.0 m -103.57 149.07 25.25 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -171.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 CA--C 1.568 1.669 0 CA-C-O 116.792 -1.575 . . . . 0.0 107.876 -177.817 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.556 1.604 0 N-CA-C 114.641 0.977 . . . . 0.0 114.641 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.0 pt -110.12 143.49 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.42 89.12 5.57 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.635 0.731 . . . . 0.0 111.359 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.9 t -144.81 120.09 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.9 p -76.75 119.1 20.08 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.2 m -95.98 154.23 17.35 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -135.74 70.73 1.42 Allowed 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 168.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.71 158.8 27.71 Favored Glycine 0 CA--C 1.552 2.362 0 CA-C-O 121.805 0.669 . . . . 0.0 113.688 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -64.96 -40.51 47.23 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 115.233 -2.317 . . . . 0.0 115.802 174.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.04 -22.61 19.32 Favored 'Trans proline' 0 CA--C 1.564 2.023 0 N-CA-C 119.94 3.016 . . . . 0.0 119.94 171.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -60.94 -38.44 85.86 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 64.1 m -74.73 -8.48 56.54 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.6 mm -61.03 -55.07 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 121.151 1.796 . . . . 0.0 112.805 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.5 mmmp? -64.73 -49.76 67.79 Favored Pre-proline 0 CA--C 1.573 1.833 0 CA-C-O 114.987 -2.435 . . . . 0.0 113.704 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.76 -40.24 47.65 Favored 'Trans proline' 0 CA--C 1.565 2.06 0 CA-C-N 125.464 2.987 . . . . 0.0 118.318 169.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.4 m -63.57 -52.81 59.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -61.15 -46.42 90.6 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -58.26 -41.38 84.12 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.36 -49.67 68.47 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.52 55.81 0.07 OUTLIER Glycine 0 CA--C 1.544 1.881 0 C-N-CA 124.36 0.981 . . . . 0.0 112.403 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 33.8 mtt -150.6 166.96 28.71 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.401 1.08 . . . . 0.0 108.939 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -84.9 -73.94 0.41 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.126 -0.984 . . . . 0.0 112.459 -171.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.32 160.09 14.84 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.146 0.974 . . . . 0.0 111.071 -169.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.84 89.04 0.37 Allowed Glycine 0 N--CA 1.478 1.499 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.698 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -105.14 118.11 35.72 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.6 t -103.27 130.16 50.44 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 91.6 mmm -85.49 -170.66 3.22 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.002 169.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -62.51 102.73 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.706 -1.246 . . . . 0.0 112.113 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 62.42 7.41 2.33 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -142.34 124.05 15.07 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 122.203 2.274 . . . . 0.0 110.244 -170.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.6 m -66.35 143.93 56.86 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -127.18 109.96 12.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -93.2 127.67 38.86 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.326 0.651 . . . . 0.0 110.862 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.6 m . . . . . 0 CA--C 1.57 1.743 0 CA-C-O 116.954 -1.498 . . . . 0.0 108.802 -176.359 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 CA--C 1.555 1.543 0 N-CA-C 114.335 0.859 . . . . 0.0 114.335 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -97.25 150.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.6 84.44 7.26 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.838 0.828 . . . . 0.0 111.387 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.3 t -144.51 115.7 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.5 p -82.08 122.86 28.38 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.837 0.455 . . . . 0.0 111.585 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 85.6 m -103.42 156.05 18.04 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 -172.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -103.17 -42.92 5.61 Favored 'General case' 0 CA--C 1.582 2.204 0 CA-C-N 112.98 -1.918 . . . . 0.0 107.378 167.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.58 -162.34 9.8 Favored Glycine 0 CA--C 1.554 2.471 0 C-N-CA 124.567 1.079 . . . . 0.0 111.212 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.1 m -66.26 -40.99 39.76 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 115.249 -2.31 . . . . 0.0 116.044 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.11 -24.95 35.21 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 N-CA-C 120.471 3.219 . . . . 0.0 120.471 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -58.97 -43.61 91.37 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 37.5 m -76.41 -13.6 60.11 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 117.507 2.41 . . . . 0.0 117.507 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.4 mm -56.53 -58.47 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-N 120.854 1.661 . . . . 0.0 113.328 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -67.53 -51.15 33.51 Favored Pre-proline 0 CA--C 1.572 1.805 0 CA-C-O 114.705 -2.569 . . . . 0.0 113.227 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -47.42 -44.96 23.92 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 CA-C-N 125.764 3.094 . . . . 0.0 118.26 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 87.9 m -60.85 -47.78 84.82 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -61.94 -49.8 74.68 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -67.11 -30.39 70.4 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.13 -55.58 13.6 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.258 1.39 . . . . 0.0 113.796 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.61 47.1 0.01 OUTLIER Glycine 0 CA--C 1.546 1.983 0 CA-C-O 119.365 -0.686 . . . . 0.0 114.353 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -142.77 178.3 7.73 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-O 122.564 1.173 . . . . 0.0 109.518 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -93.87 -74.47 0.53 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.095 0.958 . . . . 0.0 110.4 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -99.59 162.06 13.24 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.222 1.011 . . . . 0.0 110.843 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.73 97.08 0.57 Allowed Glycine 0 N--CA 1.477 1.422 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 171.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.73 111.34 23.98 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.5 t -98.08 127.13 43.85 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -171.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.2 mmt -81.02 -178.0 6.69 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.726 169.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -62.92 101.84 0.3 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.708 -1.245 . . . . 0.0 111.818 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 68.96 0.58 2.82 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 -173.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.62 125.69 27.68 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 122.416 2.371 . . . . 0.0 110.065 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.6 m -68.93 139.28 55.08 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -132.71 106.38 7.74 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 171.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.3 m -74.74 149.44 39.8 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.7 m . . . . . 0 CA--C 1.564 1.514 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 178.518 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.385 0 CA-C-O 119.554 -0.581 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.6 t -115.32 105.07 52.96 Favored Pre-proline 0 CA--C 1.57 1.723 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.04 119.14 6.15 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 123.076 2.517 . . . . 0.0 113.446 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.9 pt -106.49 142.28 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -82.47 89.69 6.66 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.806 0.812 . . . . 0.0 110.785 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.4 t -142.84 118.14 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -176.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.8 p -78.52 117.78 20.03 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 80.9 m -101.65 155.58 18.02 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -174.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -104.33 -41.0 5.9 Favored 'General case' 0 CA--C 1.582 2.197 0 CA-C-N 113.145 -1.843 . . . . 0.0 107.976 167.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.17 -166.56 12.14 Favored Glycine 0 CA--C 1.554 2.478 0 C-N-CA 124.396 0.998 . . . . 0.0 111.707 169.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.9 m -67.76 -41.94 31.94 Favored Pre-proline 0 CA--C 1.573 1.861 0 CA-C-O 115.208 -2.329 . . . . 0.0 115.897 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.61 -22.44 28.43 Favored 'Trans proline' 0 CA--C 1.564 1.989 0 N-CA-C 120.248 3.134 . . . . 0.0 120.248 174.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -58.05 -42.05 84.61 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 59.7 m -76.81 -10.26 59.25 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mm -58.83 -55.23 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 120.915 1.689 . . . . 0.0 112.924 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -68.43 -51.27 24.35 Favored Pre-proline 0 CA--C 1.572 1.798 0 CA-C-O 114.951 -2.452 . . . . 0.0 113.079 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -49.18 -43.08 38.21 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 CA-C-N 125.581 3.029 . . . . 0.0 118.326 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.8 m -60.89 -52.27 65.74 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.49 -48.95 77.85 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -62.15 -37.21 84.34 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.28 -52.9 51.24 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.36 53.22 0.02 OUTLIER Glycine 0 CA--C 1.545 1.942 0 C-N-CA 124.015 0.817 . . . . 0.0 113.095 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -142.18 166.59 24.28 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.66 1.219 . . . . 0.0 110.167 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -81.67 -63.03 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.119 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -119.49 165.34 14.51 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 122.355 1.074 . . . . 0.0 110.388 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.91 94.29 0.25 Allowed Glycine 0 N--CA 1.477 1.385 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.66 119.12 38.29 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.3 t -99.98 127.54 46.18 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.328 0.585 . . . . 0.0 112.426 -175.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 92.4 mmm -83.2 -173.42 4.7 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.78 169.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -62.32 101.14 0.21 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.784 -1.197 . . . . 0.0 112.063 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 65.96 6.32 3.98 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -141.48 127.11 19.01 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 122.686 2.493 . . . . 0.0 110.643 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.2 m -69.35 142.65 53.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -133.96 109.22 8.87 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.0 m -84.0 154.39 23.32 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.7 m -101.42 106.1 43.86 Favored Pre-proline 0 CA--C 1.569 1.709 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.23 146.38 86.26 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.13 2.553 . . . . 0.0 116.27 -171.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm . . . . . 0 C--O 1.253 1.24 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.086 -175.797 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.444 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.36 107.37 39.2 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.43 117.32 4.27 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.164 2.576 . . . . 0.0 114.537 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.2 pt -113.47 143.37 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -80.17 84.14 5.92 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.95 0.881 . . . . 0.0 111.878 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.3 t -144.51 115.34 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.4 p -80.45 120.45 24.48 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.862 0.465 . . . . 0.0 111.206 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.59 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 59.7 m -91.41 155.5 18.42 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -171.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -135.98 70.58 1.42 Allowed 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 168.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.71 155.95 28.36 Favored Glycine 0 CA--C 1.553 2.423 0 CA-C-O 121.742 0.634 . . . . 0.0 113.232 -169.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 m -63.35 -39.62 51.53 Favored Pre-proline 0 CA--C 1.573 1.856 0 CA-C-O 115.213 -2.327 . . . . 0.0 116.095 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.26 -25.25 23.17 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 CA-C-N 125.336 2.941 . . . . 0.0 119.734 171.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -59.13 -40.66 86.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.59 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 65.8 m -73.67 -14.86 61.23 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.0 mm -57.07 -56.57 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-N 120.727 1.603 . . . . 0.0 113.069 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -66.29 -51.42 43.93 Favored Pre-proline 0 CA--C 1.572 1.816 0 CA-C-O 114.696 -2.573 . . . . 0.0 113.447 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -46.75 -46.0 19.02 Favored 'Trans proline' 0 CA--C 1.564 1.992 0 CA-C-N 125.78 3.1 . . . . 0.0 118.071 171.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -59.8 -49.24 78.49 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -61.88 -49.91 74.32 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.7 -31.12 72.21 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.86 -56.02 14.02 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.082 1.31 . . . . 0.0 113.637 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.31 51.77 0.01 OUTLIER Glycine 0 CA--C 1.545 1.949 0 C-N-CA 123.707 0.67 . . . . 0.0 113.516 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -142.83 168.73 19.03 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 122.534 1.159 . . . . 0.0 110.181 -174.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -82.28 -64.02 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.534 -0.729 . . . . 0.0 111.747 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -116.45 163.57 15.85 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.245 1.021 . . . . 0.0 110.348 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -132.45 95.58 0.3 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -108.98 122.93 48.28 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.474 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.8 t -102.06 132.36 47.96 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -171.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.97 -164.04 1.08 Allowed 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -63.29 99.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.415 -1.428 . . . . 0.0 112.227 -171.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 58.83 15.24 3.71 Favored 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -139.6 122.61 16.74 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.524 1.965 . . . . 0.0 110.595 -170.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 66.2 m -71.05 135.88 48.0 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -132.61 112.71 12.28 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.7 m -86.35 151.51 23.51 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.0 m -98.96 107.13 42.1 Favored Pre-proline 0 CA--C 1.569 1.699 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.47 146.29 67.72 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 123.029 2.486 . . . . 0.0 115.955 -170.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt . . . . . 0 C--O 1.254 1.303 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.2 -175.279 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.422 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.5 m -80.22 139.12 52.36 Favored Pre-proline 0 CA--C 1.575 1.927 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.607 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.55 133.64 16.02 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 122.988 2.459 . . . . 0.0 114.743 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.3 pt -118.45 142.35 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 169.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -81.07 88.99 5.94 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.671 0.748 . . . . 0.0 111.276 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.6 t -143.62 119.8 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.8 p -75.91 119.69 20.23 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.992 0.517 . . . . 0.0 112.306 -176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 70.2 m -97.24 154.81 17.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -174.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 t -135.29 70.03 1.44 Allowed 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.52 157.45 25.76 Favored Glycine 0 CA--C 1.551 2.331 0 CA-C-O 121.877 0.709 . . . . 0.0 113.579 -169.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.4 m -65.48 -41.13 47.89 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 115.328 -2.272 . . . . 0.0 115.899 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.6 -21.73 20.07 Favored 'Trans proline' 0 CA--C 1.566 2.124 0 N-CA-C 119.88 2.992 . . . . 0.0 119.88 171.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -60.63 -37.58 81.94 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 66.3 m -74.83 -8.79 57.49 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.67 -54.75 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 120.983 1.72 . . . . 0.0 112.847 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.33 -51.16 54.83 Favored Pre-proline 0 CA--C 1.574 1.867 0 CA-C-O 114.758 -2.544 . . . . 0.0 112.713 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.59 -41.0 30.58 Favored 'Trans proline' 0 CA--C 1.565 2.031 0 CA-C-N 125.856 3.127 . . . . 0.0 118.636 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.0 m -62.36 -54.81 34.99 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -59.81 -46.7 88.41 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.21 -41.44 79.44 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.47 -49.75 67.92 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.8 55.49 0.07 OUTLIER Glycine 0 CA--C 1.545 1.925 0 C-N-CA 124.413 1.006 . . . . 0.0 112.228 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.9 mtt -147.24 162.53 38.71 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.434 1.111 . . . . 0.0 109.364 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -79.48 -71.24 0.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 112.582 -170.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -110.96 166.0 11.4 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.972 0.891 . . . . 0.0 110.474 -170.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.68 90.55 0.24 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -107.43 118.56 37.04 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.4 t -97.97 131.76 44.13 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -175.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 79.9 mtp -87.2 -167.28 1.83 Allowed 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 169.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -62.11 99.83 0.14 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.572 -1.33 . . . . 0.0 112.713 -170.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 58.63 13.5 2.63 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -172.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -143.45 124.69 14.58 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 121.85 2.114 . . . . 0.0 109.874 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.7 m -66.19 141.74 57.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -126.69 105.34 8.63 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.7 m -88.54 136.54 32.94 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.465 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.0 m -83.25 115.19 57.84 Favored Pre-proline 0 CA--C 1.568 1.667 0 CA-C-O 117.176 -1.392 . . . . 0.0 107.767 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.53 138.34 29.45 Favored 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 122.788 2.325 . . . . 0.0 114.811 -169.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.874 -178.78 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 85.8 t -99.7 112.78 64.33 Favored Pre-proline 0 CA--C 1.571 1.769 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.4 107.87 2.55 Favored 'Trans proline' 0 CA--C 1.558 1.704 0 C-N-CA 122.864 2.376 . . . . 0.0 113.378 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.9 pt -98.54 146.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -80.16 84.82 5.79 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.864 0.84 . . . . 0.0 111.683 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.8 t -145.83 115.31 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.1 p -81.34 120.41 24.92 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.793 0.437 . . . . 0.0 111.293 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 71.6 m -95.34 153.77 17.52 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -172.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -130.05 50.03 2.22 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.562 168.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.69 162.85 11.66 Favored Glycine 0 CA--C 1.553 2.43 0 C-N-CA 124.212 0.911 . . . . 0.0 112.342 -169.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.0 m -66.47 -41.39 40.39 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 115.167 -2.349 . . . . 0.0 116.288 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -53.66 -24.25 29.05 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 N-CA-C 120.134 3.09 . . . . 0.0 120.134 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -58.7 -39.51 80.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 175.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 60.7 m -76.0 -11.8 60.02 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.8 mm -59.43 -57.93 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 120.723 1.601 . . . . 0.0 112.982 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -68.15 -45.59 40.12 Favored Pre-proline 0 CA--C 1.571 1.76 0 CA-C-O 114.931 -2.461 . . . . 0.0 114.249 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.02 -42.46 64.41 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.757 3.092 . . . . 0.0 117.697 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 99.0 m -59.73 -52.35 65.86 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -56.72 -48.64 77.28 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 174.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.12 -40.05 84.22 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.82 -50.62 68.2 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 171.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.85 57.12 0.05 OUTLIER Glycine 0 CA--C 1.545 1.923 0 C-N-CA 124.481 1.039 . . . . 0.0 111.713 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.6 mmt -144.36 158.85 43.53 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.441 1.115 . . . . 0.0 109.112 -172.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -80.3 -74.84 0.29 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.841 0.856 . . . . 0.0 111.487 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -98.75 161.85 13.43 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.264 1.031 . . . . 0.0 111.071 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.83 93.42 0.3 Allowed Glycine 0 N--CA 1.478 1.434 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -111.36 120.19 41.38 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 4.5 t -99.02 129.85 45.33 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -171.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 86.2 mtp -84.9 -167.95 2.02 Favored 'General case' 0 CA--C 1.575 1.926 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.792 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.83 100.14 0.28 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.58 -1.325 . . . . 0.0 112.086 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 59.25 15.61 4.37 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -172.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -142.21 122.51 13.92 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.365 1.893 . . . . 0.0 110.024 -170.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.3 m -70.6 134.91 48.03 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -129.19 109.52 11.22 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.4 m -83.67 150.52 25.82 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.2 m -106.11 111.67 64.31 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -59.25 149.85 78.1 Favored 'Trans proline' 0 CA--C 1.558 1.711 0 C-N-CA 123.212 2.608 . . . . 0.0 117.304 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt . . . . . 0 N--CA 1.488 1.429 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.354 177.516 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.475 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.2 m -74.49 132.95 77.75 Favored Pre-proline 0 CA--C 1.577 2.009 0 CA-C-O 117.713 -1.137 . . . . 0.0 111.663 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -64.99 141.76 71.89 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 123.114 2.542 . . . . 0.0 116.678 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.6 pt -129.18 143.53 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 169.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.69 87.62 6.74 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.812 0.815 . . . . 0.0 111.546 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.9 t -144.5 119.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.8 p -79.9 121.89 25.99 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.972 0.509 . . . . 0.0 112.157 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 83.0 m -104.52 156.63 17.78 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -174.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 t -103.98 -42.37 5.59 Favored 'General case' 0 CA--C 1.582 2.197 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.484 167.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.7 -164.53 10.85 Favored Glycine 0 CA--C 1.554 2.485 0 C-N-CA 124.476 1.036 . . . . 0.0 111.411 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.3 m -67.6 -41.2 29.42 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-O 115.238 -2.315 . . . . 0.0 115.822 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.48 -22.89 29.25 Favored 'Trans proline' 0 CA--C 1.564 2.0 0 N-CA-C 120.433 3.205 . . . . 0.0 120.433 175.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -58.62 -41.76 86.65 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 40.9 m -75.84 -10.34 59.34 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.44 -55.26 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.824 1.647 . . . . 0.0 112.831 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.73 -51.57 48.34 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 114.607 -2.616 . . . . 0.0 112.568 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.47 -41.36 36.47 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 CA-C-N 125.962 3.165 . . . . 0.0 118.717 170.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 76.9 m -63.12 -54.48 37.14 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -60.98 -46.16 91.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.87 -41.5 78.11 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.59 -49.35 71.48 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 170.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.13 56.08 0.08 OUTLIER Glycine 0 CA--C 1.543 1.826 0 C-N-CA 124.566 1.079 . . . . 0.0 112.174 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 51.2 mtt -143.79 164.6 30.04 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.611 1.196 . . . . 0.0 109.754 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -76.52 -64.2 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.82 0.848 . . . . 0.0 113.286 -169.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -125.2 162.44 24.67 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.014 0.911 . . . . 0.0 110.171 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.09 92.67 0.45 Allowed Glycine 0 N--CA 1.477 1.429 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -109.45 116.32 31.59 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.4 t -101.31 127.5 47.89 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -173.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.9 mtt -84.24 -168.66 2.25 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.028 169.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -63.05 100.56 0.22 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.755 -1.216 . . . . 0.0 112.166 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 60.81 13.04 4.13 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -141.87 123.23 14.85 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.808 2.094 . . . . 0.0 110.324 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.402 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 39.1 m -70.36 141.62 52.23 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -133.0 108.15 8.71 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.6 m -87.73 136.28 33.02 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.331 0.652 . . . . 0.0 111.505 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m -82.49 115.08 56.07 Favored Pre-proline 0 CA--C 1.57 1.721 0 CA-C-O 117.082 -1.437 . . . . 0.0 107.456 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.97 142.71 39.2 Favored 'Trans proline' 0 CA--C 1.56 1.78 0 C-N-CA 122.755 2.303 . . . . 0.0 115.088 -169.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.1 tttp . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.289 -178.853 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.387 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.7 t -120.0 107.22 40.15 Favored Pre-proline 0 CA--C 1.567 1.63 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 -176.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.32 107.14 2.31 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.745 2.297 . . . . 0.0 113.566 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.4 pt -95.24 145.41 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.83 83.98 6.45 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.933 0.873 . . . . 0.0 111.598 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.3 t -145.06 114.95 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 103.876 -2.638 . . . . 0.0 103.876 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.0 p -81.03 120.79 25.25 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.709 0.404 . . . . 0.0 110.924 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 27.3 m -89.64 153.33 20.83 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -170.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -132.26 69.69 1.48 Allowed 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.81 150.9 22.88 Favored Glycine 0 CA--C 1.552 2.348 0 C-N-CA 123.497 0.57 . . . . 0.0 112.813 -169.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 t -61.83 -41.46 77.27 Favored Pre-proline 0 CA--C 1.574 1.891 0 CA-C-O 115.241 -2.314 . . . . 0.0 115.913 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -54.19 -24.15 32.5 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 N-CA-C 119.755 2.944 . . . . 0.0 119.755 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -57.58 -38.18 74.43 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 67.4 m -72.13 -14.24 61.77 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 176.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 71.5 mt -65.1 -51.48 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.88 1.673 . . . . 0.0 112.617 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -64.1 -49.61 73.04 Favored Pre-proline 0 CA--C 1.577 2.013 0 CA-C-O 115.008 -2.425 . . . . 0.0 112.97 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.02 -41.28 65.03 Favored 'Trans proline' 0 CA--C 1.565 2.04 0 CA-C-N 125.493 2.998 . . . . 0.0 118.046 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.8 m -61.41 -51.25 69.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -59.11 -46.77 87.47 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -57.57 -41.15 80.53 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 -51.61 58.64 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 170.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.16 55.25 0.04 OUTLIER Glycine 0 CA--C 1.544 1.848 0 C-N-CA 124.192 0.901 . . . . 0.0 113.114 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -143.09 165.79 26.44 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.817 1.294 . . . . 0.0 110.218 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -83.51 -74.55 0.36 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 124.23 1.012 . . . . 0.0 111.021 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -95.82 159.71 14.84 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.25 1.024 . . . . 0.0 111.077 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.22 94.58 0.33 Allowed Glycine 0 N--CA 1.478 1.496 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -113.94 125.0 53.54 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.402 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 11.7 t -102.27 132.31 48.3 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -169.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -85.26 -161.25 0.57 Allowed 'General case' 0 CA--C 1.578 2.055 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.296 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -63.74 94.16 0.09 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.402 -1.436 . . . . 0.0 111.827 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.1 mtp-105 51.24 30.1 5.53 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -169.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -139.79 117.68 11.73 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 119.706 1.139 . . . . 0.0 109.409 -171.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.9 m -71.89 131.05 42.46 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -126.88 115.27 19.05 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -87.93 146.71 25.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.203 0.601 . . . . 0.0 112.255 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m -106.91 109.83 63.3 Favored Pre-proline 0 CA--C 1.566 1.592 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -54.43 149.09 39.76 Favored 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 123.609 2.873 . . . . 0.0 118.223 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt . . . . . 0 N--CA 1.485 1.325 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.3 -178.593 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.464 0 N-CA-C 111.806 -0.517 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.4 m -79.24 123.52 84.66 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.611 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -67.05 134.71 35.05 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.99 2.46 . . . . 0.0 115.249 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.5 pt -122.97 140.05 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -81.77 87.01 6.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.805 0.812 . . . . 0.0 111.293 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.2 t -144.34 118.8 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 87.6 p -78.3 122.54 25.86 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.897 0.479 . . . . 0.0 111.852 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.599 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 62.6 m -96.09 155.04 16.92 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -172.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 t -134.94 69.68 1.45 Allowed 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 168.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 156.48 24.89 Favored Glycine 0 CA--C 1.553 2.436 0 C-N-CA 123.58 0.61 . . . . 0.0 113.717 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 t -64.74 -41.56 57.51 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 115.22 -2.324 . . . . 0.0 115.684 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -53.58 -22.77 23.17 Favored 'Trans proline' 0 CA--C 1.566 2.101 0 N-CA-C 119.846 2.979 . . . . 0.0 119.846 171.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -59.76 -39.03 83.46 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.599 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 63.8 m -75.02 -10.07 59.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.0 mm -59.21 -56.15 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-N 120.838 1.654 . . . . 0.0 112.817 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -67.04 -48.06 50.74 Favored Pre-proline 0 CA--C 1.574 1.887 0 CA-C-O 115.022 -2.418 . . . . 0.0 113.776 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.68 -41.82 59.72 Favored 'Trans proline' 0 CA--C 1.564 2.02 0 CA-C-N 125.668 3.06 . . . . 0.0 118.065 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.2 m -60.86 -50.97 71.28 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -57.4 -46.78 83.1 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 173.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.49 -41.25 89.42 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.39 -50.38 65.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.75 54.44 0.04 OUTLIER Glycine 0 CA--C 1.545 1.923 0 C-N-CA 124.212 0.91 . . . . 0.0 112.768 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -143.63 162.8 34.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.869 1.319 . . . . 0.0 110.029 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -81.78 -72.45 0.43 Allowed 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.19 0.996 . . . . 0.0 111.233 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -101.34 165.35 11.31 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.399 1.095 . . . . 0.0 110.887 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.16 94.04 0.22 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 174.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -107.61 125.23 51.07 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.4 t -104.32 133.46 49.19 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -172.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 86.0 mtp -87.71 -165.92 1.44 Allowed 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.316 169.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -63.47 99.66 0.22 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.458 -1.401 . . . . 0.0 112.096 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 59.72 16.81 5.79 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -140.85 118.83 11.86 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 121.677 2.035 . . . . 0.0 110.443 -169.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.4 m -69.8 137.91 52.24 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -134.25 108.69 8.39 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.3 m -82.98 153.19 25.12 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 m -109.35 106.08 58.1 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -60.03 144.97 99.43 Favored 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 123.152 2.568 . . . . 0.0 117.39 -175.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 117.838 -1.077 . . . . 0.0 113.213 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.459 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.6 t -135.35 113.21 11.17 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.86 107.5 2.36 Favored 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 122.854 2.369 . . . . 0.0 113.712 -175.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.9 pt -99.2 144.57 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 170.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.45 87.46 5.07 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.86 0.838 . . . . 0.0 111.515 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.6 t -145.55 116.98 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.1 p -80.07 117.79 21.21 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.728 0.411 . . . . 0.0 111.571 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 86.2 m -95.17 155.22 16.82 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -174.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 t -130.54 48.97 2.35 Favored 'General case' 0 CA--C 1.58 2.134 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.381 168.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.57 160.62 10.98 Favored Glycine 0 CA--C 1.555 2.57 0 C-N-CA 124.369 0.985 . . . . 0.0 112.17 -169.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.0 m -64.75 -40.33 47.34 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-O 115.118 -2.372 . . . . 0.0 116.201 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.15 -23.68 23.34 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 N-CA-C 120.191 3.112 . . . . 0.0 120.191 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -61.53 -41.45 97.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 62.7 m -73.43 -12.45 60.81 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 117.954 2.575 . . . . 0.0 117.954 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.2 mm -60.46 -49.84 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 120.884 1.674 . . . . 0.0 113.065 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.64 -53.93 40.48 Favored Pre-proline 0 CA--C 1.572 1.823 0 CA-C-O 115.1 -2.381 . . . . 0.0 112.756 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.59 -43.61 44.48 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 125.351 2.947 . . . . 0.0 118.738 171.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.0 m -63.4 -51.0 67.63 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 173.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -61.46 -45.45 94.21 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -58.37 -40.95 83.66 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.2 -50.43 70.34 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.71 55.79 0.06 OUTLIER Glycine 0 CA--C 1.543 1.798 0 C-N-CA 124.262 0.934 . . . . 0.0 112.293 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 43.3 mtt -143.59 168.47 19.81 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.617 1.199 . . . . 0.0 109.968 -174.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -75.81 -62.76 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -170.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -129.97 160.56 33.26 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.228 1.013 . . . . 0.0 110.076 -170.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.47 93.22 0.59 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -106.3 111.7 24.4 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 6.1 t -97.67 128.13 44.14 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 83.1 mtp -84.19 -165.9 1.28 Allowed 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.158 169.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -63.51 98.41 0.17 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.738 -1.226 . . . . 0.0 112.445 -170.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 54.18 22.01 3.37 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -170.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -143.73 122.8 12.86 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 120.886 1.676 . . . . 0.0 109.718 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 67.1 m -68.98 134.87 50.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -125.12 110.79 14.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.7 m -83.83 140.51 31.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.142 0.577 . . . . 0.0 112.077 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.3 m -90.25 111.09 45.05 Favored Pre-proline 0 CA--C 1.57 1.739 0 CA-C-O 117.193 -1.384 . . . . 0.0 107.321 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.63 148.47 25.97 Favored 'Trans proline' 0 CA--C 1.558 1.703 0 C-N-CA 122.737 2.291 . . . . 0.0 115.04 -170.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.771 174.924 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.353 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.2 t -108.93 108.17 60.5 Favored Pre-proline 0 CA--C 1.567 1.634 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.64 105.2 2.01 Favored 'Trans proline' 0 CA--C 1.557 1.631 0 C-N-CA 122.784 2.323 . . . . 0.0 113.304 -175.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.1 pt -94.46 145.61 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.02 86.49 6.11 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.852 0.834 . . . . 0.0 111.382 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.8 t -144.44 116.97 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.9 p -81.61 119.53 23.91 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.807 0.443 . . . . 0.0 111.445 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 64.1 m -98.65 156.65 16.71 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -174.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -104.7 -42.98 5.24 Favored 'General case' 0 CA--C 1.582 2.185 0 CA-C-N 113.445 -1.707 . . . . 0.0 107.26 167.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.16 -167.0 11.4 Favored Glycine 0 CA--C 1.555 2.591 0 C-N-CA 124.441 1.019 . . . . 0.0 111.316 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.2 m -67.85 -41.72 30.08 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-O 115.215 -2.326 . . . . 0.0 115.665 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.64 -22.66 29.39 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 N-CA-C 120.368 3.18 . . . . 0.0 120.368 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -58.03 -43.37 86.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 55.5 m -74.71 -9.78 58.89 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.1 mm -58.63 -57.24 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-N 121.548 1.977 . . . . 0.0 112.187 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -57.04 -53.99 59.35 Favored Pre-proline 0 CA--C 1.573 1.836 0 CA-C-O 115.347 -2.263 . . . . 0.0 114.35 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -62.36 -43.51 22.59 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.41 2.968 . . . . 0.0 116.446 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.9 m -60.93 -54.68 42.01 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 173.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.36 -52.37 65.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.87 -30.98 71.67 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.39 -56.33 13.14 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 120.646 1.566 . . . . 0.0 113.735 172.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.27 49.74 0.01 OUTLIER Glycine 0 CA--C 1.544 1.855 0 CA-C-O 119.416 -0.658 . . . . 0.0 114.142 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -139.92 175.75 9.32 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 122.643 1.211 . . . . 0.0 109.91 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -84.22 -61.88 1.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 111.933 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.99 160.51 28.79 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.329 1.061 . . . . 0.0 110.452 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.81 97.61 0.61 Allowed Glycine 0 N--CA 1.478 1.469 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.528 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 118.85 37.31 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 4.6 t -102.99 128.75 49.68 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -170.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -82.13 -168.48 1.97 Allowed 'General case' 0 CA--C 1.575 1.924 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.168 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.6 98.69 0.19 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.84 -1.163 . . . . 0.0 111.965 -173.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 56.83 20.67 5.38 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -171.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -143.41 120.67 11.55 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 121.149 1.795 . . . . 0.0 110.093 -172.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.2 m -70.21 137.79 51.18 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -131.69 116.59 17.51 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -83.29 150.75 25.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.5 m -104.15 100.51 21.57 Favored Pre-proline 0 CA--C 1.569 1.698 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.33 154.07 50.98 Favored 'Trans proline' 0 CA--C 1.557 1.658 0 C-N-CA 122.917 2.411 . . . . 0.0 115.199 -172.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 118.249 -0.881 . . . . 0.0 109.653 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.389 0 CA-C-O 119.754 -0.47 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.3 m -98.04 122.1 55.43 Favored Pre-proline 0 CA--C 1.571 1.759 0 CA-C-O 117.838 -1.077 . . . . 0.0 108.236 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.71 114.16 3.96 Favored 'Trans proline' 0 CA--C 1.557 1.634 0 C-N-CA 122.979 2.453 . . . . 0.0 113.975 -173.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 pt -108.1 139.31 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.33 90.28 6.13 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.895 0.855 . . . . 0.0 110.87 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.6 t -141.96 115.61 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.1 p -74.41 116.83 15.53 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 64.5 m -91.15 154.19 19.52 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -135.14 68.78 1.46 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.93 156.33 23.0 Favored Glycine 0 CA--C 1.551 2.322 0 CA-C-O 121.713 0.619 . . . . 0.0 112.921 -169.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -67.95 -42.86 34.77 Favored Pre-proline 0 N--CA 1.495 1.812 0 CA-C-O 115.287 -2.292 . . . . 0.0 115.785 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -54.11 -22.42 25.29 Favored 'Trans proline' 0 CA--C 1.563 1.973 0 N-CA-C 119.704 2.924 . . . . 0.0 119.704 171.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -55.33 -39.07 69.55 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 75.0 m -73.44 -10.78 60.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.68 -51.95 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 120.75 1.614 . . . . 0.0 112.257 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -66.86 -49.53 47.83 Favored Pre-proline 0 CA--C 1.576 1.971 0 CA-C-O 115.034 -2.412 . . . . 0.0 113.505 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.44 -41.7 51.06 Favored 'Trans proline' 0 CA--C 1.565 2.069 0 CA-C-N 125.704 3.073 . . . . 0.0 117.95 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.0 m -60.96 -50.07 74.87 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -55.59 -52.18 64.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -64.69 -33.66 76.48 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.8 -53.73 29.88 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 119.824 1.193 . . . . 0.0 113.95 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.65 53.51 0.02 OUTLIER Glycine 0 CA--C 1.544 1.906 0 C-N-CA 124.012 0.815 . . . . 0.0 113.13 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -145.92 164.01 33.34 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.77 1.272 . . . . 0.0 110.11 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -81.21 -73.43 0.38 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.003 0.921 . . . . 0.0 111.432 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -102.44 167.91 9.65 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.03 0.919 . . . . 0.0 111.128 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.71 100.22 0.23 Allowed Glycine 0 N--CA 1.477 1.392 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 129.31 56.68 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.5 t -95.73 133.09 40.24 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.8 mmt -88.4 -166.37 1.57 Allowed 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.387 169.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -61.91 98.91 0.11 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.407 -1.433 . . . . 0.0 112.837 -170.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 56.44 13.14 1.21 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 -171.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -141.92 130.23 22.33 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 121.266 1.848 . . . . 0.0 109.951 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.3 m -66.75 135.8 54.53 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -123.66 107.78 11.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.2 m -83.96 158.56 21.5 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.772 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.3 m -111.33 103.4 54.94 Favored Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 173.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -59.15 147.77 88.97 Favored 'Trans proline' 0 CA--C 1.556 1.615 0 C-N-CA 123.224 2.616 . . . . 0.0 116.965 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.6 tptp . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.389 -176.181 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.472 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 79.6 t -86.57 122.42 71.83 Favored Pre-proline 0 CA--C 1.573 1.854 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.72 127.15 12.05 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.889 2.393 . . . . 0.0 114.611 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.446 HD11 ' SG ' ' A' ' 18' ' ' CYS . 19.8 pt -114.59 150.46 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.68 87.04 6.32 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.817 0.818 . . . . 0.0 111.38 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.7 115.72 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.2 p -78.91 118.13 20.65 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.836 0.455 . . . . 0.0 111.576 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 77.9 m -95.05 155.56 16.68 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -171.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -135.79 70.11 1.43 Allowed 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 168.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.0 157.98 25.31 Favored Glycine 0 CA--C 1.551 2.316 0 CA-C-O 121.917 0.732 . . . . 0.0 113.564 -169.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -64.19 -41.65 62.63 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 115.3 -2.286 . . . . 0.0 115.962 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.74 -22.89 24.52 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.946 3.018 . . . . 0.0 119.946 172.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -60.98 -36.67 80.05 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.9 m -71.3 -19.8 62.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.3 mm -57.73 -56.61 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 120.802 1.637 . . . . 0.0 113.575 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -68.13 -51.45 26.52 Favored Pre-proline 0 CA--C 1.575 1.941 0 CA-C-O 114.99 -2.433 . . . . 0.0 113.39 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.82 -45.55 24.01 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 125.649 3.053 . . . . 0.0 118.049 170.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 4' ' ' ILE . 98.4 m -67.62 -45.25 75.94 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -59.17 -47.91 83.56 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 173.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -61.18 -37.42 82.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 172.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.89 -52.92 57.7 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.4 59.48 0.03 OUTLIER Glycine 0 CA--C 1.543 1.833 0 C-N-CA 124.275 0.941 . . . . 0.0 111.851 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 20.4 mmt -140.91 164.18 30.96 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.77 1.272 . . . . 0.0 109.892 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -93.37 -72.15 0.62 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.4 1.08 . . . . 0.0 110.114 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -99.25 164.75 12.01 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.993 0.901 . . . . 0.0 110.846 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.52 88.86 0.18 Allowed Glycine 0 N--CA 1.481 1.667 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.082 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -107.28 116.74 32.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.0 t -97.67 130.94 44.63 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.556 0.693 . . . . 0.0 112.863 -173.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -87.55 -164.74 1.14 Allowed 'General case' 0 CA--C 1.575 1.937 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.771 169.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -63.42 99.12 0.19 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.764 -1.21 . . . . 0.0 112.398 -170.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 55.6 19.31 3.21 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -171.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -144.85 121.43 11.09 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 121.574 1.988 . . . . 0.0 110.144 -172.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.7 m -67.34 136.28 54.57 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -127.14 100.67 6.19 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 170.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.1 m -107.62 128.78 54.84 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.453 -172.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.8 m -81.28 123.61 81.33 Favored Pre-proline 0 CA--C 1.566 1.558 0 CA-C-O 117.102 -1.428 . . . . 0.0 108.272 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.18 149.98 46.86 Favored 'Trans proline' 0 CA--C 1.559 1.726 0 C-N-CA 122.796 2.331 . . . . 0.0 114.658 -173.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt . . . . . 0 N--CA 1.488 1.432 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.768 -178.689 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.408 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.97 110.92 56.63 Favored Pre-proline 0 CA--C 1.568 1.665 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.66 103.45 1.64 Allowed 'Trans proline' 0 CA--C 1.559 1.736 0 C-N-CA 122.821 2.347 . . . . 0.0 113.01 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.2 pt -100.06 144.0 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -78.91 88.24 4.72 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.948 0.88 . . . . 0.0 111.258 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.6 t -145.16 114.44 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -76.97 114.62 15.96 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.066 0.46 . . . . 0.0 111.726 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.8 m -88.54 154.85 20.01 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -137.23 71.15 1.4 Allowed 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.0 159.09 29.38 Favored Glycine 0 CA--C 1.552 2.362 0 CA-C-O 121.845 0.692 . . . . 0.0 113.402 -169.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.2 m -65.63 -40.19 38.76 Favored Pre-proline 0 CA--C 1.572 1.822 0 CA-C-O 115.191 -2.337 . . . . 0.0 115.979 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.21 -23.22 22.23 Favored 'Trans proline' 0 CA--C 1.566 2.079 0 CA-C-N 125.399 2.964 . . . . 0.0 119.764 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -58.76 -38.7 79.05 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 172.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 82.4 m -73.96 -10.05 59.26 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 117.928 2.566 . . . . 0.0 117.928 177.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.76 -55.86 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 120.852 1.66 . . . . 0.0 112.606 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -64.22 -49.75 71.5 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 114.896 -2.478 . . . . 0.0 113.399 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.19 -43.3 43.65 Favored 'Trans proline' 0 CA--C 1.564 2.023 0 CA-C-N 125.714 3.076 . . . . 0.0 118.378 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.9 m -62.95 -51.63 66.15 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -59.15 -46.92 87.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -57.41 -40.85 79.17 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.71 -48.95 72.77 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.22 59.04 0.08 OUTLIER Glycine 0 CA--C 1.543 1.813 0 C-N-CA 124.478 1.037 . . . . 0.0 111.607 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.7 mmt -140.47 166.04 25.8 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.544 1.164 . . . . 0.0 109.609 -171.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -80.12 -56.66 4.08 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.914 0.886 . . . . 0.0 113.21 -176.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -131.93 164.38 26.27 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.997 0.903 . . . . 0.0 110.223 -172.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.42 95.25 0.39 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -115.66 116.39 28.03 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.4 t -93.8 129.58 40.13 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -170.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 93.5 mmm -84.44 -172.1 3.98 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.737 169.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -61.0 101.18 0.14 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.641 -1.287 . . . . 0.0 112.573 -171.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? 64.74 5.25 2.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -175.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -145.96 132.83 20.12 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 122.141 2.246 . . . . 0.0 111.013 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.4 m -66.64 138.5 57.48 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -124.39 110.39 14.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 171.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.3 m -87.28 139.8 30.19 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.863 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -83.67 115.34 59.11 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 173.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.83 150.1 43.73 Favored 'Trans proline' 0 CA--C 1.557 1.674 0 CA-C-N 123.42 2.257 . . . . 0.0 115.843 -169.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt . . . . . 0 N--CA 1.486 1.326 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.102 -176.282 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.353 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.4 t -92.03 117.72 67.85 Favored Pre-proline 0 CA--C 1.571 1.785 0 CA-C-O 117.475 -1.25 . . . . 0.0 107.914 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.95 115.87 4.27 Favored 'Trans proline' 0 CA--C 1.557 1.644 0 C-N-CA 122.891 2.394 . . . . 0.0 113.126 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.4 pt -97.36 140.88 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 169.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -80.25 88.34 5.51 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.798 0.808 . . . . 0.0 111.195 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.2 t -144.86 119.65 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.3 p -78.14 119.51 21.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.824 0.449 . . . . 0.0 111.655 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 60.7 m -92.59 153.87 18.76 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -173.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -132.99 69.07 1.49 Allowed 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 168.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.44 156.53 23.57 Favored Glycine 0 CA--C 1.552 2.347 0 CA-C-O 121.945 0.747 . . . . 0.0 113.441 -169.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.7 p -63.14 -40.67 63.51 Favored Pre-proline 0 CA--C 1.572 1.791 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -68.92 -14.84 39.51 Favored 'Trans proline' 0 CA--C 1.564 2.018 0 CA-C-N 126.428 3.331 . . . . 0.0 118.384 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -55.37 -37.9 68.14 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 171.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 81.8 m -72.86 -14.26 61.46 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.24 -50.58 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 121.096 1.771 . . . . 0.0 112.684 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.6 -51.82 63.54 Favored Pre-proline 0 CA--C 1.576 1.95 0 CA-C-O 115.258 -2.306 . . . . 0.0 113.08 174.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.54 -43.34 39.44 Favored 'Trans proline' 0 CA--C 1.563 1.965 0 C-N-CA 123.841 3.028 . . . . 0.0 118.072 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.1 m -60.46 -46.07 91.4 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 170.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.66 -52.51 65.21 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -64.45 -30.46 71.5 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.56 -55.26 14.14 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.984 1.266 . . . . 0.0 113.663 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 148.75 51.66 0.02 OUTLIER Glycine 0 N--CA 1.485 1.96 0 C-N-CA 123.847 0.737 . . . . 0.0 113.534 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -147.29 165.49 29.95 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 122.334 1.064 . . . . 0.0 109.75 -174.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -80.29 -67.78 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.527 -0.733 . . . . 0.0 112.373 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -110.7 165.21 12.01 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.024 0.916 . . . . 0.0 110.862 -169.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.61 97.77 0.28 Allowed Glycine 0 N--CA 1.477 1.407 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -108.88 123.59 49.31 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.7 t -101.43 132.75 46.86 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -170.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 92.6 mmm -84.92 -166.08 1.38 Allowed 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.786 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -63.86 98.17 0.19 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.452 -1.405 . . . . 0.0 112.228 -171.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 55.63 20.11 3.7 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -170.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.31 120.66 11.61 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 121.062 1.755 . . . . 0.0 109.79 -171.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.4 m -68.1 138.68 55.93 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -129.62 110.71 12.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.8 m -81.49 159.59 24.16 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.2 m -113.32 101.46 53.57 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 175.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -57.66 155.4 31.95 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 123.533 2.822 . . . . 0.0 118.51 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.4 tptt . . . . . 0 N--CA 1.486 1.341 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.055 176.992 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.461 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.7 m -94.92 135.66 23.46 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 118.184 -0.912 . . . . 0.0 109.458 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.66 121.96 7.05 Favored 'Trans proline' 0 CA--C 1.557 1.65 0 C-N-CA 122.874 2.383 . . . . 0.0 114.756 -174.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.0 pt -106.98 141.75 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.43 89.07 5.58 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.753 0.787 . . . . 0.0 111.397 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.9 t -144.14 119.05 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.0 p -76.01 119.09 19.48 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.926 0.49 . . . . 0.0 112.115 -176.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 66.5 m -93.21 155.22 17.58 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -174.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -136.04 69.72 1.43 Allowed 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.48 156.32 25.64 Favored Glycine 0 CA--C 1.552 2.38 0 CA-C-O 121.669 0.594 . . . . 0.0 113.165 -169.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m -65.98 -41.23 44.0 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 115.271 -2.3 . . . . 0.0 115.789 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.68 -21.98 21.29 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 N-CA-C 119.753 2.944 . . . . 0.0 119.753 171.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -59.24 -37.44 77.58 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 74.2 m -73.52 -9.8 59.06 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.36 -55.95 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.904 1.684 . . . . 0.0 112.584 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.49 -50.12 74.79 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 114.935 -2.46 . . . . 0.0 113.507 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.57 -40.28 37.5 Favored 'Trans proline' 0 CA--C 1.564 2.015 0 CA-C-N 125.58 3.028 . . . . 0.0 118.476 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 77.0 m -63.62 -53.73 47.0 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -60.32 -47.11 87.45 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 175.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.65 -41.5 81.57 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 173.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.63 -48.02 73.62 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 171.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.42 54.73 0.09 OUTLIER Glycine 0 CA--C 1.545 1.91 0 C-N-CA 124.472 1.034 . . . . 0.0 112.297 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 46.5 mtt -147.65 163.05 37.84 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.45 1.119 . . . . 0.0 109.013 -171.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -80.35 -72.14 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.428 -0.795 . . . . 0.0 112.638 -169.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.65 166.78 10.64 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.922 0.867 . . . . 0.0 110.42 -171.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.01 91.19 0.2 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.386 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -111.7 123.54 50.45 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.7 t -96.28 132.34 41.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.12 -164.59 1.14 Allowed 'General case' 0 CA--C 1.576 1.965 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.54 169.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -62.85 98.78 0.13 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.595 -1.316 . . . . 0.0 112.602 -170.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? 57.15 15.39 2.44 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -171.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -144.07 124.74 14.11 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 121.154 1.797 . . . . 0.0 109.832 -171.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.5 m -66.33 139.29 58.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -123.17 108.01 12.36 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.7 m -91.31 132.89 35.86 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.868 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.0 m -80.17 115.46 54.67 Favored Pre-proline 0 CA--C 1.57 1.716 0 CA-C-O 117.317 -1.325 . . . . 0.0 107.786 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.67 140.82 33.19 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.682 2.255 . . . . 0.0 115.161 -169.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.0 tptp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.023 178.926 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.395 0 CA-C-O 119.807 -0.441 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.1 m -94.57 122.57 60.6 Favored Pre-proline 0 CA--C 1.571 1.75 0 CA-C-O 117.92 -1.038 . . . . 0.0 108.531 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.11 133.06 9.73 Favored 'Trans proline' 0 CA--C 1.556 1.609 0 C-N-CA 122.477 2.118 . . . . 0.0 114.93 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.5 pt -106.28 160.2 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.883 0.849 . . . . 0.0 108.752 169.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -82.1 81.64 7.96 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.909 0.862 . . . . 0.0 111.61 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.7 t -145.17 114.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.3 p -84.28 117.19 23.4 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.933 0.493 . . . . 0.0 110.519 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 59.6 m -94.95 156.69 16.22 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -169.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -98.49 -48.98 4.81 Favored 'General case' 0 CA--C 1.581 2.136 0 CA-C-N 113.575 -1.648 . . . . 0.0 106.937 167.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.93 -152.3 5.6 Favored Glycine 0 CA--C 1.554 2.527 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -68.05 -42.08 30.03 Favored Pre-proline 0 CA--C 1.576 1.958 0 CA-C-O 115.236 -2.316 . . . . 0.0 115.853 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.87 -32.42 77.48 Favored 'Trans proline' 0 C--N 1.376 1.974 0 N-CA-C 120.682 3.301 . . . . 0.0 120.682 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -62.28 -26.91 68.66 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 72.1 m -82.2 -25.8 33.92 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 171.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.38 -53.87 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-N 120.534 1.515 . . . . 0.0 112.413 -172.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -65.27 -54.05 35.26 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 114.943 -2.456 . . . . 0.0 113.003 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -47.7 -47.19 19.03 Favored 'Trans proline' 0 CA--C 1.562 1.922 0 C-N-CA 123.922 3.081 . . . . 0.0 118.521 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -65.88 -48.74 70.5 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -59.21 -46.76 87.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -61.97 -37.81 86.15 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.42 -54.64 33.52 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 172.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.97 53.73 0.01 OUTLIER Glycine 0 CA--C 1.545 1.965 0 C-N-CA 123.884 0.754 . . . . 0.0 112.985 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 17.8 mmt -137.28 169.64 17.45 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 122.484 1.135 . . . . 0.0 109.694 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -90.05 -62.37 1.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.457 -0.777 . . . . 0.0 110.783 174.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -118.18 164.25 15.43 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.167 0.984 . . . . 0.0 110.491 -172.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.0 90.15 0.25 Allowed Glycine 0 N--CA 1.478 1.473 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 173.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -97.97 109.08 21.9 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.441 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.2 t -94.48 125.23 38.99 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.238 0.542 . . . . 0.0 111.98 -174.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.2 mmt -83.26 -168.36 2.06 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.992 169.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -61.98 100.53 0.16 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.683 -1.26 . . . . 0.0 112.254 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.3 mtm-85 62.76 10.39 4.2 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 117.149 2.278 . . . . 0.0 117.149 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -145.4 127.1 15.24 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 122.028 2.195 . . . . 0.0 110.82 -173.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.2 m -63.84 145.99 54.79 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -142.36 103.04 4.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.0 m -103.57 149.07 25.25 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -171.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.0 m -96.52 111.91 58.46 Favored Pre-proline 0 CA--C 1.568 1.669 0 CA-C-O 116.792 -1.575 . . . . 0.0 107.876 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -64.97 156.91 59.81 Favored 'Trans proline' 0 CA--C 1.557 1.653 0 C-N-CA 122.978 2.452 . . . . 0.0 117.523 -174.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? . . . . . 0 C--O 1.255 1.36 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.635 179.778 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.29 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.7 t 67.18 93.05 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.032 0 C-N-CA 125.039 1.336 . . . . 0.0 109.937 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -79.13 130.13 9.16 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.703 2.268 . . . . 0.0 114.641 -175.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.0 pt -110.12 143.49 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.42 89.12 5.57 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.635 0.731 . . . . 0.0 111.359 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.9 t -144.81 120.09 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.9 p -76.75 119.1 20.08 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.2 m -95.98 154.23 17.35 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -135.74 70.73 1.42 Allowed 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 168.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.71 158.8 27.71 Favored Glycine 0 CA--C 1.552 2.362 0 CA-C-O 121.805 0.669 . . . . 0.0 113.688 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -64.96 -40.51 47.23 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 115.233 -2.317 . . . . 0.0 115.802 174.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.04 -22.61 19.32 Favored 'Trans proline' 0 CA--C 1.564 2.023 0 N-CA-C 119.94 3.016 . . . . 0.0 119.94 171.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -60.94 -38.44 85.86 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 64.1 m -74.73 -8.48 56.54 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.6 mm -61.03 -55.07 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 121.151 1.796 . . . . 0.0 112.805 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.5 mmmp? -64.73 -49.76 67.79 Favored Pre-proline 0 CA--C 1.573 1.833 0 CA-C-O 114.987 -2.435 . . . . 0.0 113.704 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.76 -40.24 47.65 Favored 'Trans proline' 0 CA--C 1.565 2.06 0 CA-C-N 125.464 2.987 . . . . 0.0 118.318 169.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.4 m -63.57 -52.81 59.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -61.15 -46.42 90.6 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -58.26 -41.38 84.12 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.36 -49.67 68.47 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.52 55.81 0.07 OUTLIER Glycine 0 CA--C 1.544 1.881 0 C-N-CA 124.36 0.981 . . . . 0.0 112.403 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 33.8 mtt -150.6 166.96 28.71 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.401 1.08 . . . . 0.0 108.939 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -84.9 -73.94 0.41 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.126 -0.984 . . . . 0.0 112.459 -171.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.32 160.09 14.84 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.146 0.974 . . . . 0.0 111.071 -169.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.84 89.04 0.37 Allowed Glycine 0 N--CA 1.478 1.499 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.698 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -105.14 118.11 35.72 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.6 t -103.27 130.16 50.44 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 91.6 mmm -85.49 -170.66 3.22 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.002 169.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -62.51 102.73 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.706 -1.246 . . . . 0.0 112.113 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 62.42 7.41 2.33 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -142.34 124.05 15.07 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 122.203 2.274 . . . . 0.0 110.244 -170.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.6 m -66.35 143.93 56.86 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -127.18 109.96 12.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -93.2 127.67 38.86 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.326 0.651 . . . . 0.0 110.862 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.6 m -83.37 114.82 55.77 Favored Pre-proline 0 CA--C 1.57 1.743 0 CA-C-O 116.954 -1.498 . . . . 0.0 108.802 -176.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.59 147.12 95.66 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.22 2.613 . . . . 0.0 117.151 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.4 pttp . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 123.16 0.584 . . . . 0.0 111.846 178.433 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.312 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.293 16.4 m 40.76 80.26 0.29 Allowed Pre-proline 0 N--CA 1.502 2.131 0 C-N-CA 125.623 1.569 . . . . 0.0 115.17 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -76.16 126.46 9.24 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.689 2.259 . . . . 0.0 114.335 -172.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -97.25 150.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.6 84.44 7.26 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.838 0.828 . . . . 0.0 111.387 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.3 t -144.51 115.7 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.5 p -82.08 122.86 28.38 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.837 0.455 . . . . 0.0 111.585 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 85.6 m -103.42 156.05 18.04 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 -172.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -103.17 -42.92 5.61 Favored 'General case' 0 CA--C 1.582 2.204 0 CA-C-N 112.98 -1.918 . . . . 0.0 107.378 167.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.58 -162.34 9.8 Favored Glycine 0 CA--C 1.554 2.471 0 C-N-CA 124.567 1.079 . . . . 0.0 111.212 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.1 m -66.26 -40.99 39.76 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 115.249 -2.31 . . . . 0.0 116.044 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.11 -24.95 35.21 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 N-CA-C 120.471 3.219 . . . . 0.0 120.471 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -58.97 -43.61 91.37 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 37.5 m -76.41 -13.6 60.11 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 117.507 2.41 . . . . 0.0 117.507 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.4 mm -56.53 -58.47 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-N 120.854 1.661 . . . . 0.0 113.328 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -67.53 -51.15 33.51 Favored Pre-proline 0 CA--C 1.572 1.805 0 CA-C-O 114.705 -2.569 . . . . 0.0 113.227 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -47.42 -44.96 23.92 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 CA-C-N 125.764 3.094 . . . . 0.0 118.26 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 87.9 m -60.85 -47.78 84.82 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -61.94 -49.8 74.68 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -67.11 -30.39 70.4 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.13 -55.58 13.6 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.258 1.39 . . . . 0.0 113.796 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.61 47.1 0.01 OUTLIER Glycine 0 CA--C 1.546 1.983 0 CA-C-O 119.365 -0.686 . . . . 0.0 114.353 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -142.77 178.3 7.73 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-O 122.564 1.173 . . . . 0.0 109.518 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -93.87 -74.47 0.53 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.095 0.958 . . . . 0.0 110.4 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -99.59 162.06 13.24 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.222 1.011 . . . . 0.0 110.843 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.73 97.08 0.57 Allowed Glycine 0 N--CA 1.477 1.422 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 171.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.73 111.34 23.98 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.5 t -98.08 127.13 43.85 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -171.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.2 mmt -81.02 -178.0 6.69 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.726 169.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -62.92 101.84 0.3 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.708 -1.245 . . . . 0.0 111.818 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 68.96 0.58 2.82 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 -173.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.62 125.69 27.68 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 122.416 2.371 . . . . 0.0 110.065 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.6 m -68.93 139.28 55.08 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -132.71 106.38 7.74 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 171.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.3 m -74.74 149.44 39.8 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.7 m -109.3 106.17 58.26 Favored Pre-proline 0 CA--C 1.564 1.514 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.1 153.67 37.73 Favored 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 123.473 2.782 . . . . 0.0 116.994 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.451 -177.7 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo . . . . . 0 CA--C 1.557 1.649 0 N-CA-C 113.446 0.518 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.9 pt -106.49 142.28 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -82.47 89.69 6.66 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.806 0.812 . . . . 0.0 110.785 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.4 t -142.84 118.14 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -176.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.8 p -78.52 117.78 20.03 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 80.9 m -101.65 155.58 18.02 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -174.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -104.33 -41.0 5.9 Favored 'General case' 0 CA--C 1.582 2.197 0 CA-C-N 113.145 -1.843 . . . . 0.0 107.976 167.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.17 -166.56 12.14 Favored Glycine 0 CA--C 1.554 2.478 0 C-N-CA 124.396 0.998 . . . . 0.0 111.707 169.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.9 m -67.76 -41.94 31.94 Favored Pre-proline 0 CA--C 1.573 1.861 0 CA-C-O 115.208 -2.329 . . . . 0.0 115.897 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.61 -22.44 28.43 Favored 'Trans proline' 0 CA--C 1.564 1.989 0 N-CA-C 120.248 3.134 . . . . 0.0 120.248 174.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -58.05 -42.05 84.61 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 59.7 m -76.81 -10.26 59.25 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mm -58.83 -55.23 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 120.915 1.689 . . . . 0.0 112.924 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -68.43 -51.27 24.35 Favored Pre-proline 0 CA--C 1.572 1.798 0 CA-C-O 114.951 -2.452 . . . . 0.0 113.079 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -49.18 -43.08 38.21 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 CA-C-N 125.581 3.029 . . . . 0.0 118.326 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.8 m -60.89 -52.27 65.74 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.49 -48.95 77.85 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -62.15 -37.21 84.34 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.28 -52.9 51.24 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.36 53.22 0.02 OUTLIER Glycine 0 CA--C 1.545 1.942 0 C-N-CA 124.015 0.817 . . . . 0.0 113.095 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -142.18 166.59 24.28 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.66 1.219 . . . . 0.0 110.167 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -81.67 -63.03 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.119 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -119.49 165.34 14.51 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 122.355 1.074 . . . . 0.0 110.388 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.91 94.29 0.25 Allowed Glycine 0 N--CA 1.477 1.385 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.66 119.12 38.29 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.3 t -99.98 127.54 46.18 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.328 0.585 . . . . 0.0 112.426 -175.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 92.4 mmm -83.2 -173.42 4.7 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.78 169.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -62.32 101.14 0.21 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.784 -1.197 . . . . 0.0 112.063 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 65.96 6.32 3.98 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -141.48 127.11 19.01 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 122.686 2.493 . . . . 0.0 110.643 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.2 m -69.35 142.65 53.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -133.96 109.22 8.87 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.0 m -84.0 154.39 23.32 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.7 m . . . . . 0 CA--C 1.569 1.709 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.948 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 CA--C 1.558 1.675 0 N-CA-C 114.537 0.937 . . . . 0.0 114.537 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.2 pt -113.47 143.37 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -80.17 84.14 5.92 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.95 0.881 . . . . 0.0 111.878 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.3 t -144.51 115.34 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.4 p -80.45 120.45 24.48 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.862 0.465 . . . . 0.0 111.206 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.59 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 59.7 m -91.41 155.5 18.42 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -171.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -135.98 70.58 1.42 Allowed 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 168.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.71 155.95 28.36 Favored Glycine 0 CA--C 1.553 2.423 0 CA-C-O 121.742 0.634 . . . . 0.0 113.232 -169.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 m -63.35 -39.62 51.53 Favored Pre-proline 0 CA--C 1.573 1.856 0 CA-C-O 115.213 -2.327 . . . . 0.0 116.095 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.26 -25.25 23.17 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 CA-C-N 125.336 2.941 . . . . 0.0 119.734 171.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -59.13 -40.66 86.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.59 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 65.8 m -73.67 -14.86 61.23 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.0 mm -57.07 -56.57 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-N 120.727 1.603 . . . . 0.0 113.069 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -66.29 -51.42 43.93 Favored Pre-proline 0 CA--C 1.572 1.816 0 CA-C-O 114.696 -2.573 . . . . 0.0 113.447 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -46.75 -46.0 19.02 Favored 'Trans proline' 0 CA--C 1.564 1.992 0 CA-C-N 125.78 3.1 . . . . 0.0 118.071 171.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -59.8 -49.24 78.49 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -61.88 -49.91 74.32 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.7 -31.12 72.21 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.86 -56.02 14.02 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.082 1.31 . . . . 0.0 113.637 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.31 51.77 0.01 OUTLIER Glycine 0 CA--C 1.545 1.949 0 C-N-CA 123.707 0.67 . . . . 0.0 113.516 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -142.83 168.73 19.03 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 122.534 1.159 . . . . 0.0 110.181 -174.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -82.28 -64.02 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.534 -0.729 . . . . 0.0 111.747 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -116.45 163.57 15.85 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.245 1.021 . . . . 0.0 110.348 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -132.45 95.58 0.3 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -108.98 122.93 48.28 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.474 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.8 t -102.06 132.36 47.96 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -171.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.97 -164.04 1.08 Allowed 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -63.29 99.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.415 -1.428 . . . . 0.0 112.227 -171.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 58.83 15.24 3.71 Favored 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -139.6 122.61 16.74 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.524 1.965 . . . . 0.0 110.595 -170.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 66.2 m -71.05 135.88 48.0 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -132.61 112.71 12.28 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.7 m -86.35 151.51 23.51 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.0 m . . . . . 0 CA--C 1.569 1.699 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 175.745 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.558 1.687 0 N-CA-C 114.743 1.017 . . . . 0.0 114.743 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.3 pt -118.45 142.35 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 169.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -81.07 88.99 5.94 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.671 0.748 . . . . 0.0 111.276 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.6 t -143.62 119.8 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.8 p -75.91 119.69 20.23 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.992 0.517 . . . . 0.0 112.306 -176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 70.2 m -97.24 154.81 17.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -174.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 t -135.29 70.03 1.44 Allowed 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.52 157.45 25.76 Favored Glycine 0 CA--C 1.551 2.331 0 CA-C-O 121.877 0.709 . . . . 0.0 113.579 -169.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.4 m -65.48 -41.13 47.89 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 115.328 -2.272 . . . . 0.0 115.899 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.6 -21.73 20.07 Favored 'Trans proline' 0 CA--C 1.566 2.124 0 N-CA-C 119.88 2.992 . . . . 0.0 119.88 171.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -60.63 -37.58 81.94 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 66.3 m -74.83 -8.79 57.49 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.67 -54.75 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 120.983 1.72 . . . . 0.0 112.847 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.33 -51.16 54.83 Favored Pre-proline 0 CA--C 1.574 1.867 0 CA-C-O 114.758 -2.544 . . . . 0.0 112.713 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.59 -41.0 30.58 Favored 'Trans proline' 0 CA--C 1.565 2.031 0 CA-C-N 125.856 3.127 . . . . 0.0 118.636 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.0 m -62.36 -54.81 34.99 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -59.81 -46.7 88.41 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.21 -41.44 79.44 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.47 -49.75 67.92 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.8 55.49 0.07 OUTLIER Glycine 0 CA--C 1.545 1.925 0 C-N-CA 124.413 1.006 . . . . 0.0 112.228 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.9 mtt -147.24 162.53 38.71 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.434 1.111 . . . . 0.0 109.364 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -79.48 -71.24 0.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 112.582 -170.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -110.96 166.0 11.4 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.972 0.891 . . . . 0.0 110.474 -170.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.68 90.55 0.24 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -107.43 118.56 37.04 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.4 t -97.97 131.76 44.13 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -175.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 79.9 mtp -87.2 -167.28 1.83 Allowed 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 169.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -62.11 99.83 0.14 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.572 -1.33 . . . . 0.0 112.713 -170.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 58.63 13.5 2.63 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -172.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -143.45 124.69 14.58 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 121.85 2.114 . . . . 0.0 109.874 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.7 m -66.19 141.74 57.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -126.69 105.34 8.63 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.7 m -88.54 136.54 32.94 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.465 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.0 m . . . . . 0 CA--C 1.568 1.667 0 CA-C-O 117.176 -1.392 . . . . 0.0 107.767 178.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 CA--C 1.558 1.704 0 N-CA-C 113.378 0.492 . . . . 0.0 113.378 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.9 pt -98.54 146.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -80.16 84.82 5.79 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.864 0.84 . . . . 0.0 111.683 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.8 t -145.83 115.31 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.1 p -81.34 120.41 24.92 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.793 0.437 . . . . 0.0 111.293 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 71.6 m -95.34 153.77 17.52 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -172.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -130.05 50.03 2.22 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.562 168.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.69 162.85 11.66 Favored Glycine 0 CA--C 1.553 2.43 0 C-N-CA 124.212 0.911 . . . . 0.0 112.342 -169.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.0 m -66.47 -41.39 40.39 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 115.167 -2.349 . . . . 0.0 116.288 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -53.66 -24.25 29.05 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 N-CA-C 120.134 3.09 . . . . 0.0 120.134 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -58.7 -39.51 80.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 175.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 60.7 m -76.0 -11.8 60.02 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.8 mm -59.43 -57.93 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 120.723 1.601 . . . . 0.0 112.982 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -68.15 -45.59 40.12 Favored Pre-proline 0 CA--C 1.571 1.76 0 CA-C-O 114.931 -2.461 . . . . 0.0 114.249 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.02 -42.46 64.41 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.757 3.092 . . . . 0.0 117.697 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 99.0 m -59.73 -52.35 65.86 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -56.72 -48.64 77.28 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 174.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.12 -40.05 84.22 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.82 -50.62 68.2 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 171.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.85 57.12 0.05 OUTLIER Glycine 0 CA--C 1.545 1.923 0 C-N-CA 124.481 1.039 . . . . 0.0 111.713 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.6 mmt -144.36 158.85 43.53 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.441 1.115 . . . . 0.0 109.112 -172.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -80.3 -74.84 0.29 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.841 0.856 . . . . 0.0 111.487 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -98.75 161.85 13.43 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.264 1.031 . . . . 0.0 111.071 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.83 93.42 0.3 Allowed Glycine 0 N--CA 1.478 1.434 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -111.36 120.19 41.38 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 4.5 t -99.02 129.85 45.33 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -171.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 86.2 mtp -84.9 -167.95 2.02 Favored 'General case' 0 CA--C 1.575 1.926 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.792 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.83 100.14 0.28 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.58 -1.325 . . . . 0.0 112.086 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 59.25 15.61 4.37 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -172.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -142.21 122.51 13.92 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.365 1.893 . . . . 0.0 110.024 -170.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.3 m -70.6 134.91 48.03 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -129.19 109.52 11.22 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.4 m -83.67 150.52 25.82 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.2 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.684 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo . . . . . 0 CA--C 1.558 1.719 0 N-CA-C 116.678 1.761 . . . . 0.0 116.678 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.6 pt -129.18 143.53 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 169.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.69 87.62 6.74 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.812 0.815 . . . . 0.0 111.546 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.9 t -144.5 119.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.8 p -79.9 121.89 25.99 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.972 0.509 . . . . 0.0 112.157 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 83.0 m -104.52 156.63 17.78 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -174.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 t -103.98 -42.37 5.59 Favored 'General case' 0 CA--C 1.582 2.197 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.484 167.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.7 -164.53 10.85 Favored Glycine 0 CA--C 1.554 2.485 0 C-N-CA 124.476 1.036 . . . . 0.0 111.411 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.3 m -67.6 -41.2 29.42 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-O 115.238 -2.315 . . . . 0.0 115.822 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.48 -22.89 29.25 Favored 'Trans proline' 0 CA--C 1.564 2.0 0 N-CA-C 120.433 3.205 . . . . 0.0 120.433 175.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -58.62 -41.76 86.65 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 40.9 m -75.84 -10.34 59.34 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.44 -55.26 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.824 1.647 . . . . 0.0 112.831 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.73 -51.57 48.34 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 114.607 -2.616 . . . . 0.0 112.568 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.47 -41.36 36.47 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 CA-C-N 125.962 3.165 . . . . 0.0 118.717 170.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 76.9 m -63.12 -54.48 37.14 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -60.98 -46.16 91.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.87 -41.5 78.11 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.59 -49.35 71.48 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 170.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.13 56.08 0.08 OUTLIER Glycine 0 CA--C 1.543 1.826 0 C-N-CA 124.566 1.079 . . . . 0.0 112.174 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 51.2 mtt -143.79 164.6 30.04 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.611 1.196 . . . . 0.0 109.754 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -76.52 -64.2 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.82 0.848 . . . . 0.0 113.286 -169.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -125.2 162.44 24.67 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.014 0.911 . . . . 0.0 110.171 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.09 92.67 0.45 Allowed Glycine 0 N--CA 1.477 1.429 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -109.45 116.32 31.59 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.4 t -101.31 127.5 47.89 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -173.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.9 mtt -84.24 -168.66 2.25 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.028 169.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -63.05 100.56 0.22 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.755 -1.216 . . . . 0.0 112.166 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 60.81 13.04 4.13 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -141.87 123.23 14.85 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.808 2.094 . . . . 0.0 110.324 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.402 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 39.1 m -70.36 141.62 52.23 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -133.0 108.15 8.71 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.6 m -87.73 136.28 33.02 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.331 0.652 . . . . 0.0 111.505 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 CA--C 1.57 1.721 0 CA-C-O 117.082 -1.437 . . . . 0.0 107.456 177.328 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 CA--C 1.557 1.636 0 N-CA-C 113.566 0.564 . . . . 0.0 113.566 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.4 pt -95.24 145.41 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.83 83.98 6.45 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.933 0.873 . . . . 0.0 111.598 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.3 t -145.06 114.95 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 103.876 -2.638 . . . . 0.0 103.876 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.0 p -81.03 120.79 25.25 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.709 0.404 . . . . 0.0 110.924 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 27.3 m -89.64 153.33 20.83 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -170.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -132.26 69.69 1.48 Allowed 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.81 150.9 22.88 Favored Glycine 0 CA--C 1.552 2.348 0 C-N-CA 123.497 0.57 . . . . 0.0 112.813 -169.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 t -61.83 -41.46 77.27 Favored Pre-proline 0 CA--C 1.574 1.891 0 CA-C-O 115.241 -2.314 . . . . 0.0 115.913 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -54.19 -24.15 32.5 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 N-CA-C 119.755 2.944 . . . . 0.0 119.755 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -57.58 -38.18 74.43 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 67.4 m -72.13 -14.24 61.77 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 176.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 71.5 mt -65.1 -51.48 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.88 1.673 . . . . 0.0 112.617 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -64.1 -49.61 73.04 Favored Pre-proline 0 CA--C 1.577 2.013 0 CA-C-O 115.008 -2.425 . . . . 0.0 112.97 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.02 -41.28 65.03 Favored 'Trans proline' 0 CA--C 1.565 2.04 0 CA-C-N 125.493 2.998 . . . . 0.0 118.046 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.8 m -61.41 -51.25 69.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -59.11 -46.77 87.47 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -57.57 -41.15 80.53 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 -51.61 58.64 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 170.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.16 55.25 0.04 OUTLIER Glycine 0 CA--C 1.544 1.848 0 C-N-CA 124.192 0.901 . . . . 0.0 113.114 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -143.09 165.79 26.44 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.817 1.294 . . . . 0.0 110.218 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -83.51 -74.55 0.36 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 124.23 1.012 . . . . 0.0 111.021 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -95.82 159.71 14.84 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.25 1.024 . . . . 0.0 111.077 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.22 94.58 0.33 Allowed Glycine 0 N--CA 1.478 1.496 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -113.94 125.0 53.54 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.402 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 11.7 t -102.27 132.31 48.3 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -169.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -85.26 -161.25 0.57 Allowed 'General case' 0 CA--C 1.578 2.055 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.296 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -63.74 94.16 0.09 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.402 -1.436 . . . . 0.0 111.827 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.1 mtp-105 51.24 30.1 5.53 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -169.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -139.79 117.68 11.73 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 119.706 1.139 . . . . 0.0 109.409 -171.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.9 m -71.89 131.05 42.46 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -126.88 115.27 19.05 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -87.93 146.71 25.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.203 0.601 . . . . 0.0 112.255 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 CA--C 1.566 1.592 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 175.276 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo . . . . . 0 CA--C 1.557 1.671 0 N-CA-C 115.249 1.211 . . . . 0.0 115.249 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.5 pt -122.97 140.05 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -81.77 87.01 6.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.805 0.812 . . . . 0.0 111.293 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.2 t -144.34 118.8 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 87.6 p -78.3 122.54 25.86 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.897 0.479 . . . . 0.0 111.852 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.599 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 62.6 m -96.09 155.04 16.92 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -172.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 t -134.94 69.68 1.45 Allowed 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 168.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 156.48 24.89 Favored Glycine 0 CA--C 1.553 2.436 0 C-N-CA 123.58 0.61 . . . . 0.0 113.717 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 t -64.74 -41.56 57.51 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 115.22 -2.324 . . . . 0.0 115.684 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -53.58 -22.77 23.17 Favored 'Trans proline' 0 CA--C 1.566 2.101 0 N-CA-C 119.846 2.979 . . . . 0.0 119.846 171.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -59.76 -39.03 83.46 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.599 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 63.8 m -75.02 -10.07 59.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.0 mm -59.21 -56.15 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-N 120.838 1.654 . . . . 0.0 112.817 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -67.04 -48.06 50.74 Favored Pre-proline 0 CA--C 1.574 1.887 0 CA-C-O 115.022 -2.418 . . . . 0.0 113.776 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.68 -41.82 59.72 Favored 'Trans proline' 0 CA--C 1.564 2.02 0 CA-C-N 125.668 3.06 . . . . 0.0 118.065 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.2 m -60.86 -50.97 71.28 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -57.4 -46.78 83.1 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 173.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.49 -41.25 89.42 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.39 -50.38 65.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.75 54.44 0.04 OUTLIER Glycine 0 CA--C 1.545 1.923 0 C-N-CA 124.212 0.91 . . . . 0.0 112.768 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -143.63 162.8 34.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.869 1.319 . . . . 0.0 110.029 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -81.78 -72.45 0.43 Allowed 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.19 0.996 . . . . 0.0 111.233 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -101.34 165.35 11.31 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.399 1.095 . . . . 0.0 110.887 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.16 94.04 0.22 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 174.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -107.61 125.23 51.07 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.4 t -104.32 133.46 49.19 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -172.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 86.0 mtp -87.71 -165.92 1.44 Allowed 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.316 169.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -63.47 99.66 0.22 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.458 -1.401 . . . . 0.0 112.096 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 59.72 16.81 5.79 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -140.85 118.83 11.86 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 121.677 2.035 . . . . 0.0 110.443 -169.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.4 m -69.8 137.91 52.24 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -134.25 108.69 8.39 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.3 m -82.98 153.19 25.12 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 m . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 174.444 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 CA--C 1.558 1.694 0 N-CA-C 113.712 0.62 . . . . 0.0 113.712 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.9 pt -99.2 144.57 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 170.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.45 87.46 5.07 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.86 0.838 . . . . 0.0 111.515 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.6 t -145.55 116.98 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.1 p -80.07 117.79 21.21 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.728 0.411 . . . . 0.0 111.571 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 86.2 m -95.17 155.22 16.82 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -174.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 t -130.54 48.97 2.35 Favored 'General case' 0 CA--C 1.58 2.134 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.381 168.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.57 160.62 10.98 Favored Glycine 0 CA--C 1.555 2.57 0 C-N-CA 124.369 0.985 . . . . 0.0 112.17 -169.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.0 m -64.75 -40.33 47.34 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-O 115.118 -2.372 . . . . 0.0 116.201 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.15 -23.68 23.34 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 N-CA-C 120.191 3.112 . . . . 0.0 120.191 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -61.53 -41.45 97.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 62.7 m -73.43 -12.45 60.81 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 117.954 2.575 . . . . 0.0 117.954 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.2 mm -60.46 -49.84 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 120.884 1.674 . . . . 0.0 113.065 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.64 -53.93 40.48 Favored Pre-proline 0 CA--C 1.572 1.823 0 CA-C-O 115.1 -2.381 . . . . 0.0 112.756 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.59 -43.61 44.48 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 125.351 2.947 . . . . 0.0 118.738 171.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.0 m -63.4 -51.0 67.63 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 173.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -61.46 -45.45 94.21 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -58.37 -40.95 83.66 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.2 -50.43 70.34 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.71 55.79 0.06 OUTLIER Glycine 0 CA--C 1.543 1.798 0 C-N-CA 124.262 0.934 . . . . 0.0 112.293 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 43.3 mtt -143.59 168.47 19.81 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.617 1.199 . . . . 0.0 109.968 -174.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -75.81 -62.76 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -170.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -129.97 160.56 33.26 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.228 1.013 . . . . 0.0 110.076 -170.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.47 93.22 0.59 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -106.3 111.7 24.4 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 6.1 t -97.67 128.13 44.14 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 83.1 mtp -84.19 -165.9 1.28 Allowed 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.158 169.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -63.51 98.41 0.17 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.738 -1.226 . . . . 0.0 112.445 -170.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 54.18 22.01 3.37 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -170.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -143.73 122.8 12.86 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 120.886 1.676 . . . . 0.0 109.718 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 67.1 m -68.98 134.87 50.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -125.12 110.79 14.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.7 m -83.83 140.51 31.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.142 0.577 . . . . 0.0 112.077 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.3 m . . . . . 0 CA--C 1.57 1.739 0 CA-C-O 117.193 -1.384 . . . . 0.0 107.321 178.677 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 CA--C 1.557 1.631 0 N-CA-C 113.304 0.463 . . . . 0.0 113.304 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.1 pt -94.46 145.61 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.02 86.49 6.11 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.852 0.834 . . . . 0.0 111.382 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.8 t -144.44 116.97 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.9 p -81.61 119.53 23.91 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.807 0.443 . . . . 0.0 111.445 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 64.1 m -98.65 156.65 16.71 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -174.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -104.7 -42.98 5.24 Favored 'General case' 0 CA--C 1.582 2.185 0 CA-C-N 113.445 -1.707 . . . . 0.0 107.26 167.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.16 -167.0 11.4 Favored Glycine 0 CA--C 1.555 2.591 0 C-N-CA 124.441 1.019 . . . . 0.0 111.316 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.2 m -67.85 -41.72 30.08 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-O 115.215 -2.326 . . . . 0.0 115.665 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.64 -22.66 29.39 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 N-CA-C 120.368 3.18 . . . . 0.0 120.368 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -58.03 -43.37 86.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 55.5 m -74.71 -9.78 58.89 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.1 mm -58.63 -57.24 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-N 121.548 1.977 . . . . 0.0 112.187 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -57.04 -53.99 59.35 Favored Pre-proline 0 CA--C 1.573 1.836 0 CA-C-O 115.347 -2.263 . . . . 0.0 114.35 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -62.36 -43.51 22.59 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.41 2.968 . . . . 0.0 116.446 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.9 m -60.93 -54.68 42.01 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 173.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.36 -52.37 65.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.87 -30.98 71.67 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.39 -56.33 13.14 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 120.646 1.566 . . . . 0.0 113.735 172.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.27 49.74 0.01 OUTLIER Glycine 0 CA--C 1.544 1.855 0 CA-C-O 119.416 -0.658 . . . . 0.0 114.142 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -139.92 175.75 9.32 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 122.643 1.211 . . . . 0.0 109.91 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -84.22 -61.88 1.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 111.933 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.99 160.51 28.79 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.329 1.061 . . . . 0.0 110.452 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.81 97.61 0.61 Allowed Glycine 0 N--CA 1.478 1.469 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.528 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 118.85 37.31 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 4.6 t -102.99 128.75 49.68 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -170.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -82.13 -168.48 1.97 Allowed 'General case' 0 CA--C 1.575 1.924 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.168 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.6 98.69 0.19 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.84 -1.163 . . . . 0.0 111.965 -173.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 56.83 20.67 5.38 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -171.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -143.41 120.67 11.55 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 121.149 1.795 . . . . 0.0 110.093 -172.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.2 m -70.21 137.79 51.18 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -131.69 116.59 17.51 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -83.29 150.75 25.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.5 m . . . . . 0 CA--C 1.569 1.698 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.961 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 CA--C 1.557 1.634 0 N-CA-C 113.975 0.721 . . . . 0.0 113.975 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 pt -108.1 139.31 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.33 90.28 6.13 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.895 0.855 . . . . 0.0 110.87 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.6 t -141.96 115.61 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.1 p -74.41 116.83 15.53 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 64.5 m -91.15 154.19 19.52 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -135.14 68.78 1.46 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.93 156.33 23.0 Favored Glycine 0 CA--C 1.551 2.322 0 CA-C-O 121.713 0.619 . . . . 0.0 112.921 -169.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -67.95 -42.86 34.77 Favored Pre-proline 0 N--CA 1.495 1.812 0 CA-C-O 115.287 -2.292 . . . . 0.0 115.785 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -54.11 -22.42 25.29 Favored 'Trans proline' 0 CA--C 1.563 1.973 0 N-CA-C 119.704 2.924 . . . . 0.0 119.704 171.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -55.33 -39.07 69.55 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 75.0 m -73.44 -10.78 60.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.68 -51.95 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 120.75 1.614 . . . . 0.0 112.257 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -66.86 -49.53 47.83 Favored Pre-proline 0 CA--C 1.576 1.971 0 CA-C-O 115.034 -2.412 . . . . 0.0 113.505 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.44 -41.7 51.06 Favored 'Trans proline' 0 CA--C 1.565 2.069 0 CA-C-N 125.704 3.073 . . . . 0.0 117.95 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.0 m -60.96 -50.07 74.87 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -55.59 -52.18 64.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -64.69 -33.66 76.48 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.8 -53.73 29.88 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 119.824 1.193 . . . . 0.0 113.95 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.65 53.51 0.02 OUTLIER Glycine 0 CA--C 1.544 1.906 0 C-N-CA 124.012 0.815 . . . . 0.0 113.13 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -145.92 164.01 33.34 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.77 1.272 . . . . 0.0 110.11 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -81.21 -73.43 0.38 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.003 0.921 . . . . 0.0 111.432 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -102.44 167.91 9.65 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.03 0.919 . . . . 0.0 111.128 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.71 100.22 0.23 Allowed Glycine 0 N--CA 1.477 1.392 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 129.31 56.68 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.5 t -95.73 133.09 40.24 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.8 mmt -88.4 -166.37 1.57 Allowed 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.387 169.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -61.91 98.91 0.11 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.407 -1.433 . . . . 0.0 112.837 -170.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 56.44 13.14 1.21 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 -171.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -141.92 130.23 22.33 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 121.266 1.848 . . . . 0.0 109.951 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.3 m -66.75 135.8 54.53 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -123.66 107.78 11.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.2 m -83.96 158.56 21.5 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.772 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.3 m . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 173.134 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 CA--C 1.557 1.648 0 N-CA-C 114.611 0.966 . . . . 0.0 114.611 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.446 HD11 ' SG ' ' A' ' 18' ' ' CYS . 19.8 pt -114.59 150.46 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.68 87.04 6.32 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.817 0.818 . . . . 0.0 111.38 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.7 115.72 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.2 p -78.91 118.13 20.65 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.836 0.455 . . . . 0.0 111.576 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 77.9 m -95.05 155.56 16.68 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -171.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -135.79 70.11 1.43 Allowed 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 168.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.0 157.98 25.31 Favored Glycine 0 CA--C 1.551 2.316 0 CA-C-O 121.917 0.732 . . . . 0.0 113.564 -169.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -64.19 -41.65 62.63 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 115.3 -2.286 . . . . 0.0 115.962 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.74 -22.89 24.52 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.946 3.018 . . . . 0.0 119.946 172.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -60.98 -36.67 80.05 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.9 m -71.3 -19.8 62.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.3 mm -57.73 -56.61 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 120.802 1.637 . . . . 0.0 113.575 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -68.13 -51.45 26.52 Favored Pre-proline 0 CA--C 1.575 1.941 0 CA-C-O 114.99 -2.433 . . . . 0.0 113.39 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.82 -45.55 24.01 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 125.649 3.053 . . . . 0.0 118.049 170.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 4' ' ' ILE . 98.4 m -67.62 -45.25 75.94 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -59.17 -47.91 83.56 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 173.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -61.18 -37.42 82.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 172.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.89 -52.92 57.7 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.4 59.48 0.03 OUTLIER Glycine 0 CA--C 1.543 1.833 0 C-N-CA 124.275 0.941 . . . . 0.0 111.851 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 20.4 mmt -140.91 164.18 30.96 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.77 1.272 . . . . 0.0 109.892 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -93.37 -72.15 0.62 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.4 1.08 . . . . 0.0 110.114 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -99.25 164.75 12.01 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.993 0.901 . . . . 0.0 110.846 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.52 88.86 0.18 Allowed Glycine 0 N--CA 1.481 1.667 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.082 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -107.28 116.74 32.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.0 t -97.67 130.94 44.63 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.556 0.693 . . . . 0.0 112.863 -173.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -87.55 -164.74 1.14 Allowed 'General case' 0 CA--C 1.575 1.937 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.771 169.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -63.42 99.12 0.19 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.764 -1.21 . . . . 0.0 112.398 -170.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 55.6 19.31 3.21 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -171.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -144.85 121.43 11.09 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 121.574 1.988 . . . . 0.0 110.144 -172.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.7 m -67.34 136.28 54.57 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -127.14 100.67 6.19 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 170.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.1 m -107.62 128.78 54.84 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.453 -172.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.8 m . . . . . 0 CA--C 1.566 1.558 0 CA-C-O 117.102 -1.428 . . . . 0.0 108.272 -175.882 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 CA--C 1.559 1.736 0 CA-C-O 121.123 0.385 . . . . 0.0 113.01 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.2 pt -100.06 144.0 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -78.91 88.24 4.72 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.948 0.88 . . . . 0.0 111.258 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.6 t -145.16 114.44 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -76.97 114.62 15.96 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.066 0.46 . . . . 0.0 111.726 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.8 m -88.54 154.85 20.01 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -137.23 71.15 1.4 Allowed 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.0 159.09 29.38 Favored Glycine 0 CA--C 1.552 2.362 0 CA-C-O 121.845 0.692 . . . . 0.0 113.402 -169.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.2 m -65.63 -40.19 38.76 Favored Pre-proline 0 CA--C 1.572 1.822 0 CA-C-O 115.191 -2.337 . . . . 0.0 115.979 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.21 -23.22 22.23 Favored 'Trans proline' 0 CA--C 1.566 2.079 0 CA-C-N 125.399 2.964 . . . . 0.0 119.764 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -58.76 -38.7 79.05 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 172.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 82.4 m -73.96 -10.05 59.26 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 117.928 2.566 . . . . 0.0 117.928 177.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.76 -55.86 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 120.852 1.66 . . . . 0.0 112.606 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -64.22 -49.75 71.5 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 114.896 -2.478 . . . . 0.0 113.399 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.19 -43.3 43.65 Favored 'Trans proline' 0 CA--C 1.564 2.023 0 CA-C-N 125.714 3.076 . . . . 0.0 118.378 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.9 m -62.95 -51.63 66.15 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -59.15 -46.92 87.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -57.41 -40.85 79.17 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.71 -48.95 72.77 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.22 59.04 0.08 OUTLIER Glycine 0 CA--C 1.543 1.813 0 C-N-CA 124.478 1.037 . . . . 0.0 111.607 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.7 mmt -140.47 166.04 25.8 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.544 1.164 . . . . 0.0 109.609 -171.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -80.12 -56.66 4.08 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.914 0.886 . . . . 0.0 113.21 -176.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -131.93 164.38 26.27 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.997 0.903 . . . . 0.0 110.223 -172.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.42 95.25 0.39 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -115.66 116.39 28.03 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.4 t -93.8 129.58 40.13 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -170.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 93.5 mmm -84.44 -172.1 3.98 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.737 169.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -61.0 101.18 0.14 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.641 -1.287 . . . . 0.0 112.573 -171.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? 64.74 5.25 2.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -175.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -145.96 132.83 20.12 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 122.141 2.246 . . . . 0.0 111.013 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.4 m -66.64 138.5 57.48 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -124.39 110.39 14.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 171.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.3 m -87.28 139.8 30.19 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.863 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 173.221 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 CA--C 1.557 1.644 0 N-CA-C 113.126 0.395 . . . . 0.0 113.126 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.4 pt -97.36 140.88 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 169.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -80.25 88.34 5.51 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.798 0.808 . . . . 0.0 111.195 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.2 t -144.86 119.65 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.3 p -78.14 119.51 21.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.824 0.449 . . . . 0.0 111.655 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 60.7 m -92.59 153.87 18.76 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -173.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -132.99 69.07 1.49 Allowed 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 168.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.44 156.53 23.57 Favored Glycine 0 CA--C 1.552 2.347 0 CA-C-O 121.945 0.747 . . . . 0.0 113.441 -169.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.7 p -63.14 -40.67 63.51 Favored Pre-proline 0 CA--C 1.572 1.791 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -68.92 -14.84 39.51 Favored 'Trans proline' 0 CA--C 1.564 2.018 0 CA-C-N 126.428 3.331 . . . . 0.0 118.384 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -55.37 -37.9 68.14 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 171.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 81.8 m -72.86 -14.26 61.46 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.24 -50.58 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 121.096 1.771 . . . . 0.0 112.684 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.6 -51.82 63.54 Favored Pre-proline 0 CA--C 1.576 1.95 0 CA-C-O 115.258 -2.306 . . . . 0.0 113.08 174.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.54 -43.34 39.44 Favored 'Trans proline' 0 CA--C 1.563 1.965 0 C-N-CA 123.841 3.028 . . . . 0.0 118.072 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.1 m -60.46 -46.07 91.4 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 170.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.66 -52.51 65.21 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -64.45 -30.46 71.5 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.56 -55.26 14.14 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.984 1.266 . . . . 0.0 113.663 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 148.75 51.66 0.02 OUTLIER Glycine 0 N--CA 1.485 1.96 0 C-N-CA 123.847 0.737 . . . . 0.0 113.534 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -147.29 165.49 29.95 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 122.334 1.064 . . . . 0.0 109.75 -174.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -80.29 -67.78 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.527 -0.733 . . . . 0.0 112.373 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -110.7 165.21 12.01 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.024 0.916 . . . . 0.0 110.862 -169.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.61 97.77 0.28 Allowed Glycine 0 N--CA 1.477 1.407 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -108.88 123.59 49.31 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.7 t -101.43 132.75 46.86 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -170.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 92.6 mmm -84.92 -166.08 1.38 Allowed 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.786 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -63.86 98.17 0.19 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.452 -1.405 . . . . 0.0 112.228 -171.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 55.63 20.11 3.7 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -170.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.31 120.66 11.61 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 121.062 1.755 . . . . 0.0 109.79 -171.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.4 m -68.1 138.68 55.93 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -129.62 110.71 12.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.8 m -81.49 159.59 24.16 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.2 m . . . . . 0 CA--C 1.568 1.652 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 175.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 CA--C 1.557 1.65 0 N-CA-C 114.756 1.021 . . . . 0.0 114.756 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.0 pt -106.98 141.75 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.43 89.07 5.58 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.753 0.787 . . . . 0.0 111.397 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.9 t -144.14 119.05 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.0 p -76.01 119.09 19.48 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.926 0.49 . . . . 0.0 112.115 -176.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 66.5 m -93.21 155.22 17.58 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -174.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -136.04 69.72 1.43 Allowed 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.48 156.32 25.64 Favored Glycine 0 CA--C 1.552 2.38 0 CA-C-O 121.669 0.594 . . . . 0.0 113.165 -169.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m -65.98 -41.23 44.0 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 115.271 -2.3 . . . . 0.0 115.789 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.68 -21.98 21.29 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 N-CA-C 119.753 2.944 . . . . 0.0 119.753 171.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -59.24 -37.44 77.58 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 74.2 m -73.52 -9.8 59.06 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.36 -55.95 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.904 1.684 . . . . 0.0 112.584 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.49 -50.12 74.79 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 114.935 -2.46 . . . . 0.0 113.507 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.57 -40.28 37.5 Favored 'Trans proline' 0 CA--C 1.564 2.015 0 CA-C-N 125.58 3.028 . . . . 0.0 118.476 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 77.0 m -63.62 -53.73 47.0 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -60.32 -47.11 87.45 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 175.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.65 -41.5 81.57 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 173.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.63 -48.02 73.62 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 171.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.42 54.73 0.09 OUTLIER Glycine 0 CA--C 1.545 1.91 0 C-N-CA 124.472 1.034 . . . . 0.0 112.297 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 46.5 mtt -147.65 163.05 37.84 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.45 1.119 . . . . 0.0 109.013 -171.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -80.35 -72.14 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.428 -0.795 . . . . 0.0 112.638 -169.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.65 166.78 10.64 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.922 0.867 . . . . 0.0 110.42 -171.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.01 91.19 0.2 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.386 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -111.7 123.54 50.45 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.7 t -96.28 132.34 41.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.12 -164.59 1.14 Allowed 'General case' 0 CA--C 1.576 1.965 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.54 169.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -62.85 98.78 0.13 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.595 -1.316 . . . . 0.0 112.602 -170.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? 57.15 15.39 2.44 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -171.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -144.07 124.74 14.11 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 121.154 1.797 . . . . 0.0 109.832 -171.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.5 m -66.33 139.29 58.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -123.17 108.01 12.36 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.7 m -91.31 132.89 35.86 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.868 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.0 m . . . . . 0 CA--C 1.57 1.716 0 CA-C-O 117.317 -1.325 . . . . 0.0 107.786 179.506 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 CA--C 1.556 1.609 0 N-CA-C 114.93 1.088 . . . . 0.0 114.93 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.5 pt -106.28 160.2 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.883 0.849 . . . . 0.0 108.752 169.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -82.1 81.64 7.96 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.909 0.862 . . . . 0.0 111.61 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.7 t -145.17 114.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.3 p -84.28 117.19 23.4 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.933 0.493 . . . . 0.0 110.519 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 59.6 m -94.95 156.69 16.22 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -169.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -98.49 -48.98 4.81 Favored 'General case' 0 CA--C 1.581 2.136 0 CA-C-N 113.575 -1.648 . . . . 0.0 106.937 167.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.93 -152.3 5.6 Favored Glycine 0 CA--C 1.554 2.527 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -68.05 -42.08 30.03 Favored Pre-proline 0 CA--C 1.576 1.958 0 CA-C-O 115.236 -2.316 . . . . 0.0 115.853 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.87 -32.42 77.48 Favored 'Trans proline' 0 C--N 1.376 1.974 0 N-CA-C 120.682 3.301 . . . . 0.0 120.682 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -62.28 -26.91 68.66 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 72.1 m -82.2 -25.8 33.92 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 171.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.38 -53.87 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-N 120.534 1.515 . . . . 0.0 112.413 -172.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -65.27 -54.05 35.26 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 114.943 -2.456 . . . . 0.0 113.003 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -47.7 -47.19 19.03 Favored 'Trans proline' 0 CA--C 1.562 1.922 0 C-N-CA 123.922 3.081 . . . . 0.0 118.521 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -65.88 -48.74 70.5 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -59.21 -46.76 87.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -61.97 -37.81 86.15 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.42 -54.64 33.52 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 172.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.97 53.73 0.01 OUTLIER Glycine 0 CA--C 1.545 1.965 0 C-N-CA 123.884 0.754 . . . . 0.0 112.985 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 17.8 mmt -137.28 169.64 17.45 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 122.484 1.135 . . . . 0.0 109.694 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -90.05 -62.37 1.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.457 -0.777 . . . . 0.0 110.783 174.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -118.18 164.25 15.43 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.167 0.984 . . . . 0.0 110.491 -172.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.0 90.15 0.25 Allowed Glycine 0 N--CA 1.478 1.473 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 173.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -97.97 109.08 21.9 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.441 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.2 t -94.48 125.23 38.99 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.238 0.542 . . . . 0.0 111.98 -174.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.2 mmt -83.26 -168.36 2.06 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.992 169.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -61.98 100.53 0.16 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.683 -1.26 . . . . 0.0 112.254 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.3 mtm-85 62.76 10.39 4.2 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 117.149 2.278 . . . . 0.0 117.149 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -145.4 127.1 15.24 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 122.028 2.195 . . . . 0.0 110.82 -173.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.2 m -63.84 145.99 54.79 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -142.36 103.04 4.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.0 m -103.57 149.07 25.25 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -171.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 CA--C 1.568 1.669 0 CA-C-O 116.792 -1.575 . . . . 0.0 107.876 -177.817 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.556 1.604 0 N-CA-C 114.641 0.977 . . . . 0.0 114.641 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.0 pt -110.12 143.49 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.42 89.12 5.57 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.635 0.731 . . . . 0.0 111.359 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.9 t -144.81 120.09 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.9 p -76.75 119.1 20.08 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.2 m -95.98 154.23 17.35 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -135.74 70.73 1.42 Allowed 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 168.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.71 158.8 27.71 Favored Glycine 0 CA--C 1.552 2.362 0 CA-C-O 121.805 0.669 . . . . 0.0 113.688 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -64.96 -40.51 47.23 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 115.233 -2.317 . . . . 0.0 115.802 174.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.04 -22.61 19.32 Favored 'Trans proline' 0 CA--C 1.564 2.023 0 N-CA-C 119.94 3.016 . . . . 0.0 119.94 171.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -60.94 -38.44 85.86 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 64.1 m -74.73 -8.48 56.54 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.6 mm -61.03 -55.07 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 121.151 1.796 . . . . 0.0 112.805 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.5 mmmp? -64.73 -49.76 67.79 Favored Pre-proline 0 CA--C 1.573 1.833 0 CA-C-O 114.987 -2.435 . . . . 0.0 113.704 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.76 -40.24 47.65 Favored 'Trans proline' 0 CA--C 1.565 2.06 0 CA-C-N 125.464 2.987 . . . . 0.0 118.318 169.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.4 m -63.57 -52.81 59.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -61.15 -46.42 90.6 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -58.26 -41.38 84.12 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.36 -49.67 68.47 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.52 55.81 0.07 OUTLIER Glycine 0 CA--C 1.544 1.881 0 C-N-CA 124.36 0.981 . . . . 0.0 112.403 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 33.8 mtt -150.6 166.96 28.71 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.401 1.08 . . . . 0.0 108.939 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -84.9 -73.94 0.41 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.126 -0.984 . . . . 0.0 112.459 -171.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.32 160.09 14.84 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.146 0.974 . . . . 0.0 111.071 -169.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.84 89.04 0.37 Allowed Glycine 0 N--CA 1.478 1.499 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.698 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -105.14 118.11 35.72 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.6 t -103.27 130.16 50.44 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 91.6 mmm -85.49 -170.66 3.22 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.002 169.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -62.51 102.73 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.706 -1.246 . . . . 0.0 112.113 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 62.42 7.41 2.33 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -142.34 124.05 15.07 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 122.203 2.274 . . . . 0.0 110.244 -170.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.6 m -66.35 143.93 56.86 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -127.18 109.96 12.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -93.2 127.67 38.86 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.326 0.651 . . . . 0.0 110.862 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.6 m . . . . . 0 CA--C 1.57 1.743 0 CA-C-O 116.954 -1.498 . . . . 0.0 108.802 -176.359 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 CA--C 1.555 1.543 0 N-CA-C 114.335 0.859 . . . . 0.0 114.335 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -97.25 150.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.6 84.44 7.26 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.838 0.828 . . . . 0.0 111.387 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.3 t -144.51 115.7 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.5 p -82.08 122.86 28.38 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.837 0.455 . . . . 0.0 111.585 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 85.6 m -103.42 156.05 18.04 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 -172.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -103.17 -42.92 5.61 Favored 'General case' 0 CA--C 1.582 2.204 0 CA-C-N 112.98 -1.918 . . . . 0.0 107.378 167.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.58 -162.34 9.8 Favored Glycine 0 CA--C 1.554 2.471 0 C-N-CA 124.567 1.079 . . . . 0.0 111.212 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.1 m -66.26 -40.99 39.76 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 115.249 -2.31 . . . . 0.0 116.044 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.11 -24.95 35.21 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 N-CA-C 120.471 3.219 . . . . 0.0 120.471 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -58.97 -43.61 91.37 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 37.5 m -76.41 -13.6 60.11 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 117.507 2.41 . . . . 0.0 117.507 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.4 mm -56.53 -58.47 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-N 120.854 1.661 . . . . 0.0 113.328 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -67.53 -51.15 33.51 Favored Pre-proline 0 CA--C 1.572 1.805 0 CA-C-O 114.705 -2.569 . . . . 0.0 113.227 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -47.42 -44.96 23.92 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 CA-C-N 125.764 3.094 . . . . 0.0 118.26 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 87.9 m -60.85 -47.78 84.82 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -61.94 -49.8 74.68 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -67.11 -30.39 70.4 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.13 -55.58 13.6 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.258 1.39 . . . . 0.0 113.796 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.61 47.1 0.01 OUTLIER Glycine 0 CA--C 1.546 1.983 0 CA-C-O 119.365 -0.686 . . . . 0.0 114.353 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -142.77 178.3 7.73 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-O 122.564 1.173 . . . . 0.0 109.518 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -93.87 -74.47 0.53 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.095 0.958 . . . . 0.0 110.4 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -99.59 162.06 13.24 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.222 1.011 . . . . 0.0 110.843 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.73 97.08 0.57 Allowed Glycine 0 N--CA 1.477 1.422 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 171.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.73 111.34 23.98 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.5 t -98.08 127.13 43.85 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -171.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.2 mmt -81.02 -178.0 6.69 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.726 169.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -62.92 101.84 0.3 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.708 -1.245 . . . . 0.0 111.818 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 68.96 0.58 2.82 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 -173.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.62 125.69 27.68 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 122.416 2.371 . . . . 0.0 110.065 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.6 m -68.93 139.28 55.08 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -132.71 106.38 7.74 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 171.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.3 m -74.74 149.44 39.8 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.7 m . . . . . 0 CA--C 1.564 1.514 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 178.518 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.385 0 CA-C-O 119.554 -0.581 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.6 t -115.32 105.07 52.96 Favored Pre-proline 0 CA--C 1.57 1.723 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.04 119.14 6.15 Favored 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 123.076 2.517 . . . . 0.0 113.446 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.9 pt -106.49 142.28 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -82.47 89.69 6.66 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.806 0.812 . . . . 0.0 110.785 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.4 t -142.84 118.14 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -176.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.8 p -78.52 117.78 20.03 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 80.9 m -101.65 155.58 18.02 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -174.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -104.33 -41.0 5.9 Favored 'General case' 0 CA--C 1.582 2.197 0 CA-C-N 113.145 -1.843 . . . . 0.0 107.976 167.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.17 -166.56 12.14 Favored Glycine 0 CA--C 1.554 2.478 0 C-N-CA 124.396 0.998 . . . . 0.0 111.707 169.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.9 m -67.76 -41.94 31.94 Favored Pre-proline 0 CA--C 1.573 1.861 0 CA-C-O 115.208 -2.329 . . . . 0.0 115.897 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.61 -22.44 28.43 Favored 'Trans proline' 0 CA--C 1.564 1.989 0 N-CA-C 120.248 3.134 . . . . 0.0 120.248 174.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -58.05 -42.05 84.61 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 59.7 m -76.81 -10.26 59.25 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mm -58.83 -55.23 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 120.915 1.689 . . . . 0.0 112.924 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -68.43 -51.27 24.35 Favored Pre-proline 0 CA--C 1.572 1.798 0 CA-C-O 114.951 -2.452 . . . . 0.0 113.079 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -49.18 -43.08 38.21 Favored 'Trans proline' 0 CA--C 1.566 2.105 0 CA-C-N 125.581 3.029 . . . . 0.0 118.326 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.8 m -60.89 -52.27 65.74 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.49 -48.95 77.85 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -62.15 -37.21 84.34 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.28 -52.9 51.24 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.36 53.22 0.02 OUTLIER Glycine 0 CA--C 1.545 1.942 0 C-N-CA 124.015 0.817 . . . . 0.0 113.095 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -142.18 166.59 24.28 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.66 1.219 . . . . 0.0 110.167 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -81.67 -63.03 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.119 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -119.49 165.34 14.51 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 122.355 1.074 . . . . 0.0 110.388 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.91 94.29 0.25 Allowed Glycine 0 N--CA 1.477 1.385 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.66 119.12 38.29 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.3 t -99.98 127.54 46.18 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.328 0.585 . . . . 0.0 112.426 -175.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 92.4 mmm -83.2 -173.42 4.7 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.78 169.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -62.32 101.14 0.21 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.784 -1.197 . . . . 0.0 112.063 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 65.96 6.32 3.98 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -141.48 127.11 19.01 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 122.686 2.493 . . . . 0.0 110.643 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.2 m -69.35 142.65 53.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -133.96 109.22 8.87 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.0 m -84.0 154.39 23.32 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.7 m -101.42 106.1 43.86 Favored Pre-proline 0 CA--C 1.569 1.709 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.23 146.38 86.26 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.13 2.553 . . . . 0.0 116.27 -171.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm . . . . . 0 C--O 1.253 1.24 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.086 -175.797 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.444 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.36 107.37 39.2 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.43 117.32 4.27 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.164 2.576 . . . . 0.0 114.537 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.2 pt -113.47 143.37 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -80.17 84.14 5.92 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.95 0.881 . . . . 0.0 111.878 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.3 t -144.51 115.34 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.4 p -80.45 120.45 24.48 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.862 0.465 . . . . 0.0 111.206 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.59 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 59.7 m -91.41 155.5 18.42 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -171.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -135.98 70.58 1.42 Allowed 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 168.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.71 155.95 28.36 Favored Glycine 0 CA--C 1.553 2.423 0 CA-C-O 121.742 0.634 . . . . 0.0 113.232 -169.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 m -63.35 -39.62 51.53 Favored Pre-proline 0 CA--C 1.573 1.856 0 CA-C-O 115.213 -2.327 . . . . 0.0 116.095 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.26 -25.25 23.17 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 CA-C-N 125.336 2.941 . . . . 0.0 119.734 171.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -59.13 -40.66 86.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.59 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 65.8 m -73.67 -14.86 61.23 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.0 mm -57.07 -56.57 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-N 120.727 1.603 . . . . 0.0 113.069 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -66.29 -51.42 43.93 Favored Pre-proline 0 CA--C 1.572 1.816 0 CA-C-O 114.696 -2.573 . . . . 0.0 113.447 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -46.75 -46.0 19.02 Favored 'Trans proline' 0 CA--C 1.564 1.992 0 CA-C-N 125.78 3.1 . . . . 0.0 118.071 171.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -59.8 -49.24 78.49 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -61.88 -49.91 74.32 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.7 -31.12 72.21 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.86 -56.02 14.02 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.082 1.31 . . . . 0.0 113.637 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.31 51.77 0.01 OUTLIER Glycine 0 CA--C 1.545 1.949 0 C-N-CA 123.707 0.67 . . . . 0.0 113.516 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -142.83 168.73 19.03 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 122.534 1.159 . . . . 0.0 110.181 -174.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -82.28 -64.02 1.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.534 -0.729 . . . . 0.0 111.747 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -116.45 163.57 15.85 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.245 1.021 . . . . 0.0 110.348 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -132.45 95.58 0.3 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -108.98 122.93 48.28 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.474 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.8 t -102.06 132.36 47.96 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -171.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.97 -164.04 1.08 Allowed 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -63.29 99.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.415 -1.428 . . . . 0.0 112.227 -171.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 58.83 15.24 3.71 Favored 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -139.6 122.61 16.74 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.524 1.965 . . . . 0.0 110.595 -170.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 66.2 m -71.05 135.88 48.0 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -132.61 112.71 12.28 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.7 m -86.35 151.51 23.51 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.0 m -98.96 107.13 42.1 Favored Pre-proline 0 CA--C 1.569 1.699 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.47 146.29 67.72 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 123.029 2.486 . . . . 0.0 115.955 -170.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt . . . . . 0 C--O 1.254 1.303 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.2 -175.279 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.422 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.5 m -80.22 139.12 52.36 Favored Pre-proline 0 CA--C 1.575 1.927 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.607 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.55 133.64 16.02 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 C-N-CA 122.988 2.459 . . . . 0.0 114.743 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.3 pt -118.45 142.35 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 169.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -81.07 88.99 5.94 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.671 0.748 . . . . 0.0 111.276 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.6 t -143.62 119.8 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.8 p -75.91 119.69 20.23 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.992 0.517 . . . . 0.0 112.306 -176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 70.2 m -97.24 154.81 17.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -174.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 t -135.29 70.03 1.44 Allowed 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.52 157.45 25.76 Favored Glycine 0 CA--C 1.551 2.331 0 CA-C-O 121.877 0.709 . . . . 0.0 113.579 -169.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.4 m -65.48 -41.13 47.89 Favored Pre-proline 0 N--CA 1.495 1.792 0 CA-C-O 115.328 -2.272 . . . . 0.0 115.899 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.6 -21.73 20.07 Favored 'Trans proline' 0 CA--C 1.566 2.124 0 N-CA-C 119.88 2.992 . . . . 0.0 119.88 171.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -60.63 -37.58 81.94 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 66.3 m -74.83 -8.79 57.49 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.67 -54.75 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 120.983 1.72 . . . . 0.0 112.847 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.33 -51.16 54.83 Favored Pre-proline 0 CA--C 1.574 1.867 0 CA-C-O 114.758 -2.544 . . . . 0.0 112.713 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.59 -41.0 30.58 Favored 'Trans proline' 0 CA--C 1.565 2.031 0 CA-C-N 125.856 3.127 . . . . 0.0 118.636 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.0 m -62.36 -54.81 34.99 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -59.81 -46.7 88.41 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.21 -41.44 79.44 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.47 -49.75 67.92 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.8 55.49 0.07 OUTLIER Glycine 0 CA--C 1.545 1.925 0 C-N-CA 124.413 1.006 . . . . 0.0 112.228 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 45.9 mtt -147.24 162.53 38.71 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.434 1.111 . . . . 0.0 109.364 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -79.48 -71.24 0.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 112.582 -170.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -110.96 166.0 11.4 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.972 0.891 . . . . 0.0 110.474 -170.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.68 90.55 0.24 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -107.43 118.56 37.04 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.4 t -97.97 131.76 44.13 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -175.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 79.9 mtp -87.2 -167.28 1.83 Allowed 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 169.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -62.11 99.83 0.14 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.572 -1.33 . . . . 0.0 112.713 -170.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 58.63 13.5 2.63 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -172.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -143.45 124.69 14.58 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 121.85 2.114 . . . . 0.0 109.874 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.7 m -66.19 141.74 57.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -126.69 105.34 8.63 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.7 m -88.54 136.54 32.94 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.465 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.0 m -83.25 115.19 57.84 Favored Pre-proline 0 CA--C 1.568 1.667 0 CA-C-O 117.176 -1.392 . . . . 0.0 107.767 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.53 138.34 29.45 Favored 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 122.788 2.325 . . . . 0.0 114.811 -169.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.874 -178.78 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 85.8 t -99.7 112.78 64.33 Favored Pre-proline 0 CA--C 1.571 1.769 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.4 107.87 2.55 Favored 'Trans proline' 0 CA--C 1.558 1.704 0 C-N-CA 122.864 2.376 . . . . 0.0 113.378 -175.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.9 pt -98.54 146.84 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -80.16 84.82 5.79 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.864 0.84 . . . . 0.0 111.683 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.8 t -145.83 115.31 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.1 p -81.34 120.41 24.92 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.793 0.437 . . . . 0.0 111.293 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 71.6 m -95.34 153.77 17.52 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -172.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -130.05 50.03 2.22 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.562 168.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.69 162.85 11.66 Favored Glycine 0 CA--C 1.553 2.43 0 C-N-CA 124.212 0.911 . . . . 0.0 112.342 -169.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.0 m -66.47 -41.39 40.39 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 115.167 -2.349 . . . . 0.0 116.288 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -53.66 -24.25 29.05 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 N-CA-C 120.134 3.09 . . . . 0.0 120.134 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -58.7 -39.51 80.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 175.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 60.7 m -76.0 -11.8 60.02 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.8 mm -59.43 -57.93 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 120.723 1.601 . . . . 0.0 112.982 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -68.15 -45.59 40.12 Favored Pre-proline 0 CA--C 1.571 1.76 0 CA-C-O 114.931 -2.461 . . . . 0.0 114.249 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.02 -42.46 64.41 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.757 3.092 . . . . 0.0 117.697 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 99.0 m -59.73 -52.35 65.86 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -56.72 -48.64 77.28 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 174.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.12 -40.05 84.22 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.82 -50.62 68.2 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 171.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.85 57.12 0.05 OUTLIER Glycine 0 CA--C 1.545 1.923 0 C-N-CA 124.481 1.039 . . . . 0.0 111.713 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.6 mmt -144.36 158.85 43.53 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.441 1.115 . . . . 0.0 109.112 -172.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -80.3 -74.84 0.29 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.841 0.856 . . . . 0.0 111.487 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -98.75 161.85 13.43 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.264 1.031 . . . . 0.0 111.071 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.83 93.42 0.3 Allowed Glycine 0 N--CA 1.478 1.434 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -111.36 120.19 41.38 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 4.5 t -99.02 129.85 45.33 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -171.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 86.2 mtp -84.9 -167.95 2.02 Favored 'General case' 0 CA--C 1.575 1.926 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.792 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.83 100.14 0.28 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.58 -1.325 . . . . 0.0 112.086 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 59.25 15.61 4.37 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -172.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -142.21 122.51 13.92 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.365 1.893 . . . . 0.0 110.024 -170.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.3 m -70.6 134.91 48.03 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -129.19 109.52 11.22 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.4 m -83.67 150.52 25.82 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.2 m -106.11 111.67 64.31 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -59.25 149.85 78.1 Favored 'Trans proline' 0 CA--C 1.558 1.711 0 C-N-CA 123.212 2.608 . . . . 0.0 117.304 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt . . . . . 0 N--CA 1.488 1.429 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.354 177.516 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.475 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.2 m -74.49 132.95 77.75 Favored Pre-proline 0 CA--C 1.577 2.009 0 CA-C-O 117.713 -1.137 . . . . 0.0 111.663 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -64.99 141.76 71.89 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 123.114 2.542 . . . . 0.0 116.678 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.6 pt -129.18 143.53 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 169.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.69 87.62 6.74 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.812 0.815 . . . . 0.0 111.546 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.9 t -144.5 119.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.8 p -79.9 121.89 25.99 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.972 0.509 . . . . 0.0 112.157 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 83.0 m -104.52 156.63 17.78 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -174.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 t -103.98 -42.37 5.59 Favored 'General case' 0 CA--C 1.582 2.197 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.484 167.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.7 -164.53 10.85 Favored Glycine 0 CA--C 1.554 2.485 0 C-N-CA 124.476 1.036 . . . . 0.0 111.411 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.3 m -67.6 -41.2 29.42 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-O 115.238 -2.315 . . . . 0.0 115.822 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.48 -22.89 29.25 Favored 'Trans proline' 0 CA--C 1.564 2.0 0 N-CA-C 120.433 3.205 . . . . 0.0 120.433 175.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -58.62 -41.76 86.65 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 40.9 m -75.84 -10.34 59.34 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.44 -55.26 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.824 1.647 . . . . 0.0 112.831 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.73 -51.57 48.34 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 114.607 -2.616 . . . . 0.0 112.568 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.47 -41.36 36.47 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 CA-C-N 125.962 3.165 . . . . 0.0 118.717 170.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 76.9 m -63.12 -54.48 37.14 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -60.98 -46.16 91.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.87 -41.5 78.11 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.59 -49.35 71.48 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 170.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.13 56.08 0.08 OUTLIER Glycine 0 CA--C 1.543 1.826 0 C-N-CA 124.566 1.079 . . . . 0.0 112.174 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 51.2 mtt -143.79 164.6 30.04 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.611 1.196 . . . . 0.0 109.754 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -76.52 -64.2 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.82 0.848 . . . . 0.0 113.286 -169.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -125.2 162.44 24.67 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.014 0.911 . . . . 0.0 110.171 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.09 92.67 0.45 Allowed Glycine 0 N--CA 1.477 1.429 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -109.45 116.32 31.59 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.4 t -101.31 127.5 47.89 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -173.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.9 mtt -84.24 -168.66 2.25 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.028 169.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -63.05 100.56 0.22 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.755 -1.216 . . . . 0.0 112.166 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 60.81 13.04 4.13 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -141.87 123.23 14.85 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.808 2.094 . . . . 0.0 110.324 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.402 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 39.1 m -70.36 141.62 52.23 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -133.0 108.15 8.71 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.6 m -87.73 136.28 33.02 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.331 0.652 . . . . 0.0 111.505 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m -82.49 115.08 56.07 Favored Pre-proline 0 CA--C 1.57 1.721 0 CA-C-O 117.082 -1.437 . . . . 0.0 107.456 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.97 142.71 39.2 Favored 'Trans proline' 0 CA--C 1.56 1.78 0 C-N-CA 122.755 2.303 . . . . 0.0 115.088 -169.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.1 tttp . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.289 -178.853 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.387 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.7 t -120.0 107.22 40.15 Favored Pre-proline 0 CA--C 1.567 1.63 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 -176.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.32 107.14 2.31 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.745 2.297 . . . . 0.0 113.566 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.4 pt -95.24 145.41 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.83 83.98 6.45 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.933 0.873 . . . . 0.0 111.598 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.3 t -145.06 114.95 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 103.876 -2.638 . . . . 0.0 103.876 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.0 p -81.03 120.79 25.25 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.709 0.404 . . . . 0.0 110.924 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 27.3 m -89.64 153.33 20.83 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -170.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -132.26 69.69 1.48 Allowed 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.81 150.9 22.88 Favored Glycine 0 CA--C 1.552 2.348 0 C-N-CA 123.497 0.57 . . . . 0.0 112.813 -169.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 t -61.83 -41.46 77.27 Favored Pre-proline 0 CA--C 1.574 1.891 0 CA-C-O 115.241 -2.314 . . . . 0.0 115.913 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -54.19 -24.15 32.5 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 N-CA-C 119.755 2.944 . . . . 0.0 119.755 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -57.58 -38.18 74.43 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 67.4 m -72.13 -14.24 61.77 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 176.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 71.5 mt -65.1 -51.48 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.88 1.673 . . . . 0.0 112.617 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -64.1 -49.61 73.04 Favored Pre-proline 0 CA--C 1.577 2.013 0 CA-C-O 115.008 -2.425 . . . . 0.0 112.97 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.02 -41.28 65.03 Favored 'Trans proline' 0 CA--C 1.565 2.04 0 CA-C-N 125.493 2.998 . . . . 0.0 118.046 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.8 m -61.41 -51.25 69.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -59.11 -46.77 87.47 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -57.57 -41.15 80.53 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 -51.61 58.64 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 170.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.16 55.25 0.04 OUTLIER Glycine 0 CA--C 1.544 1.848 0 C-N-CA 124.192 0.901 . . . . 0.0 113.114 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -143.09 165.79 26.44 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.817 1.294 . . . . 0.0 110.218 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -83.51 -74.55 0.36 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 124.23 1.012 . . . . 0.0 111.021 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -95.82 159.71 14.84 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 122.25 1.024 . . . . 0.0 111.077 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.22 94.58 0.33 Allowed Glycine 0 N--CA 1.478 1.496 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 170.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -113.94 125.0 53.54 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.402 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 11.7 t -102.27 132.31 48.3 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -169.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -85.26 -161.25 0.57 Allowed 'General case' 0 CA--C 1.578 2.055 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.296 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -63.74 94.16 0.09 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.402 -1.436 . . . . 0.0 111.827 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.1 mtp-105 51.24 30.1 5.53 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -169.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -139.79 117.68 11.73 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 119.706 1.139 . . . . 0.0 109.409 -171.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.9 m -71.89 131.05 42.46 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -126.88 115.27 19.05 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -87.93 146.71 25.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.203 0.601 . . . . 0.0 112.255 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.5 m -106.91 109.83 63.3 Favored Pre-proline 0 CA--C 1.566 1.592 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -54.43 149.09 39.76 Favored 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 123.609 2.873 . . . . 0.0 118.223 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt . . . . . 0 N--CA 1.485 1.325 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.3 -178.593 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.464 0 N-CA-C 111.806 -0.517 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.4 m -79.24 123.52 84.66 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.611 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -67.05 134.71 35.05 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.99 2.46 . . . . 0.0 115.249 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.5 pt -122.97 140.05 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -81.77 87.01 6.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.805 0.812 . . . . 0.0 111.293 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.2 t -144.34 118.8 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 87.6 p -78.3 122.54 25.86 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.897 0.479 . . . . 0.0 111.852 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.599 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 62.6 m -96.09 155.04 16.92 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -172.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 t -134.94 69.68 1.45 Allowed 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 168.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 156.48 24.89 Favored Glycine 0 CA--C 1.553 2.436 0 C-N-CA 123.58 0.61 . . . . 0.0 113.717 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 t -64.74 -41.56 57.51 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 115.22 -2.324 . . . . 0.0 115.684 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -53.58 -22.77 23.17 Favored 'Trans proline' 0 CA--C 1.566 2.101 0 N-CA-C 119.846 2.979 . . . . 0.0 119.846 171.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -59.76 -39.03 83.46 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.599 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 63.8 m -75.02 -10.07 59.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.0 mm -59.21 -56.15 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-N 120.838 1.654 . . . . 0.0 112.817 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -67.04 -48.06 50.74 Favored Pre-proline 0 CA--C 1.574 1.887 0 CA-C-O 115.022 -2.418 . . . . 0.0 113.776 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.68 -41.82 59.72 Favored 'Trans proline' 0 CA--C 1.564 2.02 0 CA-C-N 125.668 3.06 . . . . 0.0 118.065 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.2 m -60.86 -50.97 71.28 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -57.4 -46.78 83.1 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 173.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.49 -41.25 89.42 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.39 -50.38 65.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.75 54.44 0.04 OUTLIER Glycine 0 CA--C 1.545 1.923 0 C-N-CA 124.212 0.91 . . . . 0.0 112.768 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -143.63 162.8 34.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.869 1.319 . . . . 0.0 110.029 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -81.78 -72.45 0.43 Allowed 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.19 0.996 . . . . 0.0 111.233 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -101.34 165.35 11.31 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.399 1.095 . . . . 0.0 110.887 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.16 94.04 0.22 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 174.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -107.61 125.23 51.07 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.4 t -104.32 133.46 49.19 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -172.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 86.0 mtp -87.71 -165.92 1.44 Allowed 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.316 169.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -63.47 99.66 0.22 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.458 -1.401 . . . . 0.0 112.096 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 59.72 16.81 5.79 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -140.85 118.83 11.86 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 121.677 2.035 . . . . 0.0 110.443 -169.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.4 m -69.8 137.91 52.24 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -134.25 108.69 8.39 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.3 m -82.98 153.19 25.12 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 m -109.35 106.08 58.1 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -60.03 144.97 99.43 Favored 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 123.152 2.568 . . . . 0.0 117.39 -175.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 117.838 -1.077 . . . . 0.0 113.213 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.459 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.6 t -135.35 113.21 11.17 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.86 107.5 2.36 Favored 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 122.854 2.369 . . . . 0.0 113.712 -175.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.9 pt -99.2 144.57 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 170.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.45 87.46 5.07 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.86 0.838 . . . . 0.0 111.515 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.6 t -145.55 116.98 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.1 p -80.07 117.79 21.21 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.728 0.411 . . . . 0.0 111.571 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 86.2 m -95.17 155.22 16.82 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -174.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 t -130.54 48.97 2.35 Favored 'General case' 0 CA--C 1.58 2.134 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.381 168.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.57 160.62 10.98 Favored Glycine 0 CA--C 1.555 2.57 0 C-N-CA 124.369 0.985 . . . . 0.0 112.17 -169.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.0 m -64.75 -40.33 47.34 Favored Pre-proline 0 CA--C 1.575 1.932 0 CA-C-O 115.118 -2.372 . . . . 0.0 116.201 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.15 -23.68 23.34 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 N-CA-C 120.191 3.112 . . . . 0.0 120.191 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -61.53 -41.45 97.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 62.7 m -73.43 -12.45 60.81 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 117.954 2.575 . . . . 0.0 117.954 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.2 mm -60.46 -49.84 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 120.884 1.674 . . . . 0.0 113.065 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.64 -53.93 40.48 Favored Pre-proline 0 CA--C 1.572 1.823 0 CA-C-O 115.1 -2.381 . . . . 0.0 112.756 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.59 -43.61 44.48 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 125.351 2.947 . . . . 0.0 118.738 171.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.0 m -63.4 -51.0 67.63 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 173.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -61.46 -45.45 94.21 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -58.37 -40.95 83.66 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.2 -50.43 70.34 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 135.71 55.79 0.06 OUTLIER Glycine 0 CA--C 1.543 1.798 0 C-N-CA 124.262 0.934 . . . . 0.0 112.293 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 43.3 mtt -143.59 168.47 19.81 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.617 1.199 . . . . 0.0 109.968 -174.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -75.81 -62.76 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -170.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -129.97 160.56 33.26 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 122.228 1.013 . . . . 0.0 110.076 -170.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.47 93.22 0.59 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -106.3 111.7 24.4 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 6.1 t -97.67 128.13 44.14 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 83.1 mtp -84.19 -165.9 1.28 Allowed 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.158 169.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -63.51 98.41 0.17 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.738 -1.226 . . . . 0.0 112.445 -170.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 54.18 22.01 3.37 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 -170.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -143.73 122.8 12.86 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 120.886 1.676 . . . . 0.0 109.718 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 67.1 m -68.98 134.87 50.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -125.12 110.79 14.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.7 m -83.83 140.51 31.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.142 0.577 . . . . 0.0 112.077 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.3 m -90.25 111.09 45.05 Favored Pre-proline 0 CA--C 1.57 1.739 0 CA-C-O 117.193 -1.384 . . . . 0.0 107.321 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.63 148.47 25.97 Favored 'Trans proline' 0 CA--C 1.558 1.703 0 C-N-CA 122.737 2.291 . . . . 0.0 115.04 -170.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.771 174.924 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.353 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.2 t -108.93 108.17 60.5 Favored Pre-proline 0 CA--C 1.567 1.634 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.64 105.2 2.01 Favored 'Trans proline' 0 CA--C 1.557 1.631 0 C-N-CA 122.784 2.323 . . . . 0.0 113.304 -175.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.1 pt -94.46 145.61 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.02 86.49 6.11 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.852 0.834 . . . . 0.0 111.382 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.8 t -144.44 116.97 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.9 p -81.61 119.53 23.91 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.807 0.443 . . . . 0.0 111.445 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 64.1 m -98.65 156.65 16.71 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -174.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -104.7 -42.98 5.24 Favored 'General case' 0 CA--C 1.582 2.185 0 CA-C-N 113.445 -1.707 . . . . 0.0 107.26 167.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.16 -167.0 11.4 Favored Glycine 0 CA--C 1.555 2.591 0 C-N-CA 124.441 1.019 . . . . 0.0 111.316 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.2 m -67.85 -41.72 30.08 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-O 115.215 -2.326 . . . . 0.0 115.665 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.64 -22.66 29.39 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 N-CA-C 120.368 3.18 . . . . 0.0 120.368 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -58.03 -43.37 86.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.546 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 55.5 m -74.71 -9.78 58.89 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.1 mm -58.63 -57.24 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-N 121.548 1.977 . . . . 0.0 112.187 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -57.04 -53.99 59.35 Favored Pre-proline 0 CA--C 1.573 1.836 0 CA-C-O 115.347 -2.263 . . . . 0.0 114.35 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -62.36 -43.51 22.59 Favored 'Trans proline' 0 CA--C 1.566 2.099 0 CA-C-N 125.41 2.968 . . . . 0.0 116.446 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.9 m -60.93 -54.68 42.01 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 173.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.36 -52.37 65.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.87 -30.98 71.67 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.39 -56.33 13.14 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 120.646 1.566 . . . . 0.0 113.735 172.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.27 49.74 0.01 OUTLIER Glycine 0 CA--C 1.544 1.855 0 CA-C-O 119.416 -0.658 . . . . 0.0 114.142 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -139.92 175.75 9.32 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 122.643 1.211 . . . . 0.0 109.91 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -84.22 -61.88 1.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 111.933 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.99 160.51 28.79 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.329 1.061 . . . . 0.0 110.452 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -121.81 97.61 0.61 Allowed Glycine 0 N--CA 1.478 1.469 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.528 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 118.85 37.31 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 4.6 t -102.99 128.75 49.68 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -170.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -82.13 -168.48 1.97 Allowed 'General case' 0 CA--C 1.575 1.924 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.168 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.6 98.69 0.19 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.84 -1.163 . . . . 0.0 111.965 -173.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 56.83 20.67 5.38 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -171.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -143.41 120.67 11.55 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 121.149 1.795 . . . . 0.0 110.093 -172.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.2 m -70.21 137.79 51.18 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -131.69 116.59 17.51 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -83.29 150.75 25.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.5 m -104.15 100.51 21.57 Favored Pre-proline 0 CA--C 1.569 1.698 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.33 154.07 50.98 Favored 'Trans proline' 0 CA--C 1.557 1.658 0 C-N-CA 122.917 2.411 . . . . 0.0 115.199 -172.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 118.249 -0.881 . . . . 0.0 109.653 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.389 0 CA-C-O 119.754 -0.47 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.3 m -98.04 122.1 55.43 Favored Pre-proline 0 CA--C 1.571 1.759 0 CA-C-O 117.838 -1.077 . . . . 0.0 108.236 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.71 114.16 3.96 Favored 'Trans proline' 0 CA--C 1.557 1.634 0 C-N-CA 122.979 2.453 . . . . 0.0 113.975 -173.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 pt -108.1 139.31 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.33 90.28 6.13 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.895 0.855 . . . . 0.0 110.87 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.6 t -141.96 115.61 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.1 p -74.41 116.83 15.53 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 64.5 m -91.15 154.19 19.52 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -135.14 68.78 1.46 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.93 156.33 23.0 Favored Glycine 0 CA--C 1.551 2.322 0 CA-C-O 121.713 0.619 . . . . 0.0 112.921 -169.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -67.95 -42.86 34.77 Favored Pre-proline 0 N--CA 1.495 1.812 0 CA-C-O 115.287 -2.292 . . . . 0.0 115.785 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -54.11 -22.42 25.29 Favored 'Trans proline' 0 CA--C 1.563 1.973 0 N-CA-C 119.704 2.924 . . . . 0.0 119.704 171.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -55.33 -39.07 69.55 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 75.0 m -73.44 -10.78 60.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.68 -51.95 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 120.75 1.614 . . . . 0.0 112.257 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -66.86 -49.53 47.83 Favored Pre-proline 0 CA--C 1.576 1.971 0 CA-C-O 115.034 -2.412 . . . . 0.0 113.505 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.44 -41.7 51.06 Favored 'Trans proline' 0 CA--C 1.565 2.069 0 CA-C-N 125.704 3.073 . . . . 0.0 117.95 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.0 m -60.96 -50.07 74.87 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -55.59 -52.18 64.64 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -64.69 -33.66 76.48 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.8 -53.73 29.88 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 119.824 1.193 . . . . 0.0 113.95 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.65 53.51 0.02 OUTLIER Glycine 0 CA--C 1.544 1.906 0 C-N-CA 124.012 0.815 . . . . 0.0 113.13 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -145.92 164.01 33.34 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.77 1.272 . . . . 0.0 110.11 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -81.21 -73.43 0.38 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.003 0.921 . . . . 0.0 111.432 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -102.44 167.91 9.65 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.03 0.919 . . . . 0.0 111.128 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.71 100.22 0.23 Allowed Glycine 0 N--CA 1.477 1.392 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 129.31 56.68 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.5 t -95.73 133.09 40.24 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -170.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.8 mmt -88.4 -166.37 1.57 Allowed 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.387 169.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -61.91 98.91 0.11 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.407 -1.433 . . . . 0.0 112.837 -170.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 56.44 13.14 1.21 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 -171.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -141.92 130.23 22.33 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 121.266 1.848 . . . . 0.0 109.951 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.3 m -66.75 135.8 54.53 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -123.66 107.78 11.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.2 m -83.96 158.56 21.5 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.772 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.3 m -111.33 103.4 54.94 Favored Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 173.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -59.15 147.77 88.97 Favored 'Trans proline' 0 CA--C 1.556 1.615 0 C-N-CA 123.224 2.616 . . . . 0.0 116.965 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.6 tptp . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.389 -176.181 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.472 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 79.6 t -86.57 122.42 71.83 Favored Pre-proline 0 CA--C 1.573 1.854 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.72 127.15 12.05 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.889 2.393 . . . . 0.0 114.611 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.446 HD11 ' SG ' ' A' ' 18' ' ' CYS . 19.8 pt -114.59 150.46 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.68 87.04 6.32 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.817 0.818 . . . . 0.0 111.38 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.7 115.72 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.2 p -78.91 118.13 20.65 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.836 0.455 . . . . 0.0 111.576 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 77.9 m -95.05 155.56 16.68 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -171.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -135.79 70.11 1.43 Allowed 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 168.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.0 157.98 25.31 Favored Glycine 0 CA--C 1.551 2.316 0 CA-C-O 121.917 0.732 . . . . 0.0 113.564 -169.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -64.19 -41.65 62.63 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-O 115.3 -2.286 . . . . 0.0 115.962 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.74 -22.89 24.52 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.946 3.018 . . . . 0.0 119.946 172.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -60.98 -36.67 80.05 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.9 m -71.3 -19.8 62.28 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 174.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.3 mm -57.73 -56.61 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 120.802 1.637 . . . . 0.0 113.575 -173.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -68.13 -51.45 26.52 Favored Pre-proline 0 CA--C 1.575 1.941 0 CA-C-O 114.99 -2.433 . . . . 0.0 113.39 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.82 -45.55 24.01 Favored 'Trans proline' 0 CA--C 1.565 2.026 0 CA-C-N 125.649 3.053 . . . . 0.0 118.049 170.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 4' ' ' ILE . 98.4 m -67.62 -45.25 75.94 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -59.17 -47.91 83.56 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 173.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -61.18 -37.42 82.87 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 172.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.89 -52.92 57.7 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.4 59.48 0.03 OUTLIER Glycine 0 CA--C 1.543 1.833 0 C-N-CA 124.275 0.941 . . . . 0.0 111.851 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 20.4 mmt -140.91 164.18 30.96 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.77 1.272 . . . . 0.0 109.892 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -93.37 -72.15 0.62 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.4 1.08 . . . . 0.0 110.114 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -99.25 164.75 12.01 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.993 0.901 . . . . 0.0 110.846 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.52 88.86 0.18 Allowed Glycine 0 N--CA 1.481 1.667 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.082 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -107.28 116.74 32.46 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.0 t -97.67 130.94 44.63 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.556 0.693 . . . . 0.0 112.863 -173.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -87.55 -164.74 1.14 Allowed 'General case' 0 CA--C 1.575 1.937 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.771 169.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -63.42 99.12 0.19 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.764 -1.21 . . . . 0.0 112.398 -170.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 55.6 19.31 3.21 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -171.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -144.85 121.43 11.09 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 121.574 1.988 . . . . 0.0 110.144 -172.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.7 m -67.34 136.28 54.57 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -127.14 100.67 6.19 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 170.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.1 m -107.62 128.78 54.84 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.453 -172.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.8 m -81.28 123.61 81.33 Favored Pre-proline 0 CA--C 1.566 1.558 0 CA-C-O 117.102 -1.428 . . . . 0.0 108.272 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.18 149.98 46.86 Favored 'Trans proline' 0 CA--C 1.559 1.726 0 C-N-CA 122.796 2.331 . . . . 0.0 114.658 -173.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt . . . . . 0 N--CA 1.488 1.432 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.768 -178.689 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.408 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.97 110.92 56.63 Favored Pre-proline 0 CA--C 1.568 1.665 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.66 103.45 1.64 Allowed 'Trans proline' 0 CA--C 1.559 1.736 0 C-N-CA 122.821 2.347 . . . . 0.0 113.01 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.2 pt -100.06 144.0 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -78.91 88.24 4.72 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.948 0.88 . . . . 0.0 111.258 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.6 t -145.16 114.44 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -76.97 114.62 15.96 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.066 0.46 . . . . 0.0 111.726 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.8 m -88.54 154.85 20.01 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -137.23 71.15 1.4 Allowed 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.0 159.09 29.38 Favored Glycine 0 CA--C 1.552 2.362 0 CA-C-O 121.845 0.692 . . . . 0.0 113.402 -169.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.2 m -65.63 -40.19 38.76 Favored Pre-proline 0 CA--C 1.572 1.822 0 CA-C-O 115.191 -2.337 . . . . 0.0 115.979 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.21 -23.22 22.23 Favored 'Trans proline' 0 CA--C 1.566 2.079 0 CA-C-N 125.399 2.964 . . . . 0.0 119.764 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -58.76 -38.7 79.05 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 172.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 82.4 m -73.96 -10.05 59.26 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 117.928 2.566 . . . . 0.0 117.928 177.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.76 -55.86 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 120.852 1.66 . . . . 0.0 112.606 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -64.22 -49.75 71.5 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 114.896 -2.478 . . . . 0.0 113.399 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.19 -43.3 43.65 Favored 'Trans proline' 0 CA--C 1.564 2.023 0 CA-C-N 125.714 3.076 . . . . 0.0 118.378 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.9 m -62.95 -51.63 66.15 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -59.15 -46.92 87.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -57.41 -40.85 79.17 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.71 -48.95 72.77 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.22 59.04 0.08 OUTLIER Glycine 0 CA--C 1.543 1.813 0 C-N-CA 124.478 1.037 . . . . 0.0 111.607 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.7 mmt -140.47 166.04 25.8 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.544 1.164 . . . . 0.0 109.609 -171.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -80.12 -56.66 4.08 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.914 0.886 . . . . 0.0 113.21 -176.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -131.93 164.38 26.27 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.997 0.903 . . . . 0.0 110.223 -172.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.42 95.25 0.39 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 176.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -115.66 116.39 28.03 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.4 t -93.8 129.58 40.13 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -170.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 93.5 mmm -84.44 -172.1 3.98 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.737 169.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -61.0 101.18 0.14 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.641 -1.287 . . . . 0.0 112.573 -171.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? 64.74 5.25 2.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -175.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -145.96 132.83 20.12 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 122.141 2.246 . . . . 0.0 111.013 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.4 m -66.64 138.5 57.48 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -124.39 110.39 14.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 171.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.3 m -87.28 139.8 30.19 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.863 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -83.67 115.34 59.11 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 173.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.83 150.1 43.73 Favored 'Trans proline' 0 CA--C 1.557 1.674 0 CA-C-N 123.42 2.257 . . . . 0.0 115.843 -169.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt . . . . . 0 N--CA 1.486 1.326 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.102 -176.282 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.353 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.4 t -92.03 117.72 67.85 Favored Pre-proline 0 CA--C 1.571 1.785 0 CA-C-O 117.475 -1.25 . . . . 0.0 107.914 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.95 115.87 4.27 Favored 'Trans proline' 0 CA--C 1.557 1.644 0 C-N-CA 122.891 2.394 . . . . 0.0 113.126 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.4 pt -97.36 140.88 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 169.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -80.25 88.34 5.51 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.798 0.808 . . . . 0.0 111.195 -176.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.2 t -144.86 119.65 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.3 p -78.14 119.51 21.64 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.824 0.449 . . . . 0.0 111.655 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 60.7 m -92.59 153.87 18.76 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -173.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -132.99 69.07 1.49 Allowed 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 168.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.44 156.53 23.57 Favored Glycine 0 CA--C 1.552 2.347 0 CA-C-O 121.945 0.747 . . . . 0.0 113.441 -169.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.7 p -63.14 -40.67 63.51 Favored Pre-proline 0 CA--C 1.572 1.791 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -68.92 -14.84 39.51 Favored 'Trans proline' 0 CA--C 1.564 2.018 0 CA-C-N 126.428 3.331 . . . . 0.0 118.384 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -55.37 -37.9 68.14 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 171.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 81.8 m -72.86 -14.26 61.46 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.24 -50.58 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-N 121.096 1.771 . . . . 0.0 112.684 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.6 -51.82 63.54 Favored Pre-proline 0 CA--C 1.576 1.95 0 CA-C-O 115.258 -2.306 . . . . 0.0 113.08 174.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.54 -43.34 39.44 Favored 'Trans proline' 0 CA--C 1.563 1.965 0 C-N-CA 123.841 3.028 . . . . 0.0 118.072 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.1 m -60.46 -46.07 91.4 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 170.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.66 -52.51 65.21 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -64.45 -30.46 71.5 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.56 -55.26 14.14 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.984 1.266 . . . . 0.0 113.663 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 148.75 51.66 0.02 OUTLIER Glycine 0 N--CA 1.485 1.96 0 C-N-CA 123.847 0.737 . . . . 0.0 113.534 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -147.29 165.49 29.95 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 122.334 1.064 . . . . 0.0 109.75 -174.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -80.29 -67.78 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.527 -0.733 . . . . 0.0 112.373 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -110.7 165.21 12.01 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.024 0.916 . . . . 0.0 110.862 -169.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.61 97.77 0.28 Allowed Glycine 0 N--CA 1.477 1.407 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -108.88 123.59 49.31 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.7 t -101.43 132.75 46.86 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -170.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 92.6 mmm -84.92 -166.08 1.38 Allowed 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.786 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -63.86 98.17 0.19 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.452 -1.405 . . . . 0.0 112.228 -171.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 55.63 20.11 3.7 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -170.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.31 120.66 11.61 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 121.062 1.755 . . . . 0.0 109.79 -171.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.4 m -68.1 138.68 55.93 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -129.62 110.71 12.03 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 172.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.8 m -81.49 159.59 24.16 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.2 m -113.32 101.46 53.57 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 175.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -57.66 155.4 31.95 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 123.533 2.822 . . . . 0.0 118.51 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.4 tptt . . . . . 0 N--CA 1.486 1.341 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.055 176.992 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.461 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.7 m -94.92 135.66 23.46 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 118.184 -0.912 . . . . 0.0 109.458 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.66 121.96 7.05 Favored 'Trans proline' 0 CA--C 1.557 1.65 0 C-N-CA 122.874 2.383 . . . . 0.0 114.756 -174.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.0 pt -106.98 141.75 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.43 89.07 5.58 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.753 0.787 . . . . 0.0 111.397 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.9 t -144.14 119.05 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.0 p -76.01 119.09 19.48 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.926 0.49 . . . . 0.0 112.115 -176.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 66.5 m -93.21 155.22 17.58 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -174.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -136.04 69.72 1.43 Allowed 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 168.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.48 156.32 25.64 Favored Glycine 0 CA--C 1.552 2.38 0 CA-C-O 121.669 0.594 . . . . 0.0 113.165 -169.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m -65.98 -41.23 44.0 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 115.271 -2.3 . . . . 0.0 115.789 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.68 -21.98 21.29 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 N-CA-C 119.753 2.944 . . . . 0.0 119.753 171.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -59.24 -37.44 77.58 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 74.2 m -73.52 -9.8 59.06 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.36 -55.95 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.904 1.684 . . . . 0.0 112.584 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.49 -50.12 74.79 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 114.935 -2.46 . . . . 0.0 113.507 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.57 -40.28 37.5 Favored 'Trans proline' 0 CA--C 1.564 2.015 0 CA-C-N 125.58 3.028 . . . . 0.0 118.476 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 77.0 m -63.62 -53.73 47.0 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -60.32 -47.11 87.45 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 175.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.65 -41.5 81.57 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 173.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.63 -48.02 73.62 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 171.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.42 54.73 0.09 OUTLIER Glycine 0 CA--C 1.545 1.91 0 C-N-CA 124.472 1.034 . . . . 0.0 112.297 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 46.5 mtt -147.65 163.05 37.84 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.45 1.119 . . . . 0.0 109.013 -171.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -80.35 -72.14 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.428 -0.795 . . . . 0.0 112.638 -169.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.65 166.78 10.64 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.922 0.867 . . . . 0.0 110.42 -171.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.01 91.19 0.2 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.386 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -111.7 123.54 50.45 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 8.7 t -96.28 132.34 41.85 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.3 mmt -88.12 -164.59 1.14 Allowed 'General case' 0 CA--C 1.576 1.965 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.54 169.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -62.85 98.78 0.13 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.595 -1.316 . . . . 0.0 112.602 -170.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? 57.15 15.39 2.44 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -171.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -144.07 124.74 14.11 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 121.154 1.797 . . . . 0.0 109.832 -171.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.5 m -66.33 139.29 58.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -123.17 108.01 12.36 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.7 m -91.31 132.89 35.86 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.868 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.0 m -80.17 115.46 54.67 Favored Pre-proline 0 CA--C 1.57 1.716 0 CA-C-O 117.317 -1.325 . . . . 0.0 107.786 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.67 140.82 33.19 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.682 2.255 . . . . 0.0 115.161 -169.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.0 tptp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.023 178.926 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.395 0 CA-C-O 119.807 -0.441 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.1 m -94.57 122.57 60.6 Favored Pre-proline 0 CA--C 1.571 1.75 0 CA-C-O 117.92 -1.038 . . . . 0.0 108.531 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -80.11 133.06 9.73 Favored 'Trans proline' 0 CA--C 1.556 1.609 0 C-N-CA 122.477 2.118 . . . . 0.0 114.93 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.5 pt -106.28 160.2 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.883 0.849 . . . . 0.0 108.752 169.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -82.1 81.64 7.96 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.909 0.862 . . . . 0.0 111.61 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.7 t -145.17 114.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.3 p -84.28 117.19 23.4 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.933 0.493 . . . . 0.0 110.519 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 59.6 m -94.95 156.69 16.22 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -169.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -98.49 -48.98 4.81 Favored 'General case' 0 CA--C 1.581 2.136 0 CA-C-N 113.575 -1.648 . . . . 0.0 106.937 167.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.93 -152.3 5.6 Favored Glycine 0 CA--C 1.554 2.527 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.8 m -68.05 -42.08 30.03 Favored Pre-proline 0 CA--C 1.576 1.958 0 CA-C-O 115.236 -2.316 . . . . 0.0 115.853 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.87 -32.42 77.48 Favored 'Trans proline' 0 C--N 1.376 1.974 0 N-CA-C 120.682 3.301 . . . . 0.0 120.682 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -62.28 -26.91 68.66 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.662 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 72.1 m -82.2 -25.8 33.92 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 171.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.38 -53.87 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-N 120.534 1.515 . . . . 0.0 112.413 -172.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -65.27 -54.05 35.26 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 114.943 -2.456 . . . . 0.0 113.003 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -47.7 -47.19 19.03 Favored 'Trans proline' 0 CA--C 1.562 1.922 0 C-N-CA 123.922 3.081 . . . . 0.0 118.521 171.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -65.88 -48.74 70.5 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 175.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -59.21 -46.76 87.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -61.97 -37.81 86.15 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.42 -54.64 33.52 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 172.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.97 53.73 0.01 OUTLIER Glycine 0 CA--C 1.545 1.965 0 C-N-CA 123.884 0.754 . . . . 0.0 112.985 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 17.8 mmt -137.28 169.64 17.45 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 122.484 1.135 . . . . 0.0 109.694 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -90.05 -62.37 1.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.457 -0.777 . . . . 0.0 110.783 174.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -118.18 164.25 15.43 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.167 0.984 . . . . 0.0 110.491 -172.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.0 90.15 0.25 Allowed Glycine 0 N--CA 1.478 1.473 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 173.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -97.97 109.08 21.9 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.441 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.2 t -94.48 125.23 38.99 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.238 0.542 . . . . 0.0 111.98 -174.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.2 mmt -83.26 -168.36 2.06 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.992 169.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -61.98 100.53 0.16 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.683 -1.26 . . . . 0.0 112.254 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.3 mtm-85 62.76 10.39 4.2 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 117.149 2.278 . . . . 0.0 117.149 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -145.4 127.1 15.24 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 122.028 2.195 . . . . 0.0 110.82 -173.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.2 m -63.84 145.99 54.79 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -142.36 103.04 4.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.0 m -103.57 149.07 25.25 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -171.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.0 m -96.52 111.91 58.46 Favored Pre-proline 0 CA--C 1.568 1.669 0 CA-C-O 116.792 -1.575 . . . . 0.0 107.876 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -64.97 156.91 59.81 Favored 'Trans proline' 0 CA--C 1.557 1.653 0 C-N-CA 122.978 2.452 . . . . 0.0 117.523 -174.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? . . . . . 0 C--O 1.255 1.36 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.635 179.778 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.29 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.7 t 67.18 93.05 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.032 0 C-N-CA 125.039 1.336 . . . . 0.0 109.937 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -79.13 130.13 9.16 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.703 2.268 . . . . 0.0 114.641 -175.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.0 pt -110.12 143.49 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -80.42 89.12 5.57 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.635 0.731 . . . . 0.0 111.359 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.9 t -144.81 120.09 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.9 p -76.75 119.1 20.08 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.2 m -95.98 154.23 17.35 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -135.74 70.73 1.42 Allowed 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 168.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.71 158.8 27.71 Favored Glycine 0 CA--C 1.552 2.362 0 CA-C-O 121.805 0.669 . . . . 0.0 113.688 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -64.96 -40.51 47.23 Favored Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 115.233 -2.317 . . . . 0.0 115.802 174.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -53.04 -22.61 19.32 Favored 'Trans proline' 0 CA--C 1.564 2.023 0 N-CA-C 119.94 3.016 . . . . 0.0 119.94 171.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -60.94 -38.44 85.86 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.536 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 64.1 m -74.73 -8.48 56.54 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.6 mm -61.03 -55.07 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 121.151 1.796 . . . . 0.0 112.805 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.5 mmmp? -64.73 -49.76 67.79 Favored Pre-proline 0 CA--C 1.573 1.833 0 CA-C-O 114.987 -2.435 . . . . 0.0 113.704 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.76 -40.24 47.65 Favored 'Trans proline' 0 CA--C 1.565 2.06 0 CA-C-N 125.464 2.987 . . . . 0.0 118.318 169.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.4 m -63.57 -52.81 59.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -61.15 -46.42 90.6 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -58.26 -41.38 84.12 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.36 -49.67 68.47 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.52 55.81 0.07 OUTLIER Glycine 0 CA--C 1.544 1.881 0 C-N-CA 124.36 0.981 . . . . 0.0 112.403 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 33.8 mtt -150.6 166.96 28.71 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.401 1.08 . . . . 0.0 108.939 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -84.9 -73.94 0.41 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.126 -0.984 . . . . 0.0 112.459 -171.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.32 160.09 14.84 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.146 0.974 . . . . 0.0 111.071 -169.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.84 89.04 0.37 Allowed Glycine 0 N--CA 1.478 1.499 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.698 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -105.14 118.11 35.72 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.6 t -103.27 130.16 50.44 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 91.6 mmm -85.49 -170.66 3.22 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.002 169.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -62.51 102.73 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.706 -1.246 . . . . 0.0 112.113 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 62.42 7.41 2.33 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -142.34 124.05 15.07 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 122.203 2.274 . . . . 0.0 110.244 -170.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 65.6 m -66.35 143.93 56.86 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -127.18 109.96 12.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -93.2 127.67 38.86 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.326 0.651 . . . . 0.0 110.862 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.6 m -83.37 114.82 55.77 Favored Pre-proline 0 CA--C 1.57 1.743 0 CA-C-O 116.954 -1.498 . . . . 0.0 108.802 -176.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.59 147.12 95.66 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.22 2.613 . . . . 0.0 117.151 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.4 pttp . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 123.16 0.584 . . . . 0.0 111.846 178.433 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.312 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.293 16.4 m 40.76 80.26 0.29 Allowed Pre-proline 0 N--CA 1.502 2.131 0 C-N-CA 125.623 1.569 . . . . 0.0 115.17 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -76.16 126.46 9.24 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.689 2.259 . . . . 0.0 114.335 -172.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -97.25 150.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.6 84.44 7.26 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.838 0.828 . . . . 0.0 111.387 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.3 t -144.51 115.7 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.5 p -82.08 122.86 28.38 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.837 0.455 . . . . 0.0 111.585 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 85.6 m -103.42 156.05 18.04 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 -172.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -103.17 -42.92 5.61 Favored 'General case' 0 CA--C 1.582 2.204 0 CA-C-N 112.98 -1.918 . . . . 0.0 107.378 167.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.58 -162.34 9.8 Favored Glycine 0 CA--C 1.554 2.471 0 C-N-CA 124.567 1.079 . . . . 0.0 111.212 169.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.1 m -66.26 -40.99 39.76 Favored Pre-proline 0 CA--C 1.574 1.903 0 CA-C-O 115.249 -2.31 . . . . 0.0 116.044 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.11 -24.95 35.21 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 N-CA-C 120.471 3.219 . . . . 0.0 120.471 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -58.97 -43.61 91.37 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 37.5 m -76.41 -13.6 60.11 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 117.507 2.41 . . . . 0.0 117.507 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.4 mm -56.53 -58.47 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-N 120.854 1.661 . . . . 0.0 113.328 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -67.53 -51.15 33.51 Favored Pre-proline 0 CA--C 1.572 1.805 0 CA-C-O 114.705 -2.569 . . . . 0.0 113.227 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -47.42 -44.96 23.92 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 CA-C-N 125.764 3.094 . . . . 0.0 118.26 171.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 87.9 m -60.85 -47.78 84.82 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -61.94 -49.8 74.68 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -67.11 -30.39 70.4 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.13 -55.58 13.6 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.258 1.39 . . . . 0.0 113.796 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.61 47.1 0.01 OUTLIER Glycine 0 CA--C 1.546 1.983 0 CA-C-O 119.365 -0.686 . . . . 0.0 114.353 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -142.77 178.3 7.73 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-O 122.564 1.173 . . . . 0.0 109.518 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -93.87 -74.47 0.53 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.095 0.958 . . . . 0.0 110.4 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -99.59 162.06 13.24 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.222 1.011 . . . . 0.0 110.843 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -122.73 97.08 0.57 Allowed Glycine 0 N--CA 1.477 1.422 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 171.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.73 111.34 23.98 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 3.5 t -98.08 127.13 43.85 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -171.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.2 mmt -81.02 -178.0 6.69 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.726 169.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -62.92 101.84 0.3 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.708 -1.245 . . . . 0.0 111.818 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 68.96 0.58 2.82 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 -173.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.62 125.69 27.68 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 122.416 2.371 . . . . 0.0 110.065 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.6 m -68.93 139.28 55.08 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -132.71 106.38 7.74 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 171.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.3 m -74.74 149.44 39.8 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.7 m -109.3 106.17 58.26 Favored Pre-proline 0 CA--C 1.564 1.514 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.1 153.67 37.73 Favored 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 123.473 2.782 . . . . 0.0 116.994 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.451 -177.7 . . . . . . . . 0 0 . 1 stop_ save_